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Abstract 
Intrinsically disordered proteins (IDPs) represent a growing area of scientific interest.  
The prevalence of IDPs within the proteomes of complex organisms and the importance of 
these proteins in cellular functions has become apparent.  The application of 
hydrogen/deuterium exchange mass spectrometry (H/D-MS) to study IDPs is presented in this 
dissertation.  Results that demonstrate improvements to the H/D-MS method are also 
presented.  A thermoelectrically cooled refrigeration system was developed in order to house 
LC components necessary for bottom-up H/D-MS.  This system was used to keep solvent 
temperatures low and stable, ensuring reproducible and minimized back exchange.  Two model 
IDPs, the interacting domains of CREB binding protein (CBP, residues 2059-2117) and activator 
of thyroid and retinoid receptors (ACTR, residues 1018-1088), were analyzed using H/D-MS.  
CBP and ACTR represent two classes of IDPs: the molten globule and random coil, 
respectively.  The mutual synergistic folding phenomenon observed when a complex is formed 
between these two proteins was also analyzed.  A lower limit of several seconds of D2O 
exposure time is imposed when manual pipetting is used to add label and quench buffers to 
protein samples.  A quench flow apparatus was used to extend the lower time scale limit of 
exposure times to 42 milliseconds.  When CBP and ACTR were labeled using the quench flow 
apparatus, analyses revealed subtle exchange protection in specific regions of both proteins.  
An H/D-MS study of the conformational dynamics of β-glucuronidase was also conducted.  The 
destabilization of β-glucuronidase that results from the W492G mutation and the partial 
conformational rescue that results from indole addition were analyzed.  A new method to 
interpret and normalize H/D-MS data was introduced to improve intra- and inter-laboratory 
comparability. 
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Chapter 1: Introduction and Overview 
1.1 Intrinsically Disordered Proteins 
 1.1.1  The Protein Quartet 
 Proteins are a class of biological molecule that many fields of science continue to study 
in order to characterize, understand, and modify major biological functions in the living cell.  
Biology has often looked toward the three-dimensional conformations and structural elements to 
analyze protein functions, from the lock and key model proposed in 1894.1-2  More recently, 
there has been a growing interest in the study of proteins that exhibit regions with high flexibility 
or lack a stable secondary and tertiary structure, but are still able to carry out important 
biological functions.3-14  While other terminology has been used, such as “natively disordered 
proteins,” these proteins will be referred to as intrinsically disordered proteins (IDPs)15 in this 
dissertation. 
Proteins may generally be categorized into a quartet of groups, depending on their 
degree of disorder: ordered, pre-molten globule, molten globule, and random coil.  Ordered 
proteins possess secondary and tertiary structural elements that have formed from the folding of 
the protein.  Structure formation transitions often follow pathways that reduce the overall Gibbs 
free energy, G, of the protein.16 By forming rigid structures and folding around a hydrophobic 
core, these proteins become compact and thermodynamically stable.  This stability limits the 
number and variability of different conformers in the equilibrium ensemble of ordered proteins.16 
The degree of structural disorder in IDPs will differentiate their properties from those of well-
structured, ordered proteins, which allows for a rough categorization of the three types of IDPs.  
The molten globule protein retains secondary structural elements.  This property allows some 
traditional methods of protein structure determination to be applied, such as NMR (see section 
1.2).17-21 The heterogeneous, inter-converting ensemble of conformers present in most molten 
globule protein samples excludes the application of conventional X-ray crystallographic studies, 
however.22 The pre-molten globule state extends the degree of conformational fluctuation within 
2 
a protein, even causing the transient disruption of secondary structure.23-24 This conformational 
disorder extends the protein’s hydrodynamic radius.23-24 This larger capture radius allows IDPs 
an advantage in forming binding interactions with partner molecules.  This advantage may 
counter the slower diffusion of IDPs relative to compact, ordered proteins.25 An IDP may also be 
classified as a random coil, a protein with no stable secondary structure and a large 
hydrodynamic radius.  While a complete random coil may not realistically exist,5, 26 the 
theoretical state of such a protein can provide a baseline for conformational dynamics studies. 
 1.1.2 Prevalence within the Proteome 
 Protein structure characterization methods have been developed mainly to study the 
three-dimensional conformation of ordered proteins (as will be discussed in section 1.2).  Even 
with a wide range of methods available to study proteins, it is obvious that attempting to 
characterize the entire human proteome would be a monumental undertaking.  Identification of 
disordered proteins has often relied on prediction algorithms and the use of genome sequence 
predicted proteome databases (see section 1.2.1).  These algorithms may be applied to entire 
databases, categorizing proteins as either ordered or disordered and also correlating disorder 
frequency with associated cellular processes.14, 27-29  These predictions reveal that the complex, 
multi-cellular organisms of the Eukaryota domain rely on a their proteomes to be relatively more 
disordered than the more simple Archaea and bacteria.12, 27, 30  Indeed, of eukaryotic PDB 
crystal structures surveyed, a predicted 33% of these proteins contain regions of extended 
disorder.27  A similar algorithm, based on consensus between cumulative distribution function 
and charge-hydropathy disorder prediction methods, categorizes 25-30% of eukaryotic proteins 
as disordered.31  The high abundance of IDPs in eukaryotic proteomes highlights their 
importance in the complex cellular processes required of nucleated cells. 
 1.1.3 Linkages to Disease States and Function 
 Proteome correlation studies reveal the wide range of cellular processes that IDPs are 
involved in.  Many nucleus- and chromosome-associated proteins are positively correlated with 
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intrinsic disorder.29  IDPs are well represented in transcriptional regulation, cellular signaling, 
post-translational modifications, and cellular recognition.14, 32-33  A correlation was drawn 
between proteins with predicted disorder within the yeast proteome and gene ontology 
annotations.27 In this study, IDPs are more strongly associated with many nuclear processes 
such as transcription regulation and DNA packaging and cellular signaling processes such as 
morphogenesis and endocytosis.  Another correlation revealed the strong association between 
IDPs and human cancer-associated proteins.34 Other correlations reveal the higher propensity 
for disordered regions to undergo post-translational modification, particularly 
signaling/regulation-vital phosphorylation.8 
 1.1.4  Coupled Binding and Folding 
 While IDPs gain an advantage of higher hydrodynamic radius for protein-binding partner 
interactions, the specific mechanisms for recognition and binding remain nebulous.  IDPs 
primarily undergo a coupled binding and folding process upon interacting with a target binding 
partner.13, 19, 21, 35-39 Folding may also be induced by changes in the chemical environment, such 
as the addition of heat or protein stabilizers.40 One popular theory for explaining IDP binding is 
the “fly-casting” mechanism.13 A minor portion of an IDP will initiate binding to a structured 
binding partner and a conformational transition to a more ordered, stable structure will follow.  
The faster on- and off-rate for protein-partner binding and lower binding free-energy barriers (i.e. 
high specificity / low affinity)41 also result from greater flexibility found in IDP conformation.25  
IDP flexibility also facilitates binding to multiple target partners.35  IDPs can adopt different 
conformations depending on the binding partner.10, 42 Differentiating these conformational 
transitions is an ongoing challenge.  Validating analytical techniques to study conformational 
properties and transitions will be a primary focus of this dissertation.  
 1.1.5  Two Model IDPS: CBP and ACTR 
Two model IDPs are studied extensively in chapters 3 and 4 of this dissertation.  These 
IDPs are the nuclear coactivator binding domain (NCBD) of mouse cAMP-responsive element 
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(CRE)-binding (CREB) binding protein (residues 2059-2117, henceforth abbreviated “CBP”) and 
a binding domain of human p160 coactivator, activator for thyroid hormone and retinoid 
receptors (residues 1018-1088, henceforth abbreviated “ACTR”).  The free proteins and the 
complex have been studied extensively by NMR, CD spectroscopy, and small angle X-ray 
scattering analyses.19-21, 43 CBP and ACTR are both intrinsically disordered in their free states, 
but they form a structured complex when bound to each other.  The complex formed between 
CBP and ACTR was the first reported observation of the synergistic folding process between 
interacting IDPs.19, 44 Chapter 3 of this dissertation includes a review of these proteins and their 
properties.  With a wealth of biophysical data available, these proteins and their complex serve 
as model systems to validate the application of hydrogen/deuterium exchange mass 
spectrometry (H/D-MS) to studying conformational dynamics of IDPs. 
1.2 Methods for Characterizing Protein Structure 
 1.2.1  Disorder Prediction 
Amino acid composition contributes to the propensity of proteins to be intrinsically 
disordered.  IDPs tend to be enriched in more polar, disorder inducing amino acid residues and 
depleted in non-polar, hydrophobic core forming residues.  Computerized algorithms predict 
disordered regions in proteins prior to an experimental characterization.  One of the first 
developed algorithms was the Predictor Of Natural Disordered Regions (PONDR).4, 45   PONDR 
was developed based on two training databases.  One training set was of ordered proteins and 
another was of disordered proteins.4, 46 A PONDR algorithm assigns a score to each residue in 
a protein based its identity and neighboring residues.  IDPs have a greater abundance of A, R, 
G, Q, S, P, E, and K residues and a depletion in W, C, F, I , Y, V, L and N residues relative to 
ordered protein.4, 46  This pattern indicates a general enrichment of charged and polar residues 
and a depletion of hydrophobic residues.  PONDR scores, assigned on a residue by residue 
basis, give the propensity for a particular amino acid to be disordered.  A PONDR score above 
0.5 indicates disorder, while a score below 0.5 indicates order.  Further iterations of PONDR 
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have been developed and adapted with expanded database information and improved 
computational techniques.47  The PONDR-VL-XT algorithm disorder predictions for ACTR and 
CBP are shown in figures 1.1 and 1.2, respectively.4, 48-49  These predictions indicate that most 
of ACTR will be disordered but CBP will be ordered along the C-terminal half of the protein.  
This correlates with the experimental evidence that indicates ACTR is a near random coil but 
CBP is a molten globule.  However, when compared with specific NMR results,19 the predictions 
do not always agree with residue specific locations of ordered and disordered regions along the 
sequence.  Also, since these predictions are based on protein sequence, they cannot predict 
folding or unfolding that results from binding or solvent conditions.  These shortcomings 
illustrate the need for experimental methods to study IDP conformations and interactions. 
 1.2.2  X-ray Crystallography 
 In an X-ray crystallography experiment, three dimensional protein structure can be 
determined by measuring the position of electron densities in a protein crystal.50-51  This 
technique is limited, however, if certain residues exhibit multiple or low intensity electron 
densities characteristic of flexible regions.51  The absence of X-ray diffraction can indicate 
disorder within a region of the protein.  IDPs will have high conformational flexibility in their 
native state and crystals will be difficult to produce.  Those crystals that may be produced from 
IDPs may not represent the native structure ensemble.52 
 1.2.3  Circular Dichroism 
 Far-UV circular dichroism (CD) is a useful technique for determining secondary structure 
content in a protein.  By measuring the interaction of circularly polarized light (λ ~250 to 180 nm) 
with optically active peptide bonds, specific secondary structure content is observed as features 
along the CD spectrum.7, 53-57  A characteristic spectrum for α-helical protein shows negative 
bands at 222 and 208 nm, with a positive band at 193 nm.  Protein β-sheet content is indicated 
by a negative band at 218 nm and a positive band at 195 nm.  An extensively disordered protein 
or random coil will also have a characteristic far-UV CD spectrum, with low ellipticity above 210 
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nm and negative bands around 195 nm.  The relative quantities of these secondary structure 
elements within a protein can also be determined using CD.  Near-UV CD (λ ~340 to 250 nm) 
may also reveal tertiary structure characteristics by measuring spectral features of aromatic side 
chains.58  An additional benefit of using CD is the ability to monitor structural property changes 
from protein denaturation.  Denaturation can be induced with pH change,58 chemical 
denaturants,59 or temperature.60  CD is an important tool in determining protein structure 
content.  However, localized information cannot be obtained from CD.  With this limitation, CD 
best serves as a complementary technique in the study of localized disorder regions in IDPs. 
 1.2.4  NMR 
 Nuclear Magnetic Resonance (NMR) is one of the most useful techniques for localizing 
conformation and dynamics properties in structured proteins in solution.  NMR works by 
measuring the local magnetic field properties of atomic nuclei that possess a spin, such as 1H, 
13C, and 15N.7, 61 When a magnetic field excites these nuclei, NMR can measure the relaxation 
resonance frequency and assign the local chemical environment of resonating nuclei within a 
molecule.7, 61 This property of NMR allows for single amino acid residue resolution conformation 
assignments.  The ability to differentiate 2H and 1H nuclei makes NMR particularly useful in 
hydrogen/deuterium exchange experiments, as well.52, 62  NMR allows the solution-phase study 
of some proteins that cannot be crystallized.62-63  NMR has been successfully applied to study 
residual structure in denatured proteins.64-65 However, there are several disadvantages to using 
NMR to study IDPs.  NMR resonance signals tend to be highly overlapped with limited shift 
dispersion for disordered regions.62 This may flood out important signals originating from 
structured regions of the protein.  IDPs are also more prone to aggregation, complicating NMR 
experiments which require protein stability and high concentration samples.62 Studying relatively 
large proteins using NMR is also challenging.  While methods can be adapted to study large 
proteins with NMR,66-67 processes requiring routine analysis of large proteins will still face this 
limitation.68-69 
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1.3 Mass Spectrometry-Based Approaches to Study IDPs 
 1.3.1  Advantages of MS for IDPs 
Mass spectrometry (MS) methods have been used to study IDP conformation.70-73  
Solution-phase analyses, such as with electrospray ionization (ESI) (see section 1.6.1),74  are 
particularly advantageous for protein studies.  Such analyses allow proteins to be prepared in 
physiological buffer prior to analysis, an advantage shared with NMR and CD.  Alternative 
methods such as crystallography may require non-native conditions.  MS also allows multi-
protein systems to be analyzed, provided an efficient separation method is available.  Such 
systems may be more difficult to analyze with NMR if the target protein is present at a very low 
relative concentration.  Multi-protein systems cannot be analyzed using CD, as CD signals arise 
from all proteins in the solution, providing only an average signal for the entire ensemble of 
proteins and their conformational states.   
 An advantage of applying MS to characterize proteins is the capability and ease in which 
one may analyze large proteins, such as monoclonal antibodies.75-78  While relevant to large 
IDPs, this advantage extends to large proteins in general.  Another advantage of using MS 
techniques is the ability to detect small amounts of protein or peptide.  Sub-femtomole MS and 
picomole tandem MS have been reported as early as 1991.79 This, again, is important to the 
study of IDPs, as samples may require preparation at low concentrations to avoid precipitation 
or aggregation.  This dissertation focuses on applications of MS to analyze IDPs.  Several MS-
based techniques to study protein conformation are discussed in the next three sections. 
 1.3.2  Approaches for Gas-Phase Analysis 
The ESI process, when paired with mass analysis, may also be utilized to serve as an 
indicator of order or disorder itself.  This technique is known as native ESI, as it is used to 
preserve proteins’ native conformations in the gas phase.  Certain considerations must be made 
when designing a native ESI method to best preserve the native conformation through 
ionization. The ESI solvent should be prepared to provide physiological conditions for an analyte 
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protein while still being compatible to the desolvation and ionization processes.  Solvent 
properties to consider include pH and solvent volatility.80  Non-volatile buffer salts can lead to a 
buildup of desolvated salts in the ESI source.  Native ESI techniques are aided by the use of 
volatile buffer salts, such as ammonium acetate.80  More compact/structured proteins will 
generally produce ions with less charge than unfolded/denatured proteins, leading to 
characteristic charge state distribution profiles.60, 81  The mass spectra can indicate how 
folded/unfolded proteins are.  Using native ESI, it is also possible to transfer weakly-associated 
protein complexes into the gas phase during ionization to study complex dissociation, structure, 
or dynamics.81  The abilities to preserve complexes in the gas phase and to analyze folded and 
disordered proteins have allowed native ESI to be applied to analyzing binding and folding 
processes in IDPs.82  ESI-MS has also been used to identify individual conformations within an 
IDP ensemble.40, 71, 83 
Ion mobility MS (IM-MS) is a specific method of the native ESI technique that also allows 
gas phase protein analysis.  In IM-MS, ion packets are separated based on a combination of 
cross-sectional area and mass-to-charge ratio (m/z), in a chamber with an applied an electric 
field.81  Ion travel is hampered by the presence of an inert gas, with collisions between the 
analyte ions and inert gas adding the factor of ion mobility to the electrophoretic separation.80-81  
IM-MS can separate folded conformers from partially unfolded ones because of differences in 
charge and cross-section between them.  Because solution-phase structural characteristics can 
be partially preserved in IM-MS, this manner of separation allows conformation changes, protein 
unfolding, and protein binding to be analyzed, even for very large proteins (i.e. in the MDa 
range).81 Native ESI and IM-MS are limited in their applications to studying intact proteins or 
large subunits that can present a wide distribution of charge states, which will prevent 
localization of folding/unfolding without complementary experiments.  The actual preservation of 
solution-phase, native conformations for proteins as they enter the gas phase is still somewhat 
controversial.  Highly charged ions formed during the electrospray process have a higher 
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likelihood of forming extended conformations due to electrostatic repulsion.83 While a folded 
protein may form ions with fewer charges, this problem may be exaggerated in IDPs, which are 
more likely to be natively extended to begin with.  When IDPs become highly charged during 
ESI, any residual structuring they might have could be disrupted and undetected. 
 1.3.3  Solution-Based Labeling 
 Covalent labeling can reveal important dynamic events, if the label is applied on the time 
scale related to these events.  A covalently bound label may provide a unique mass increase 
that may be measured and quantified by mass spectrometry.  The purpose of covalent labeling 
methods is to provide information about protein conformation and dynamics.  Covalent labeling 
can link the kinetics of label uptake to the structure of the protein, with more flexible regions 
and/or amino acid residues typically exhibiting faster incorporation rates. 
 One such labeling technique is the chemical modification of carboxyl-groups in proteins 
using a 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) or glycine ethyl ester (GEE).84  
The reaction of carboxyl groups with these chemicals selectively labels  glutamate and 
aspartate residues.84  A similar technique chemically labels exposed arginine residues using p-
hydroxyphenylglyoxal (HPG).85-86  Chemical cross-linking has also been useful in determining 
specific binding locations and affinities in proteins.81, 87  By binding proteins with targeted ligands 
or binding partners and analyzing complexes by MS, localized information regarding binding 
affinities and protein interface properties can be obtained.87  The integration of large labels onto 
a protein may disrupt the protein structure.  The slow labeling time scales can also allow more 
time for such disruptions to occur. 
 Another technique to covalently label protein side chains is fast photochemical oxidation 
of proteins (FPOP).88-89 One particular example is hydroxyl radical footprinting.  This method 
pairs a rapid generation of hydroxyl radicals in solution from hydrogen peroxide using a pulsed 
KrF laser shot (λ ~248 nm) with a dissolved hydroxyl scavenger.88-89  The concentration of 
hydroxyl radical falls by several orders of magnitude in under 1 µs in the presence of excess 
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glutamine, a hydroxyl scavenger.88  The short lifetime of hydroxyl radical limits the oxidation to 
surface exposed side chains.  The depletion rate of the hydroxyl radical is faster than most 
protein unfolding events, so the structure disturbing result of the oxidation itself is not 
measured.90  However, any secondary labeling pulses would capture structural damage caused 
by the sterically bulky label.  The label can be quantified with mass spectrometry, as the 
hydroxyl label itself increases the mass of the protein primarily in increments of +16 Da.  Amino 
acids will have different reaction rates with hydroxyl radicals.  Many amino acids that are 
enriched in IDPs relative to ordered proteins, including A, G, Q, S, and E, react more slowly with 
hydroxyl radicals relative to other amino acids.4, 46, 91  Amino acids predicted to be depleted in 
ordered proteins, including W, F, C, and I, generally possess faster hydroxyl radical reaction 
rate constants.46, 91  The hydroxyl radical footprinting method might not be ideal for IDPs given a 
rapid labeling pulse and generally slower amino acid reaction rates. 
The FPOP technique has also been adapted to use other radicals to covalently label 
proteins, such as sulfate anion and iodine radicals.92-93 Because of the microsecond labeling 
times provided by FPOP, other analytical techniques may be more suited to monitor dynamic 
events that occur on the millisecond or slower time scale, such as the transient, localized 
unfolding of protein regions.94  One goal in designing a method to label protein in a manner that 
can be detected by MS should be to make the label itself small and similar in its chemical 
properties to what it modifies or replaces on the protein molecule.  It is this goal that has made 
the hydrogen/deuterium exchange technique appealing in protein conformation studies. 
  1.3.4  H/D Exchange 
 Ideally, covalent label integration can be both initiated and halted with a great deal of 
control and avoid potentially structure-disrupting factors such as a high energy photochemical 
pulse, heating, or a sterically bulky label.  A growing number of researchers are turning to the 
method of amide hydrogen/deuterium (H/D) exchange to study conformational dynamics and 
properties of complex membrane proteins, protein pharmaceuticals, intrinsically disordered 
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proteins, and proteins simply not amenable to other methods.30, 94-95  Hydrogen atoms bonded to 
oxygen, nitrogen, or sulfur in a protein molecule are labile.  By immersing a protein in a high 
D2O content solution, deuterium on-exchange will progress as these labile hydrogens are 
replaced with deuterons on the protein molecule.94  Aliphatic hydrogens do not exchange in H/D 
exchange experiments.  The rate of H/D exchange will depend on the hydrogen environment, 
specifically the hydrogen’s involvement in conformation-stabilizing hydrogen bonding, the 
fluctuation rate of such bonds, and neighboring amino acid residues.94, 96-97  Deuterium 
exchange by most side-chains (histidine being one exception) and N/C-terminal hydrogens will 
be rapid.  These deuterium labels will rapidly back exchange for protons during the exchange 
quenching and chromatography steps in a typical H/D experiment (see sections 1.4.3 and 
1.4.4).  Amide hydrogen exchange will occur more frequently on a time scale that can be 
conveniently measured in a laboratory.  The substitution of deuterium for hydrogen is much less 
likely to cause any conformational perturbations than the addition of a sterically large, polar 
label such as a hydroxyl group.  The research presented in the following chapters of this 
dissertation utilizes H/D exchange to study proteins. Thus, a more in depth overview of H/D 
exchange mechanisms and methods are presented in sections 1.4 and 1.5. 
1.4 Overview of Hydrogen/Deuterium Exchange 
 1.4.1  Linderstrøm-Lang Scheme and Intrinsic Exchange 
The method of H/D exchange for amide hydrogen was first described by Hvidt and 
Linderstrøm-Lang in 1954.98  The mechanism of H/D exchange, usually described by the 
Linderstrøm-Lang model developed in 1966, is shown in equation 1:94, 99-100 
 
(1) 
Each amide hydrogen is in dynamic equilibrium between a “closed” (exchange incompetent) 
state and an “open” (exchange competent) state.  The transition between these two states may 
rely on local fluctuations, slight molecular “breathing” motions, or more global unfolding events.  
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The opening rate, kop, will determine the frequency at which a residue will enter the exchange 
competent state before reforming the closed conformation, with the closing rate, kcl.  These 
dynamic events result in the temporary breaking of H-bonds, which exposes the amide 
hydrogens to exchange with hydrogen or deuterium from the solvent at a rate defined by the 
intrinsic rate of exchange, kint.101-102  An alternative theory includes the degree of solvent 
penetration and exposure among factors affecting H/D exchange.  The use of excess D2O 
ensures that the exchange goes only toward the right. 
The intrinsic rate constant is defined by how quickly an amino acid residue from a 
random coil will exchange.  The residue-specific kint value depends primarily on the identity of 
the amino acid residue, its neighboring residues, pH, and temperature.96, 103  Figure 1.3 
illustrates the relationship of pH and temperature to forward exchange kint for a mid-sequence 
alanine residue.  The forward exchange process (i.e. H→D) itself is both acid and base 
catalyzed.  Acid catalysis is dominant below about pH 3.5 and base catalysis is dominant above 
pH 3.5 (see figure 1.3).94  In the base-catalysis dominated pH region above about pH 5, the rate 
of exchange increases by one order of magnitude for each pH unit increase.  In the acid-
catalysis dominated pH region below pH 2, the rate of exchange increases by one order of 
magnitude for each pH unit decrease.  A pH-independent water catalysis is more significant 
around the pH minimum.96  The forward exchange may be slowed with colder temperatures, as 
well.   
When an amide enters an exchange competent, open state and H/D exchange occurs 
before the conformation closes, the amide becomes labeled.  The observed rate of H/D 
exchange for each residue, kex, is defined in equation 2:104 
 
(2) 
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The approximation shown in equation 3 can be made if the amide is assumed to be mostly in 
the closed state, i.e. kop << kcl:104 
 
(3) 
The approximation of kop << kcl almost always applies, but IDPs will have very fast kop. Chapter 
3 discusses how exchange approximations are adjusted for IDPs.  The kinetics of exchange can 
fall under two main regimes, EX1 and EX2, depending on the conditions of exchange.  Under 
EX1 conditions, the structure closing step proceeds slower than the rate of exchange, kcl < kint, 
so exchange is limited by kop:105   
 (4) 
In other words, observed exchange with EX1 conditions will reveal the kinetics of an unfolding 
event, as unfolded protein will immediately exchange.  The ratio of unlabeled to labeled protein 
will lessen as exchange progresses.  Characteristic EX1 exchange mass spectra will show a 
simultaneous disappearance of the unlabeled isotopic envelope and growth of the labeled 
isotopic envelope as a function of labeling time.104  Under EX2 conditions, kcl >> kint and 
exchange proceeds as described in equation 5:105 
 
(5) 
Exchange under EX2 conditions may take multiple opening and closing events before exchange 
actually occurs per exchange site.  Measured kinetics of exchange under EX2 conditions can 
provide information about the thermodynamic stability, ΔGuo’, of a protein.104   
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Characteristic EX2 exchange mass spectra will show an increasing mass shift in the isotopic 
envelope as a function of labeling time.104 
1.4.2  Sample Preparation and Labeling 
 H/D exchange is a useful technique that has been developed for its capabilities in 
capturing protein conformation and conformational dynamics information.74, 104, 106-107 There are 
two types of H/D labeling: pulsed and continuous.  In pulsed labeling H/D exchange, a short 
D2O labeling pulse is applied after measured time intervals.  The progression of conformational 
transitions can then be analyzed at each time interval.  For example, a denatured protein can be 
introduced to a solution environment that will promote folding over time.  The length of the D2O 
pulse is kept constant.  Information about protein intermediate states is what is captured by the 
pulse.94  SUPREX (stability of unpurified proteins from rates of H/D exchange) represents 
another pulsed labeling technique. In SUPREX, the pulse label is applied to a series of samples 
that contain increasing amounts of denaturant, such as urea or guanidinium chloride 
(GdmCl).108  Using SUPREX, the conformational stability of proteins in the presence and 
absence of ligands can be measured.108  Another pulsed labeling technique is PLIMSTEX 
(protein-ligand interaction by mass spectrometry, titration, and H/D exchange).  In a typical 
PLIMSTEX procedure, a D2O pulse is applied to samples with varied ligand concentrations.108  
The duration of the pulse may be chosen from a continuous labeling experiment, wherein the 
difference between bound and unbound protein deuterium uptake is at a maximum.108  In a 
typical continuous labeling H/D exchange experiment, deuterium exchange kinetics of a protein 
or peptide are measured as a function of D2O exposure time.  Proteins or peptides that exhibit 
slow exchange will require longer exposure times to reach a deuteration maximum.  Exchange 
is slowed as a function of the stability of intramolecular amide hydrogen bonds and the 
subsequently slower transient bond disruption rates.101  Faster exchanging regions will reach 
deuteration maxima relatively quickly.  Such rapid exchange is indicative of highly flexible or 
unstructured regions. 
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 1.4.3  Quenching 
 Following a set amount of time of D2O exposure, a quenching step is used to halt the 
forward exchange reaction.  This quenching step typically includes a decrease in pH to about 
2.5 and a decrease of the solution temperature.  Figure 1.3 illustrates the effects of reduced 
temperature and pH on the intrinsic exchange rate constant.  The quenching step slows intrinsic 
exchange kinetics by several orders of magnitude and reduces back exchange.96, 103  Typical 
labeling conditions and quenched conditions are indicated by black circles in figure 1.3.  The 
curved arrow represents the several order of magnitude slowing of kint in the quenching step.  
The specific kinetic parameters of the back exchange process (i.e. D→H) differ slightly from 
those of the forward exchange process.  These differences result from D2O having a different 
autoprotolysis constant than H2O as well as a difference in the strengths of N-H and N-D 
bonds.96  A consequence is the slight adjustment to the pH of minimum exchange.  The 
exchange minimum saddle region is formed by the combined effects of acid-catalysis, base-
catalysis, and water-catalysis on exchange.  While acidic conditions may denature protein 
conformation, exchange kinetics are slowed so drastically that deuterium labels are well 
preserved. 
 1.4.4  Factors Affecting Loss of Deuterium Label 
 The final deuterium uptake measurement obtained by mass spectrometry will depend 
not only on the forward exchange, but also on the additional effects of back exchange.109  The 
quenching step and subsequent chromatography steps add H2O based solutions to the H/D 
reaction mixture.  The added H2O introduces new equilibrium conditions that result in a loss of 
deuterium label from the protein or peptides.  This label loss is known as back exchange.109-110  
The effects of chromatography temperature, column type, and gradient duration all play critical 
roles in the controlling of back exchange.110-111  In studies of proteins under native conditions, 
deuterated buffers are often prepared to approximate physiological pH and ionic strength.  The 
specific conditions under which different laboratories conduct H/D labeling are highly variable,112 
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including differences in labeling temperature,113 pH,96, 103 buffer compositions,96 deuterium-to-
sample ratios, and solution additives such as denaturants.114  While the purpose of such 
experiments may be to study the effects these conditions have on protein conformation, it is 
also important to consider the loss in inter-laboratory comparability due to these conditions’ 
effects on the intrinsic rate of exchange.96, 103  The different experimental conditions and 
equipment used in different laboratories will lead to variation in the magnitude of back exchange 
measured between laboratories.   
1.4.5  Steps to Reduce Back Exchange  
One continuing goal in H/D exchange experiments is the reduction of back exchange 
effects.115  This is often accomplished with the use of refrigeration or ice baths, which help 
reduce temperature during chromatography. A reduction in pH, both of the quenched sample 
and of mobile phase, also slows back exchange.110, 112, 115 Acid additives in the mobile phase aid 
in the electrospray ionization process (see section 1.6.1) as well as in the slowing of back-
exchange.  The type of acid used also plays an important role in deuterium recovery as well as 
signal intensity.  In an H/D exchange study of bovine carbonic anhydrase, formic acid provided 
better deuterium recovery and electrospray ionization signal intensity than acetic acid.112 In the 
works presented in this dissertation, 0.1% formic acid was used as the mobile phase additive in 
most chromatography methods.  The volatility of formic acid gives it an advantage over 
hydrochloric acid, as HCl may facilitate salt buildup in the electrospray source.  Formic acid is 
also safer to handle and easier to dispose of than trifluoroacetic acid (TFA), another common 
acid additive in electrospray experiments.  TFA also causes ion suppression effects in 
electrospray ionization, but may improve chromatographic peak shapes.116 
1.4.6  Back Exchange Controls 
Specific control samples can be utilized to assess an amount of back exchange in H/D-
MS methods.  A common method of performing this assessment involves simply labeling protein 
or test peptides with D2O for a much longer time than typical H/D experiment samples.112  Long 
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labeling times may also be paired with a denaturant and/or higher temperatures.117-119  The 
difference between the average mass of a fully deuterated control and the average mass of an 
undeuterated control, ΔmTD, provides a maximum experimental mass increase.  Deuterium 
recovery, %Drec, can then be defined as the percent quotient of this maximum mass increase 
divided by the maximum number of exchangeable amide hydrogens, Dmax (see section 1.5.2 for 
how Dmax is determined): 
 
(7) 
Mean deuterium recovery of around 80%, a value achieved using a refrigerated HPLC 
system as explained in chapter 2, should be considered excellent for bottom up H/D-MS.  Using 
residue specific properties, some researchers may use theoretical calculations to model back 
exchange.119-120  
1.5 H/D Exchange Mass Spectrometry (H/D-MS) 
 1.5.1  Top-down H/D-MS 
 H/D exchange mass spectrometry (H/D-MS) represents the combination of an easily 
applied deuterium label and mass spectrometry instrumentation in order to capture and analyze 
conformational properties of proteins.  As more researchers adopt H/D-MS methods in protein 
dynamics studies, the method continues to gain optimizations, modifications, and 
improvements.  One common goal is the improvement of sequence spatial resolution to obtain 
amino acid residue specific uptake kinetics information. 
A gas phase fragmentation method to cleave an initially intact protein in a mass 
spectrometer is referred to as a “top-down” approach.94  MS/MS techniques such as electron 
transfer dissociation (ETD) or electron capture dissociation (ECD) are examples of top down 
approaches.  The use of collision induced dissociation (CID) in H/D-MS experiments will likely 
exhibit intramolecular hydrogen and deuterium migrations.  These migrations result in a 
randomization of deuterium label locations known as scrambling.121  Scrambling effects are 
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greatly reduced in optimized ECD and ETD experiments.122-123  Some top-down H/D-MS 
methods offer the advantage of bypassing chromatography altogether and using direct infusion 
into the ionization source to avoid back exchange effects.124  Experiments using such top-down 
techniques have even demonstrated spatial resolution as small as one or two residues,123-124 
though sensitivity limitations may exclude such methods from the study of IDPs.  Large proteins 
and multi-protein systems would also be problematic for top-down MS studies, as the number 
and size of ion fragments will increase.  This complicates the ability of MS/MS to isolate 
precursor ions for further fragmentation, as each analyzed ion requires a narrow m/z filter and 
additional time for fragmentation and analysis.  Narrow m/z precursor isolation also exacerbates 
potential hydrogen scrambling effects.123 
1.5.2  Bottom-up H/D-MS 
Many H/D-MS methods include a proteolytic digestion step prior to analysis, which 
allows information to be localized on a peptide resolved basis.  When digesting or chemically 
cleaving the protein prior to its introduction to the MS, this approach is referred to as a “bottom-
up” analysis.94  Acid-tolerant proteases, such as pepsin and protease type XIII, are required for 
back exchange minimization because of quench conditions.125  Improvements to the peptide 
digestion and chromatographic separation of peptides can lead to better analysis of large 
proteins.77, 106  Though peptide resolution may be improved through the use of long gradients, 
the more time a peptide spends in aqueous mobile phase, the greater its amount of back 
exchange.  This issue of poor resolution in fast gradient separations led to the implementation of 
ultra performance liquid chromatography (UPLC).126  In UPLC techniques, small particle size 
coupled with high pressure improves resolution and reduces gradient times.  Other studies have 
demonstrated a benefit to deuterium recovery through the use of immobilized protease columns 
for peptide digestions over using solution-phase digests.106  While some techniques use 
solution-phase digests to prepare quenched H/D samples, an immobilized protease column 
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allows rapid, on-line digestion of samples into peptide fragments prior to a chromatographic 
separation.106 
 Throughout bottom-up H/D-MS experiments, the number of exchangeable amide 
hydrogens, Dmax, is limited because the first residue does not have a peptide bond and the 
second residue undergoes rapid back exchange.96, 103 This limitation is accounted for in each 
chapter of this dissertation, with peptide protection maps in chapters 3 and 4 showing the first 
two residues grayed out.  This property also limits H/D-MS analysis to peptides of three amino 
acids in length or more.  Also excluded from contributing to exchangeable amide hydrogen 
counts are proline residues as proline lacks an amide hydrogen.  Determining the maximum 
number of exchangeable hydrogens is important in discerning if any data is nonsensical (i.e. 
having significantly greater exchange than the maximum) and providing a theoretical maximum 
if totally deuterated controls were not used or not detected.  This dissertation outlines the 
application of bottom-up H/D-MS to study IDPs.  Improvements or optimizations made to the 
bottom-up H/D-MS technique as a whole, including considerations in proteolysis, HPLC, and 
data analysis, are also discussed. 
1.6 Mass Spectrometry Instrumentation 
 1.6.1  Electrospray Ionization 
Electrospray ionization (ESI) is often applied in H/D-MS, as ESI allows soft ionization of 
liquid-phase samples.127  ESI can be used to interface HPLC to a mass spectrometer, with 
eluent being simultaneously evaporated and ionized.  To summarize the process for positive 
mode ESI briefly;127 a strong electric field is generated by holding an introduction capillary tip at 
a high potential relative to the counter-electrode walls of the source chamber.  This electric field 
causes dispersion of eluent into a mist of charged droplets.  A heated drying gas will assist in 
evaporating the solvent from droplets, causing droplet shrinkage.  Nitrogen is often used as an 
economical drying gas.  As the droplets become smaller, repulsive forces between charged 
particles (i.e. protons in the initially acidic sample) at the surface of the droplet overcome the 
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surface tension.  This causes the droplets to undergo fission to form smaller droplets.  
Eventually, solvent evaporation will lead to biomolecules, such as proteins or peptides, gaining 
a positive charge as they enter the gas phase.  The specific mechanism of desolvation and 
charge acquisition by biomolecules is still under debate.128-130  Following desolvation, the 
positively charges ions must be carried to a detector.  Ions are guided through a series of 
filtering stages, such as transfer capillaries, skimmer cones, and multipoles, where vacuum 
pumps reduce the pressure at various stages.  Many parameters regarding electric field 
strength in the ESI source are controllable.  This is beneficial in studying large proteins, as the 
multiple charging of single molecules produces mass-to-charge ratio (m/z) that can be detected 
by mass analyzers with limited detection ranges.127 
 1.6.2  Time-of-Flight Mass Spectrometer 
The choice of mass spectrometer in H/D-MS will vary from one laboratory to another.  
The MS experiments presented in this dissertation were all performed using an Agilent 
Technologies Accurate Mass 6220 TOF LC/MS.  This instrument is an orthogonal time-of-flight 
mass spectrometer (TOF-MS).131 Filtered ions generated by the ESI source are guided into an 
ion pulser.  The ion pulser applies a high voltage pulse to accelerate the ions orthogonally into a 
flight tube.  The pulse gives all ions the same amount of kinetic energy to travel through the 
flight tube.  The flight tube contains an ion mirror, which directs the ions onto a detector.131  The 
amount of time it takes an ion to reach the detector will be determined by its mass-to-charge 
ratio, m/z.127  In a simple linear flight tube, the velocity, υ, of an ion is inversely related to the m/z 
of the ion and the applied ion acceleration potential, V:127 
 
(8) 
Thus, the time, t, required for an ion to travel the length, L, of the flight tube to reach a detector 
is given by equation 9:127 
2zV
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(9) 
Thus, a detector that is able to measure the flight time of ion packets can be used to draw an 
m/z spectrum.  Time-of-flight MS instruments exhibit high sensitivity, allowing small amounts of 
proteins or peptides to be more readily detected in H/D-MS.127  High mass accuracy and m/z 
peak resolution provided by using TOF-MS are also important in peptide sequence 
assignments.127 
 1.6.3  CID / MSE and Peptide Fragmentation 
Another capability of some MS instrument is nozzle-skimmer dissociation (NSD), a 
variant of collision-induced dissociation (CID).  This technique allows the formation of peptide 
ion fragments without the need for an MS/MS instrument, however the single MS 
instrumentation used does not provide any selectivity in choosing precursor or product ions as a 
typical tandem MS experiment could.132  (A similar technique in which a collision cell is present 
but precursor isolation is not used is also possible.133) Despite this limitation, this technique is 
useful if peptides are initially resolved chromatographically; a chromatogram may be rebuilt in 
which product ions are matched with precursors.  This is necessary to assign sequences to 
peptides that would otherwise have ambiguous assignments with single MS analysis.  While 
tandem MS techniques are more commonly used in sequence assignments, an NSD technique 
may provide an expedient alternative.  This technique will fail if peptides are not 
chromatographically resolved efficiently enough.  While single MS spectra may resolve co-
eluting peptides from each other, the spectral features for product ions resulting from the 
simultaneous fragmentation of multiple peptides may be too highly overlapped for proper 
resolution.  This technique may also produce insufficient signal intensity, as fragmentation is 
likely to greatly reduce peak intensity of product ions relative to the precursor ion.  The 
application of such an NSD technique is described in chapter 3 of this work, wherein ion 
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fragmentor voltage was rapidly cycled to produce three simultaneous ion chromatograms.  Low 
voltage scans measured unfragmented peptide m/z values while high voltage scans revealed 
b/y ion fragments, allowing specific peptide identities to be assigned. 
1.7 Data Analysis 
 1.7.1  Mass Spectra Workflow 
 This section will briefly describe a general procedure for extracting deuterium uptake 
data from raw mass spectral data.  The first step is to build a peptide database using the 
spectra obtained from undeuterated control samples.  MS software is used to find peptide 
features within the total ion chromatogram (TIC, figure 1.4A) and isolate each feature’s specific 
monoisotopic m/z values in order to build a set of extracted ion chromatograms (EIC, figure 
1.4B) and the integrated mass spectra (figure 1.4C).  Peptide mass is determined by multiplying 
the monoisotopic m/z value and the charge, z, then subtracting the mass of the charge carriers.  
The value of z is indicated by the peptide’s isotopic peak spacing.  When a protein sequence 
and predicted proteolysis cleavages are entered, the software can assign peptide identities to 
each matching EIC based on each peptide’s predicted mass.  This process is known as peptide 
mapping.  After ambiguous assignments are clarified (such as with NSD, as described in section 
1.6.3), a peptide database can be made that contains information such as retention time, 
sequence numbering, sequence composition, formula, and predicted mass.  The software 
identifies mass spectral features of peptides based on the expected distribution of isotopes 
within a peptide population, which is dominated by 13C distribution.  When a peptide is 
deuterated, the isotopic distribution becomes representative of the number of integrated 
deuterium isotopes, 2H, as well.  Figure 1.4D shows the isotopic distribution for a peptide’s 
undeuterated mass spectrum (top) and deuterated mass spectrum (bottom).  Because of the 
atypical distribution of m/z values for deuterated peptides, the peptide database is expanded to 
account for deuteron substitutions.  Because the monoisotopic m/z peak of a deuterated peptide 
can be both difficult to determine and of very low relative intensity compared to other m/z peaks, 
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average m/z is used instead of monoisotopic m/z.  The average m/z of a peptide is defined as 
the center of mass of the isotopic distribution.  The deuterated peptide database provides the 
MS software with specific m/z values and retention times to search for in the deuterated sample 
TIC.  The software then extracts spectra of deuterated peptides and converts average m/z 
values to average mass values.  The difference between average deuterated mass, mdeut, and 
the average mass of undeuterated control, mUD, represents the mass increase, Δm: 
 (10) 
 Mass increase is displayed by plotting Δm versus D2O exposure time for a particular 
peptide or protein (figure 1.4E).  Δm is used instead of counting deuterons, #D, to avoid any 
discrepancy between the integer counting of deuterons and actual mass increase.  An addition 
of a deuteron results in a mass increase slightly higher than 1 Da.  Back-exchange effects will 
also obscure any counting of individual deuterons.  Figure 1.4E shows deuterium uptake curves 
from a protein with and without a mutation.  H/D exchange for multiple protein conditions can be 
compared on a single graph.  The mutation causes faster H/D exchange in this peptide.  Thus, 
the mutation condition causes the region to lose conformational stability when compared to wild-
type, WT.  In this dissertation, some differential conditions explored include mutant versus wild-
type, presence of a small molecule to restore function of a mutant, and unbound versus bound.  
Other examples include exploring the effects of denaturants,134 chromatography pH or 
temperature change,112 post-translational modifications,135 buffer condition changes,134 and 
more.   
 1.7.2  Quantitative Analysis in H/D-MS 
One of the goals of this dissertation, and in the field of H/D-MS methodology in general, 
is to improve quantitation and comparability of H/D exchange data.  Comparisons in H/D 
exchange data analysis are most often subjective, such as the qualitative comparison made in 
section 1.7.1.  With deuterium uptake curves plotted in a graphical format, such as in figure 
deut UDm m m∆ = −
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1.4E, curve fitting functions may be calculated using software such as SigmaPlot (Systat 
Software Inc., San Jose, CA).  Rate constants derived from curve fitting allow quantitative 
comparisons between uptake curves, as discussed in chapters 3 and 4.  Other comparison 
methods are discussed in chapter 5.  One of the more common methods for comparing 
deuterium exchange in NMR is the use of protection factors, PF.101-102, 118  Protection factors are 
calculated as the ratio between the intrinsic H/D exchange rate constant,96 kint, and the 
experimentally measured rate constant, kex: 
 
(11) 
Describing deuterium uptake behavior in terms of protection factors manner is ubiquitous in 
NMR experiments,101-102 but still excluded from MS methods without single-residue resolution.  
Protection factors supply information about the rates of opening and closing of structural 
conformations in the Linderstrøm-Lang model,98 presented in equation 1.  These opening and 
closing events limit amide hydrogen exposure to H/D exchange, as described by equations 2-5. 
Protection factor determination, however, provides little information about the identity of 
structured elements, by itself.  A specific type of structural feature, such as α-helices, can exhibit 
wide ranges of PF.  These PF ranges will often overlap between the different features, as well.  
A specific α-helix may share a similar PF value as a β-sheet elsewhere.  Recent work has made 
progress toward relating exchange protection factors to structural elements with residue-specific 
resolution.101 The theory that H-bonding properties limits H/D exchange was supported by an 
NMR analysis of mutated Staphylococcal nuclease.  The type of H-bond acceptor affects how 
protected an amide hydrogen will be from exchange, with incorporated water, side chain, and 
backbone carbonyl H-bond acceptors causing protection factors of almost 108.  However, 
protection factor ranges (such as between 102 and 108 for backbone bonded amide hydrogen) 
int
ex
kPF
k
=
25 
are still too broad to distinguish one structural element type from another, as both α-helical and 
β-sheet incorporated amide hydrogens exhibit such ranges in protection.101 
1.8 Motivation of Dissertation 
 As it becomes more apparent that IDPs fulfill vital roles in cells, there is a necessity to 
adapt current methods and develop new ones to study conformational dynamics of IDPs.  The 
purpose of this dissertation research is to demonstrate the application of the H/D-MS method 
toward better understanding the conformational behavior of IDPs.  This research was also 
conducted to elucidate synergistic folding effects in a pair of model IDPs.  In the course of 
conducting this research, improvements to H/D-MS methods were also made.  The following 
chapters discuss gains not only from a purely scientific standpoint, but also the practical benefits 
this research offers as H/D-MS becomes more important in applications requiring routine 
analyses. 
 Many researchers use bulky and messy ice/water baths or high pressure columns to 
prevent back exchange and maintain cold temperatures in H/D experiments.  The construction 
of a thermoelectrically refrigerated system for HPLC components is discussed in chapter 2.  The 
inexpensive refrigerated system was constructed to ensure that solvent, enclosure, and column 
oven temperatures could be controlled to within ±0.1 °C.  Such tight temperature control allows 
back exchange to be both minimal and highly reproducible.  Proteolytic digestion efficiency was 
also improved.  The refrigerated system is a solution for online digestion and reverse-phase 
separation in a bottom-up H/D-MS method. 
 The synergistic folding in IDP interactions is explored in chapter 3.  CBP and ACTR 
represent two classifications of IDPs in their native, unbound states: the molten globule and 
random coil, respectively.  Together, they form a stable complex that resists H/D exchange.  
CBP and ACTR were chosen as model systems for the development of H/D-MS to study IDPs.  
The H/D-MS analysis of CBP and ACTR are compared with NMR structural analyses of these 
proteins in order to validate the usefulness of H/D-MS to study multiple states of IDPs.  This 
26 
comparison reveals that unbound CBP exchanges rapidly, despite evidence of a stable 
structure revealed by NMR.  Expression, purification, assay, and preservation procedures are 
also included to explain how to separate and store IDPs that share similar properties.  IDPs 
such as these may require special handling and preparation procedures, as they may be prone 
to aggregation or post-translational modification. 
 As shown in chapter 3, H/D exchange for IDPs, such as ACTR, proceeded too quickly 
for accurate analysis.  That is, many unbound ACTR peptides exhibited full deuteration near or 
before the minimum D2O exposure time of 5 seconds.  To extend the scope of H/D-MS 
measurements introduced in chapter 3, chapter 4 introduces a quench flow apparatus for H/D 
exchange.  By extending the time scale from the lower limits imposed by pipetting (~5 seconds) 
to 42 milliseconds, more complete deuterium uptake curves can be measured.  This provides 
more accurate kinetic parameters for deuterium uptake.  The quench flow apparatus can be re-
assembled using inexpensive, off-the-shelf parts.  This chapter discusses the correlation of 
subtle exchange protection in specific regions of CBP and ACTR to residual structure measured 
by NMR. 
 The applications of H/D-MS are many, as is the range of instrumentation available to 
conduct such experiments.  However, there has yet to be established a standard method by 
which H/D exchange information from a differential condition study (illustrated by figure 1.4E) 
may be compared.  Typically, data is presented on a peptide level basis, without accounting for 
peptide length, relative position along an amino acid sequence, or fractional deuterium uptake.  
Chapter 5 proposes an averaging of overlapping deuterium uptake to better resolve amino acid 
residue specific information.  The extensions discussed in chapter 5 include a normalization of 
deuterium uptake to quantify exchange as fractional. 
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Figure 1.1. The PONDR-VL-XT disorder prediction for ACTR domain sequence. 
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Figure 1.2. The PONDR-VL-XT disorder prediction for CBP domain sequence. 
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Figure 1.3. This graph shows the calculated96, 103 forward exchange intrinsic rate constant for 
the 4th residue in a (Ala)7 peptide chain as a function of pH at two different temperatures. 
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Figure 1.4. Example mass spectra workflow.  A) Initial TIC measuring total ion intensity over 
time.  B) EICs show intensity of specific m/z values.  This EIC shows the intensity of the 609.63 
m/z peak and reveals that this peptide elutes at about 10.1 minutes.  C) Mass spectra integrated 
from the peak revealed by an EIC.  Here, the high intensity 609.63 m/z peak can be seen in the 
mass spectrum extracted from a window around 10.1 minutes.  D) Clipped mass spectra 
showing the distribution of m/z values for an undeuterated and deuterated peptide.  The 
average mass of the undeuterated peptide is 1826.98 Da.  The average mass of the deuterated 
peptide is 1830.46 Da.  The measured mass increase is 3.48 Da.  E) Deuterium uptake curves 
showing average mass increase at each D2O exposure time point for a peptide from both the 
mutant protein and WT protein. 
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Chapter 2: An Efficient and Inexpensive Refrigerated LC System for H/D-MS 
2.1 Introduction 
Hydrogen/deuterium exchange mass spectrometry (H/D-MS) has become widespread in 
studying protein conformation and dynamics in solution.1-4  In a typical experiment, a protein is 
exposed to a large excess of deuterium oxide (D2O) so that amide hydrogens will exchange with 
solvent deuterium.  The rate of deuterium uptake is limited by hydrogen-bonding and secondary 
structure; measurement of the rate provides information regarding structural fluctuations within a 
protein.2, 5-6 H/D exchange is carried out for set periods of time so that the progression of 
deuterium uptake can be measured over time. The H/D exchange reaction is then quenched by 
mixing samples with acid to decrease the pH to ~2.5, followed by rapid cooling of the samples.  
Deuterium uptake information may also be localized using digestion of deuterated proteins with 
acid-tolerant proteases followed by HPLC separation.7-8  Retention of the deuterium label is 
pivotal to the success and usefulness of H/D-MS studies. Unfortunately, once the reaction has 
been quenched, the deuterium label slowly back-exchanges with solvent hydrogen.8  Immediate 
and stable cooling is necessary to slow the rate of back-exchange during a short LC run. 
A typical approach is to immerse all LC components in an ice/water8-10 or temperature-
controlled water bath.11  Baths are inexpensive and offer efficient cooling of LC components.  
However, troubleshooting leaks is nearly impossible and water can damage submerged 
components.  Baths also pose the risk of spills or leaks into the LC/MS.  Hence, iceless cooling 
systems for refrigerated HPLC have been developed for H/D-MS.12-14  In our lab, conventional 
refrigerators had unacceptable variation in temperature, typically at 4±2 oC, and long re-
equilibration when solvent reservoirs were refilled.  Furthermore, even with forced-air 
convection, cooling is inefficient since heat must be transferred from the mobile phase to the LC 
components and then dissipated into the air.  A system featuring direct mobile phase cooling 
using thermoelectrically-cooled mobile phase heat exchangers could only reach 4 oC and 
suffered from long gradient delays.14  A thermal chamber to cool the HPLC components to 1.25 
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oC has been reported, but little detail was provided.12  A UHPLC system, designed specifically 
for the Waters nanoAcquity, has also been reported but requires specialized LC pumps and 
bulky water chillers for heat dissipation.13  
Here, we detail the performance of a compact “all-in-one” refrigerated unit.  The system 
features an internal protease column oven to enhance digestion efficiency.  The unit is 
constructed from off-the-shelf components, requires minimal specialized assembly, and has a 
small footprint.  A novel single valve design simplifies sample injection and HPLC separation 
procedures.  We also provide an empirical demonstration of cooling efficiency, chromatographic 
performance, and deuterium recovery. 
2.2 Experimental 
2.2.1 Reagents 
 Optima LC/MS grade acetonitrile and water were obtained from Fisher Scientific 
(Hanover Park, IL).  99+% formic acid in 1 mL ampules was obtained from Thermo Scientific 
(West Palm Beach, FL).  Deuterium oxide (99.9% D) and myoglobin from horse skeletal muscle 
were obtained from Sigma (St. Louis, MO). 
2.2.2 Columns and Traps 
The 50 × 2.1 mm immobilized protease column was prepared in-house, as previously 
described,15-16 using pepsin from porcine gastric mucosa (Sigma, St. Louis, MO), and POROS 
20 AL column packing material (Applied Biosystems, Carlsbad, CA).  A 10 × 1.0 mm C12 trap, 
packed in-house with Jupiter 4u Proteo 90 Å stationary phase from Phenomenex (Torrance, 
CA), was used for peptide trapping.  Myoglobin digests were separated on a 50 × 1.0 mm 
Ascentis Express Peptide ES-C18 column with 2.7 μm superficially porous particles (Supelco 
Analytical, Bellefonte, PA). 
2.2.3 Construction of the Refrigerated System 
For the housing, we used a prefabricated moisture-tight steel box with a hinged lid (35 cm × 30 
cm × 20 cm, National Electrical Manufacturers Association standard 13).  The housing is 
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insulated with hand-cut panels made from 2.5 cm-thick high density closed-cell PVC foam 
insulation (R value of 5).  The side and bottom panels were press-fitted into place while the top 
panel is removable.  In some parts of the housing, the insulation was thinned to ~ 1 cm to 
accommodate fittings.  Liquids feed through the walls through 1/16 inch stainless steel bulkhead 
unions with 0.25 mm bore (VICI-Valco, Houston, TX).  The unions are sealed to the outer face 
of the housing with pressure-sealing washers.  Gaskets to seal the openings for the 
thermoelectric coolers and the switch valve standoff were hand-cut from 1/16 inch thick Buna-N 
rubber.  Except where noted, all basic construction materials were obtained from McMaster-Carr 
(Elmhurst, IL).  To prevent condensation and frost accumulation, the housing is briefly purged 
with dry air before cooling is started. 
 The enclosure air is cooled by a thermoelectric air conditioner (76 W capacity, 
MAA260T-24, MELCOR, Trenton, NJ) (see figure 2.1).  The enclosure air temperature is 
measured using a 15 kΩ thermistor (TS136-76, McShane, Medina, OH) placed at the point 
where air flow enters the air conditioner heat exchanger.  The mobile phase cooler consists of 
two 1.6 µL chromatographic heat exchangers (G1316-80003, Agilent, Santa Clara, CA) 
mounted to a thermoelectric cold plate (36 W capacity, CP-036, TE Technology, Traverse City, 
MI) (see figure 2.1).  Heat transfer between the cold plate and heat exchangers is mediated by a 
thin layer of zinc oxide thermal paste (TP-1, TE Technology, Traverse City, MI) applied to the 
heat exchangers.  The cold plate temperature is measured using a 15 kΩ thermistor (MP-2996, 
TE Technology, Traverse City, MI).  The thermoelectric coolers are powered by two 300 W DC 
programmable power supplies (RKW 24-14K for the air conditioner and RKW 12-27K for the 
cold plate, Kepko, Flushing, NY).  The power supply voltages are controlled by separate 
proportional-integral-derivative (PID) temperature controllers operating in cool-only proportional 
output mode (TC-48-20, TE Technology, Traverse City, MI).  An integrated assembly 
comprising the temperature controllers, power supplies, and system power was constructed in-
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house.  The controller features switches that allow the thermoelectric cooler fans to be run 
independently from the thermoelectric elements. 
The protease column oven consists of a 3 inch long × 0.563 inch ID ceramic tube (99.5% 
high purity alumina, Sentro Tech Corp., Berea, OH) with nichrome wire (28 gage, 60% nickel / 
16% chromium, Omega Engineering, Inc., Stamford, CT) coiled around the outer surface and 
affixed with epoxy.  The column oven is insulated with two PVC foam insulation blocks.  The 
column oven  is powered by a 1000 mA / 12 VDC output plug-in voltage transformer (McMaster-
Carr, Elmhurst, NJ) regulated by a CSi32 Series RTD-input PID bench-top controller (Omega 
Engineering, Inc., Stamford, CT).  The bench-top controller measures the temperature of the 
protease column oven via a PT100 class “B” 4-wire RTD surface sensor (Omega) placed 
between the protease column and inner wall of the ceramic tube. While placing the oven outside 
the enclosure would decrease the heat load, the long runs of tubing required would introduce 
undesirable system volume.  
2.2.4 Chromatographic System 
 The chromatographic system consists of a capillary binary gradient pump with high 
pressure mixing (G1376A, Agilent, Santa Clara, CA), used for elution flow, and an isocratic 
pump (G1310A, Agilent, Santa Clara, CA), used for the digestion flow (see figure 2.2).  All 
mobile phases were degassed by an in-line vacuum degasser (G1379B, Agilent, Santa Clara, 
CA).  All tubing that comes into contact with sample is 1/16 inch outer diameter PEEK-clad 
fused silica capillary with inner diameters ranging from 75 µm to 150 µm (SGE, Austin, TX).  
Upstream solvent delivery lines are 1/16 inch outer diameter PEEK. 
 The switch valve is a two-position 12 port valve with 0.25 mm ports (D6C12CW-RAD, 
VICI-Valco, Houston, TX).  The valve is attached to a right angle drive gearbox and mounted to 
a 15 cm stand-off assembly.  Switching of the valve is actuated by a microelectric actuator and 
controller (EP, VICI-Valco, Houston, TX).  The actuator is mounted to the outside of the 
enclosure (see figure 2.3).  The valve is actuated by software-controlled contact closure outputs 
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sent to the valve controller by a BCD interface board (G1351-68701, Agilent, Santa Clara, CA) 
installed in the isocratic pump (see figure 2.2).  A manual push-button is used to trigger the 
LC/MS run start after manual sample loading.  The push-button start and valve control buttons 
are incorporated into a simple one-piece assembly constructed in-house.  
2.2.5 Temperature Measurements 
 Fluid temperature measurements were measured with an insulated ultra fine type T 
thermocouple (PY2 72-7567, Harvard Apparatus, Holliston, MA)  The air temperature sensor 
was a glass braid insulated type K thermocouple with a bare junction (SC-TT-K, Omega 
Engineering, Stamford, CT).  Temperatures were recorded at 1 sec intervals using a logging 
dual-channel temperature meter with a wireless computer interface (HH806W, Omega 
Engineering, Stamford, CT) and computed as ten second averages.   
 Our mobile phase temperature measurements were restricted to pure water to prevent 
damage to the thermocouple.  While there are differences in the thermal properties of water and 
acetonitrile, a simple thermal analysis17 shows that these differences are negligible.  Mobile 
phase heat exchange in our system can be approximated as a fluid undergoing laminar flow 
through a tube with an isothermal surface.  Under these conditions, heat transfer out of the fluid 
is dominated by heat transfer from the fluid to the tube wall.  The fluid temperature at the exit 
(Te) of a heat exchanger with a wall surface temperature of Ts is calculated by equation 1. 
( ) NTUe s s iT T T T e−= − −  (1) 
Here, Ti is the inlet temperature and NTU is the number of transfer units, a dimensionless 
measure of heat transfer.  The number of transfer units is calculated by equation 2. 
3.66NTU
P
Lk
V C
•
π
=
ρ
 (2) 
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Here, L is the length of the tubing, k is the thermal conductivity of the fluid, V
•
 is the volume flow 
rate, ρ is the bulk density of the fluid, and CP is the specific heat capacity of the fluid.  The factor 
of 3.66 arises under the condition of laminar flow in a cylindrical tube.  Examination of equation 
1 shows that the exit temperature asymptotically reaches the surface temperature above ~5 
NTUs.  Although water has a higher thermal conductivity than acetonitrile (k = 0.606 W m−1 K−1 
for H2O vs. k = 0.188 W m−1 K−1 for CH3CN at 25 °C), the product of specific heat and density is 
also considerably higher (ρCP =  4.2 J cm−3 K−1 for H2O at 25 °C vs. ρCP = 1.8 J cm−3 K−1 for 
CH3CN at 20 °C).18  Hence, in the asymptotic limit of NTU > 5, the differences in the thermal 
properties are negligible.  On this basis, our temperature measurements, based only on water 
can be extrapolated to organic solvents. 
Fluid temperature was measured by diverting flow through a short piece of PEEK tubing 
at various points.  An insulated thermocouple was fed into the open end of the PEEK tubing.  
Water from this deliberate leak was collected in a beaker.  Air temperature was measured with a 
bare junction thermocouple.  Both thermocouples were calibrated against melting ice using a 
single-point offset correction. 
2.2.6 LC/MS Measurements 
 Injected peptide samples were passed through the pepsin column and loaded onto the 
C12 trap by 0.1% formic acid in water at 0.2 mL min-1 for 2.5 minutes to desalt and focus 
samples.  Solvent A was 0.1% formic acid in water, and solvent B was 90% acetonitrile / 10% 
water / 0.1% formic acid.  The peptides were separated on the ES-C18 column using a 15% to 
70% B gradient in 5 minutes at 50 μL min-1.  The optimized gradient omitted a few outlying 
peptides that were not retained on the column or that failed to elute until the column washing 
step.  The refrigerated enclosure temperature was maintained at 0 oC and the protease column 
was unheated.  Eluted peptides were ionized by electrospray and analyzed by a time of flight 
mass spectrometer (Agilent model 6220) operating in positive ion mode.  Nitrogen drying gas 
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was heated to 275 oC at a flow rate of 10 L min-1, with a nebulizer pressure of 30 psig.  
Fragmentor, skimmer, and capillary voltages were set to 150 V, 50 V, and 4000 V, respectively.  
In measuring deuterium recovery, the cold protease column was used in the system to keep 
flow path volumes and conditions constant, despite the fact that deuterated myoglobin was 
pepsin-digested prior to injection. 
2.2.7 H/D Exchange 
To ensure complete deuteration, peptic peptides were prepared by digesting myoglobin 
with pepsin before labeling.19  5 µL aliquots of myoglobin peptides or angiotensin I were 
deuterated with 95 µL of deuteration buffer (10 mM phosphate, 50 mM sodium chloride 
dissolved, pD 6.9).  Exchange was quenched after at least 89 minutes with 100 μL of ice-cold 
200 mM sodium phosphate (pH 2.6).  To maximize reproducibility, quenched samples were 
loaded into the 100 μL sample loop (figure 2.3) 60 seconds after quench followed by sample 
injection after an additional 30 seconds.  19-fold dilution with D2O gives a maximum possible 
deuteration of 95%.  Our deuteration values were normalized as a percentage of this maximum.  
Fully deuterated angiotensin I was prepared as described above except it was not digested with 
pepsin. 
2.2.8 Data Processing 
Undeuterated samples of myoglobin peptic peptides were analyzed first, and identified 
peptides were matched to the sequence of myoglobin using MassHunter Qualitative Analysis 
software with BioConfirm (version B.03.01, Agilent Technologies, Santa Clara, CA).  Only non-
ambiguous peptides identified with a mass tolerance of ±20 ppm were used in this study.  The 
raw spectra of deuterated peptides were analyzed with HX-Express software20 to find the 
average mass of each peptide.  The difference between the average deuterated mass and the 
theoretical undeuterated mass was used as the measurement of deuterium uptake.  The 
maximum number of exchangeable amide hydrogens was calculated by taking the number of 
amino acid residues in a peptide, subtracting two for the rapid back-exchange of the first two 
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residues, and subtracting the number of proline residues (since proline lacks an amide 
hydrogen). 
2.3 Results and Discussion 
 2.3.1 Description of the Refrigerated System 
 Back-exchange is minimized when LC conditions are maintained at the lowest possible 
temperature.  To meet this need, we constructed a thermoelectrically cooled (i.e., Peltier effect) 
compartment with precise mobile phase and independent protease column temperature controls 
(see figure 2.1).  The enclosure is cooled using an air-to-air thermoelectric cooler module.  
Mobile phases are cooled by heat exchangers (2 µL internal volume) mounted to a 
thermoelectric cold plate assembly.  Heat is dissipated to the surroundings by forced air 
convection, eliminating the need for secondary heat transfer to a circulating chiller.13  Since 
proteolysis can be more efficient at elevated temperatures,13 we incorporated an insulated, low 
power oven (< 5W) so that the protease column can be warmed up to 20 °C above the 
enclosure temperature.  Temperatures are regulated by independent PID (proportional integral 
derivative) temperature controllers (see figure 2.1).  One innovative feature of our system is 
immediate cooling of peptides back to 0 °C at the outlet of the protease column oven (see figure 
2.3).  The efficiency of the heat exchangers increases with increasing flow rate (see figure 2.4 
and table 2.1).  By setting the heat exchangers to –4 °C, the mobile phase cools to at least 0 °C 
at all flow rates.  The unit was fabricated almost entirely from off-the-shelf assemblies.  The total 
cost of materials was less than US$5,000.  Assembly required only simple machining of metal 
parts and hand cutting of foam insulation.   The chromatographic system consists of two 
pumps and online digestion using an immobilized protease column,16 but we use a single twelve 
port valve to handle the entire analysis (see figure 2.3).  Simple contact closures programmed in 
the gradient time-table trigger valve actuation (see figure 2.2).  The loop is manually loaded with 
the valve in the elute position (figure 2.3, lower panel).  When triggered by an external push-
button controller, the valve switches to the digest and trap position (figure 2.3, middle panel).  
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The digestion flow (0.1% formic acid) carries the sample through the loop and protease column.  
The resultant peptides are trapped, concentrated, and desalted on a reversed-phase peptide 
trap.  (Our system is readily converted to analysis of intact proteins by replacing the protease 
column with a union.)  When the valve is switched back to the elute position, a water/acetonitrile 
gradient elutes the peptides from the trap and separates them on a reversed-phase column.  
Simultaneously, the protease column is flushed to waste.  By forming the gradient outside the 
housing, our refrigerated system is readily interfaced with any gradient HPLC system without re-
plumbing.  In particular, our capillary HPLC pump includes a mixer, pulse damper, proportioning 
valve, and flow sensor that remain under ambient conditions.  Although our system is not 
compatible with 600 bar pressures, simple upgrades would enable UHPLC operation.  
2.3.2 Dependence of the Cooling Efficiency on Flow Rate 
To determine the efficiency of the Peltier-cooled mobile phase heat exchangers, we first 
measured the temperature of water immediately downstream of the heat exchanger.  In our 
initial experiments, we set the enclosure air temperature to 0 °C and the heat exchanger cold 
plate to −4 °C.  We measured the temperature of water exiting the heat exchanger as a function 
of flow rate (see figure 2.4).  As the flow rate was increased, the fluid temperature 
asymptotically approached the −4 °C temperature of the cold plate, showing that heat exchange 
becomes more efficient as the flow rate increases.  The cold plate set point temperature that 
was required to reach 0 °C at various flow rates is listed in table 2.1.  While we use the 50 µL 
min−1 flow rate for the gradient separation of the peptides, we use a flow rate of 200 µL min−1 for 
the digestion flow (see figure 2.3).  Significant under-cooling of the heat exchanger cold plate 
was required to reach ~0 °C at the 50 µL min−1 flow rate (see figure 2.4).  Setting the cold plate 
to –4 °C caused water, flowing at 200 µL min−1, to supercool to −1.8 °C.  Supercooling of water 
in small volumes in the absence of ice-nucleating surfaces is a very well-known phenomenon 
with a body of literature that dates back almost two hundred years.21 As a recent example, NMR 
spectra of proteins in liquid water at –15 °C were acquired from samples in 1.0 mm diameter 
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glass capillaries.22  Given the narrow dimensions of our tubing (< 200 µm) and the short 
residence time of the fluid in the heat exchanger, it is not at all surprising that we observed 
limited supercooling.  Since our flow path should be in thermal equilibrium with the air inside the 
chamber, held at 0 °C, we expected that water would not remain supercooled once it had 
passed through the tubing and valve downstream from the heat exchanger.  Indeed, when we 
measured the temperature of water flowing at 200 µL min–1 as it exited port #8 (see figure 2.3), 
we found that the water temperature had increased to 0.1 °C.  We have used this system 
routinely for over one year and have never encountered any blockages or clogging due to the 
instantaneous nucleation of supercooled water. 
 2.3.3 Temperature Stability 
 We measured air temperature in the enclosure and the mobile phase temperature 
(water, 200 µL min–1) over a period of nine hours from a room temperature start.  The system 
reached a stable operating temperature of ~0 °C in less than one hour (see figure 2.5).  With the 
protease column oven set to 15 °C, the enclosure air temperature was stable at 0.5±0.1 °C.  
(With the protease column oven turned off, the enclosure temperature was –0.1±0.1 °C.)  We 
evaluated the stability of the fluid temperature under several different scenarios.  Water exiting 
the heat-exchanger positioned at the outlet of an unheated protease column (see figure 2.3) 
was –2.2±0.1 °C (see figure 2.5, Heater Off).  With the protease column oven heated to 15 °C, 
the protease column effluent remained near 13.0 °C (figure 2.5, Protease Out), demonstrating 
both its stability and efficiency.  Heating the protease column increases digestion efficiency, but 
would accelerate back-exchange.  A heat exchanger located immediately downstream from the 
protease column cools the effluent back to –2.2±0.1 °C (figure 2.5, Exchanger Out).  The rapid, 
but small fluctuations are on the order of the precision limit of our temperature meters.  Under 
quench conditions (pH 2.5), these fluctuations would result in approximately a 1% decrease in 
the half-life of amide D/H back-exchange,23-24 hence this degree of temperature stability is 
suitable for carrying out H/D-MS. 
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 2.3.4 Chromatographic Performance 
We assessed chromatographic performance under refrigerated conditions using an 
optimized water/acetonitrile gradient and a column with superficially porous C18 particles.  For 
complex digests, chromatographic resolution is critical for minimizing MS overlap and ion 
suppression.  For the myoglobin digest, peak widths at half maximum ranged from 3.6 to 7.5 
seconds, with a median of 4.4 seconds (see table 2.2 and figure 2.6).  For comparison, the 
median peak width obtained using UHPLC for the room temperature separation of a 
phosphorylase B digest was 2.7 seconds.13  Hence the chromatographic performance remains 
commendable.  In addition, since our system does not operate at the high system pressures 
required in UHPLC, we minimize the potential of extra back-exchange caused by frictional 
heating in the column.25 
 2.3.5 Deuterium Recovery 
 For fully deuterated myoglobin peptides, the deuterium recovery ranged from 63.2% to 
97.7% with a mean of 80.2% (table 2.2 and figure 2.7).  Back-exchange calculations (at pH 2.5, 
0 °C)23-24 show that the wide range of deuterium recoveries is not surprising.  For example, for 
peptide 110-134, which has a calculated half-life of 46 minutes, we measured 63.2% deuterium 
recovery, while for peptide 8-13, which has a half-life of 128 minutes, we measured 97.7% 
deuterium recovery.  Heating the protease column from 0 °C to 15 °C resulted in a slight 
decrease in deuterium recovery, from 71.7% to 70.5%, with fully deuterated angiotensin I (see 
table 2.2). 
 Our deuterium recovery results are at least as good as recovery obtained using other 
systems.  An average of 70.0% recovery for cytochrome c peptides was obtained with a UHPLC 
system.13  With an ultrafast elution gradient 78% recovery for the test peptide LHRH was 
obtained.26  Recovery using an HPLC system in a 0 °C water bath was measured using 
angiotensin I that had been labeled for over one month11 appears to be  ~84% (~5.9 Da 
increase), but when we account for slow H/D exchange at the C2 carbons of the imidazole rings 
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of two histidine residues,27 the amide deuterium recovery was ~56%.  Hence, our recovery of 
71.7% for this same peptide, labeled for only 1-2 hours, was considerably higher.  In addition to 
excellent recovery, our system demonstrated outstanding reproducibility, with a mean relative 
standard deviation of ±0.91% for measured deuterium uptake in myoglobin peptides (table 2.2).  
For the ultrafast elution gradient of test peptide LHRH, 0.71% error was reported in deuterium 
uptake measurements.26  While these results may not be directly comparable because of 
differences between methods, deuterium recovery using our refrigerated system and a typical 
gradient is more than satisfactory for H/D-MS analyses. 
2.4 Conclusions 
We have constructed an inexpensive refrigerated system and evaluated its performance 
for H/D-MS.  The temperatures of the mobile phases were directly measured to validate the 
effectiveness of cooling, something that has not been previously reported.  Small volume heat 
exchangers efficiently cooled the mobile phases, allowing gradients to be formed at room 
temperature.  This efficiency eliminates the need for large dwell volume for cooling that can 
delay or broaden gradients, a significant advantage when many samples need to be run in 
succession.  Efficient and stable cooling of the system resulted in excellent deuterium recovery 
and reproducibility.  Use of a superficially porous reversed-phase column gave excellent 
chromatographic results with short gradients under quenched conditions (pH 2.5, 0 °C) without 
the need for ultra-high pressures.  Finally, our refrigerated LC system can be readily interfaced 
with any LC/MS system since only simple contact closures are required to drive valve actuation.   
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Figures and Tables 
Table 2.1.  Heat exchanger set points required to reach 0 °C mobile phase at different flow 
rates. 
flow rate (µL min−1) heat exchanger set point (°C) fluid temperature (°C) 
50 −4.0 −0.1 
100 −2.0 −0.1 
200 −0.8 −0.1 
The enclosure set point was 0 °C for these measurements. 
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Table 2.2.  Deuterium recovery for deuterated peptides. 
 
1Peptides with residue numbers are from myoglobin. 
2Mean value of 3 replicates ± standard deviation. 
3Deuterated mass – undeuterated mass. 
4Relative standard deviation (%) calculated as standard deviation of the average deuterated 
mass divided by mass increase. 
5For a peptide with a free N-terminus, the number of exchangeable amides = number of 
residues – number of prolines not in the first two residues – 2. 
6Chromatographic peak full width at half-maximum, mean value of 3 replicates ± standard 
deviation. 
7-8Angiotensin I with 0 °C7 and 15 °C8 protease column. 
  
Peptide1 Sequence 
Average 
deuterated mass 
Theoretical 
undeuterat
ed mass 
Mass 
Increase Precision Exchangeable Deuteration 
Peak 
width6 
    (Da)2 (Da) (Da)3 RSD (%)4 amide H5 (%) (s) 
1-7 GLSDGEW 766.82 ± 0.05 762.76 4.06 1.2 5 85.4 3.56 ± 0.03 
8-13 QQVLNV 703.51 ± 0.02 699.80 3.71 0.66 4 97.7 3.76 ± 0.03 
8-29 QQVLNVWGKVEADIAGHGQEVL 2407.27 ± 0.16 2390.65 16.62 0.93 20 87.5 5.78 ± 0.25 
14-29 WGKVEADIAGHGQEVL 1719.69 ± 0.10 1708.87 10.82 0.94 14 81.3 4.38 ± 0.06 
56-69 KASEDLKKHGTVVL 1533.16 ± 0.10 1524.76 8.40 1.2 12 73.7 7.48 ± 0.54 
84-96 AELKPLAQSHATK 1400.95 ± 0.08 1393.59 7.36 1.0 10 77.5 4.44 ± 0.16 
110-134 AIIHVLHSKHPGDFGADAQGAMTKA 2586.11 ± 0.12 2572.90 13.21 0.88 22 63.2 4.18 ± 0.28 
125-139 ADAQGAMTKALELFR 1631.09 ± 0.07 1621.86 9.23 0.77 13 74.7 6.12 ± 0.31 
137-153 LFRNDIAAKYKELGFQG 1981.75 ± 0.08 1970.23 11.52 0.67 15 80.9 4.56 ± 0.12 
Mean     0.91  80.2  
Angiotensin I7 DRVYIHPFHL 1301.24 ± 0.02 1296.48 4.76 0.34 7 71.7  
Angiotensin I8 DRVYIHPFHL 1301.16 ± 0.02 1296.48 4.69 0.44 7 70.5  
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Figure 2.1. The mobile phase temperature, enclosure air temperature, and protease column 
oven temperature are independently controlled by three different thermoelectric coolers with 
independent temperature sensors.  Further details are provided in the Experimental section. 
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Figure 2.2.  The entire refrigerated system is interfaced to the LC/MS (enclosed in the dashed 
line) using a single input and two outputs, as shown in this schematic diagram of the valve 
control and instrument interface.  A single manual input signal triggers the start of the LC/MS 
run.  The two position switching valve is interfaced to the LC/MS system via two contact 
closures. (The CAN connectors are part of the Agilent inter-module communication network.) 
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Figure 2.3. Liquid handling in the refrigerated system.  The top panel is a photograph of the 
refrigerated system viewed from above with the lid open.  The labeled parts are (1) 
thermoelectric air cooler module, (2) thermoelectric cold plate module, (3) mobile phase heat 
exchangers, (4) twelve port switching valve, (5) valve actuator, (6) needle port, (7) sample loop, 
(8) protease column inside oven, (9) peptide trap, (10) peptide separation column, (11) MS inlet 
line, (12) waste lines, and (13) inlet and outlet for dry air purge.  For visual presentation, the 
cover of the protease column oven (8) has been removed.  The temperature controllers are not 
shown.  The image was processed using Photoshop (Adobe Systems Inc., San Jose, CA) to 
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correct for lens distortion, to remove glare spots, and to remove the background, cover, and 
some wiring.  The lower panels show schematic diagrams of the flow paths with the switching 
valve in the digest and trap position (middle) and the elute position (bottom).  For clarity, not all 
components are oriented as shown in the photograph. 
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Figure 2.4.  The efficiency of the liquid heat exchangers depends on the fluid flow rate, but even 
at the lowest flow rate, water can be cooled from ambient inlet temperature to 0 °C.  Here, the 
liquid heat exchanger set point was −4 °C and the enclosure air temperature set point was 0 °C.  
Between flow rate changes, the temperature was allowed to stabilize for 5 min before the 
temperature was recorded. 
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Figure 2.5. Refrigeration of mobile phases and enclosure air from the initial startup is rapid and 
temperatures are stable once set points are reached. The top panel (Startup) shows the 
amount of time required for both temperatures to reach their respective set points.  Here, the 
water temperature was measured at the inlet of the sample loop.  The lower panels show 
temperature stability after the set points had been reached. (Enclosure) shows the air 
temperature with the protease column oven operating at a set point of 15 oC. (Heater Off) 
shows the temperature of water emerging from the heat exchanger immediately downstream of 
the protease column with the column oven turned off. (Protease Out) shows the temperature of 
water emerging from the protease column operating at a set point of 15 oC. (Exchanger Out) 
shows the temperature of water after being cooled by the post-oven heat exchanger. The flow 
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rate for all measurements was 200 µL min−1.  Temperature measurements were started when 
the cooling system was turned on at t = 0 hr. 
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Figure 2.6. The high resolution of our chromatography system is shown by these representative 
chromatograms from myoglobin peptides.  The total ion chromatogram is shown at the top 
(TIC).  Extracted ion chromatograms for select peptides are identified by their amino acid 
residue numbers.  The full widths at half-maximum are the averages of three successive 
samples (see table 2.2).  Each chromatogram has been normalized to 100% maximum relative 
intensity. 
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Figure 2.7.  Representative mass spectra show deuterium uptake by several myoglobin 
peptides.  The undeuterated isotope envelope spectrum for each peptide is shown with dotted 
lines.  The mass spectra of 95% deuterated peptides are shown with overlaid solid lines.  Each 
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spectrum was normalized to 100% intensity.  Sequential amino acid residue numbers are given 
in parentheses.  The sequences of the peptides can be found in table 2.2. 
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Chapter 3: Mapping Unstructured Regions and Synergistic Folding in IDPs with H/D-MS 
3.1 Introduction 
Intrinsically disordered proteins (IDPs) contain one or more regions that exhibit a high 
degree of conformational flexibility and lack a structured conformation.  Many IDPs use 
disordered regions to carry out function.1-11  Intrinsically disordered proteins differ from 
structured proteins by low sequence complexity and a bias against hydrophobic residues; these 
difference have become the basis of a variety of algorithms to predict disorder.12  Disorder 
prediction algorithms have shown that IDPs are ubiquitous in the proteomes of higher 
organisms and comprise roughly one third of all proteins.13-14  Bioinformatic approaches have 
demonstrated a clear distinction between the functions of structured proteins and disordered 
proteins.  While protein structure is associated primarily with functions such as enzyme 
catalysis, ion channels, and cellular structure, protein disorder is associated primarily with 
functions that require protein-protein interactions such as signaling.14   
In many cases, the disordered regions that mediate protein-protein interactions undergo 
coupled binding and folding.15-16  It has been speculated that the affinity of many IDP-mediated 
protein-protein interactions is significantly decreased by the strong entropic driving force for the 
free unstructured protein.8  At the same time, the conformational flexibility of the unstructured 
protein allows it to sample many different conformational states.  Higher chain flexibility also 
produces greater binding rates in IDPs due to a larger target capture radius in solution.17  Low 
affinity, coupled with high specificity, is an essential element for the transient protein-protein 
interactions required in cellular signaling.  In many cases a single disordered protein can 
recognize many different binding partners with the same disordered region, often adopting 
different folds upon binding.18   Understanding the mechanisms of disorder-mediated protein 
interactions requires information about the unstructured regions of the proteins and their 
disorder-to-order transitions. 
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Many different experimental techniques are available to characterize disordered 
proteins.19-21  The techniques can be divided into those that provide only a global picture of the 
extent of disorder (e.g., size exclusion chromatography, intrinsic fluorescence, circular 
dichroism, small angle x-ray scattering, atomic force microscopy) and a more limited list of those 
that provide localized to atomic-scale resolution (e.g., NMR, limited proteolysis, FRET).  In order 
to map regions of a protein that undergo coupled binding and folding, localized information is 
essential.  One technique that has seen only limited application to the characterization of 
disordered proteins is amide H/D exchange.  Amide hydrogens along the protein backbone 
become susceptible to exchange with deuterium from D2O during structural fluctuations that 
disrupt amide hydrogen bonding.22-24  By diluting a protein with a large excess of D2O, amide 
H/D exchange can be used as a probe of the backbone flexibility.  By measuring the rate at 
which deuterium is incorporated, the relative flexibility of different backbone segments can be 
determined.  When H/D exchange is measured by NMR,25-26 by mass spectrometry of 
proteolytic fragments27 or by a top-down fragmentation approach28 one can obtain localized 
information about the backbone flexibility of the protein of interest.  The MS approach offers 
several advantages including the ability to work with large proteins at low protein concentrations 
in physiologically relevant buffers and the ability to detect all proteins in a complex without 
selective isotopic labeling. 
There are many examples of disordered segments in otherwise well-folded proteins 
identified by H/D-MS.29-30  The technique has also been used to characterize chemically 
unfolded proteins.31-32   Yet the use of H/D-MS to obtain local flexibility data on natively 
unstructured proteins is considerably more limited.33-35  The tyrosine kinase interacting protein 
(Tip) from Herpesvirus saimiri was predicted to be disordered and exhibited two characteristics 
of an intrinsically disordered protein:  a far UV CD spectrum and aberrantly high apparent 
molecular weight by gel filtration chromatography.33  However, the analysis of the H/D exchange 
kinetics was limited to rather long D2O exposure times and the effects of binding to the 
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structured target, lymphocytic cell kinase (Lck), were not measured.  To establish the utility of 
H/D exchange measurements for the characterization of IDPs and their interactions, we have 
undertaken an H/D exchange study of the nuclear co-activator binding domain of the CREB 
binding protein (CBP, CBP_MOUSE, residues 2059-2117) and the activation domain of the 
activator of thyroid and retinoid receptors (ACTR, NCOA3_HUMAN, residues 1018-1088).  The 
interacting domains of CBP and ACTR are intrinsically disordered and undergo coupled binding 
and folding.15  Both the isolated disordered domains and the folded complex have been well-
characterized by a variety of biophysical techniques.15, 36-39  Here, we have used isolated CBP 
and ACTR and their complex as model systems to explore the capability of the H/D exchange 
MS technique to characterize intrinsically disordered proteins and coupled binding and folding. 
3.2 Materials and Methods 
 3.2.1  Materials 
Ampicillin and isopropyl β-D-1-thiogalactopyranoside (IPTG) were obtained from 
Research Products International Corp (Mt. Prospect, IL).  LB Medium used for cell cultures was 
prepared with Bacto Tryptone and Bacto Yeast Extract obtained from Becton, Dickinson, and 
Company (Franklin Lakes, NJ).  Pepsin from porcine gastric mucosa, piperazine, sodium 
hydroxide, DL-dithiothreitol, bestatin hydrochloride, E-64, 4-(2-aminoethyl)benzenesulfonyl 
fluoride hydrochloride (AEBSF), pepstatin A2, and deuterium oxide (99.9% D) were obtained 
from Sigma (St. Louis, MO). Benzonase nuclease was obtained from EMD Chemicals 
(Gibbstown, NJ).  99+% formic acid, used as an additive in prepared mobile phases, was 
obtained from Thermo Scientific (West Palm Beach, FL).  Sodium phosphate monobasic, 
sodium phosphate dibasic, sodium hydroxide hydrochloric acid, boric acid, tris base, and 
sodium chloride, were obtained from Fisher Scientific (Hanover Park, IL).  Optima LC/MS grade 
acetonitrile and water used in chromatography were both obtained from Fisher Scientific.  
POROS 20 AL column packing material was obtained from Applied Biosystems (Carlsbad, CA). 
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 3.2.2  Protein Expression 
CBP and ACTR domains were co-expressed from a pET22B co-expression vector15 in 
E. coli strain BL21 Star(DE3) (Invitrogen, Carlsbad, CA).  Glycerol stock was streaked onto agar 
plates containing 0.1 g L-1 ampicillin and grown overnight at 37 °C.  All cell cultures were grown 
in LB medium (10 g L−1 tryptone, 5 g L−1 yeast extract, 10 g L−1 NaCl, pH 7.0) containing 0.1 g L-
1 ampicillin.  Cells were grown at 37 °C in a rotary shaker at 225 rpm.  25 mL starter cultures 
were grown overnight following inoculation with single colonies. 10 mL of the starter culture was 
used to inoculate a 500 mL culture.  Cell cultures were induced with 1 mM IPTG after reaching 
OD600 = 1.0 and incubated for an additional 4 hours.  The cells were pelleted at 5000 × g for 10 
minutes at 4 oC and stored at −20 oC.    
 3.2.3  Protein Purification 
Cell pellets were resuspended in 10 mL of lysis buffer (20 mM Tris, 1 mM EDTA, 1 g L-1 
lysozyme, 5 units benzonase nuclease, pH 7.5) to which was added 250 μL of protease inhibitor 
cocktail per gram of pellet.  The protease inhibitor cocktail contained 23 mM AEBSF, 2 mM 
bestatin, 0.3 mM pepstatin A2, 0.3 mM E-64.  The resuspended pellet was incubated at room 
temperature for 10 minutes with gentle shaking.  Cellular debris was removed by centrifugation 
(15000 × g for 10 min at 4 °C).  Protein purification chromatography steps were performed using 
a fast protein liquid chromatography (FPLC) system (ÄKTAPrime plus, GE Healthcare, 
Piscataway, NJ) at 4 °C using 214 nm detection.  While both proteins were co-expressed in E. 
coli and share similar molecular mass, ACTR and CBP have drastically different theoretical pI 
values of 4.2 and 11.1, respectively.40  Because of this, we chose ion exchange to isolate the 
two proteins.  ACTR was purified using a buffer exchange step followed by anion exchange and 
gel filtration at 4 oC.  The lysis buffer was exchanged for anion exchange buffer (50 mM 
piperazine, pH 9.0) using a desalting column (HiPrep 26/10 Desalting, GE Healthcare).  
Collected protein fractions containing ACTR were identified by apparent mass using SDS-
PAGE, pooled, and passed through an anion exchange column (HiTrap Q XL, GE Healthcare) 
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in 50 mM piperazine using a 0 to 1 M NaCl gradient over 70 min at 1 mL min−1.  Fractions 
containing ACTR were identified by SDS-PAGE, pooled, then loaded onto a gel filtration column 
(HiPrep 16/60 Sephacryl S-100 HR, GE Healthcare) and eluted into 10 mM phosphate, 50 mM 
NaCl buffer, pH 6.9.  ACTR stock concentration was determined to be 14 μM using a BCA 
assay41 with 595 nm detection and calibration with BSA standards (Thermo Fisher Scientific). 
To purify CBP, we used a buffer exchange step followed by cation exchange and a 
second buffer exchange step at 4 oC.  Clarified lysate was passed through the desalting column 
with 50 mM boric acid, pH 9.0, with 3 mM dithiothreitol (DTT) to prevent oxidation of methionine 
residues.  Collected protein fractions containing CBP were identified by apparent mass using 
SDS-PAGE, pooled, and passed through cation exchange column (HiTrap SP FF, GE 
Healthcare) in 50 mM boric acid with 0.03 M DTT using a 0 to 1 M NaCl gradient over 70 min at 
1 ml min−1.  Fractions containing ACTR were identified by SDS-PAGE, then loaded onto the 
desalting column and eluted into 10 mM phosphate, 50 mM NaCl, 3 mM DTT buffer, pH 6.9.  
DTT was removed from an aliquot of CBP stock by using acetone precipitation and 
reconstitution of protein in buffer without DTT prior to the protein assay.  CBP stock 
concentration was determined to be 17 μM using a BCA assay41 with 595 nm detection and 
calibration with BSA standards.  Both ACTR and CBP protein identities were confirmed by mass 
spectrometry (see section 3.2.6).  Protein stocks were split into aliquots, frozen with liquid 
nitrogen, and stored at −74oC. 
 3.2.4  H/D Exchange Labeling 
Based on the reported dissociation constant of 34 nM for the ACTR/CBP complex,15 a 5-
fold molar excess of CBP will bind greater than 90% of ACTR, and vice versa under labeling 
conditions (see below).  Four sample pools were prepared to represent both ACTR and CBP in 
free and complex states.  A 1:4.9 molar ratio of ACTR to CBP was prepared by mixing 19 μL of 
ACTR stock was mixed with 81 μL CBP stock (complex).  Under labeling conditions (1:20 
dilution, see below), 94% of ACTR is bound.  Similarly, a 1:4.7 molar ratio of CBP to ACTR was 
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prepared by mixing 15 μL of CBP stock with 85 μL ACTR stock (complex) yielding 93% bound 
CBP under labeling conditions.   For the individual free proteins, an equal volume phosphate 
buffer was substituted for the binding partner.  All pools were incubated at room temperature for 
an hour prior to deuterium labeling. 
Samples were labeled by rapidly diluting 5 μL of a sample pool with 100 μL of 10 mM 
phosphate, 50 mM NaCl in D2O, pD 6.9.  After labeling intervals ranging between 5 sec and 12 
hr, the labeling reaction was quenched with 17 μL 0.1 M HCl to decrease the pH to 2.6.  
Undeuterated controls were prepared for each sample pool by mixing 5 μL of a sample with 100 
μL phosphate buffer in H2O, pH 6.9, and 17 μL 0.1 M HCl.  Totally deuterated controls were 
prepared for each sample by diluting 5 μL with 100 μL phosphate buffer in D2O, pH 6.9, followed 
by quench after 24 hours with 17 μL 0.1 M HCl.  After quenching, all samples were immediately 
flash frozen with liquid nitrogen and stored at −74 oC.  Individual samples were thawed by hand 
in approximately 2 min just prior to analysis. 
 3.2.5  Chromatography 
An Agilent Technologies 1200 series isocratic pump and a 12-port injector valve (Valco 
Instruments Co. Inc.) were used to inject the loaded sample through a 50 × 2.1 mm immobilized 
pepsin column prepared in-house as described previously42 at 0.2 mL min–1 flow rate of 0.1% 
formic acid in water onto a self-packed C12 trap (10 mm × 1 mm, Jupiter 4 μm Proteo 90 Å, 
Phenomenex, Torrence, CA) for 2.5 minutes to desalt and concentrate the samples.  An Agilent 
Technologies 1200 series binary pump was used to carry out a high performance liquid 
chromatography separation of peptic fragments.  Solvent A was 0.1% formic acid in water and 
solvent B was 90% acetonitrile / 10% water / 0.1% formic acid.  Peptic peptides were separated 
on a C12 column (50 mm × 1 mm Jupiter 4 μm Proteo 90 Å, Phenomenex) using 
water/acetonitrile gradient (10% to 35% B in 5 minutes at 50 μL min-1).  A thermoelectrically 
cooled system, constructed in-house, kept the loop, valve, columns, and solvent lines at 0 oC 
(see chapter 2). 
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3.2.6  MS Analysis 
Following separation, peptides were eluted into the electrospray ionization source of a 
time of flight mass spectrometer (Model 6220, Agilent Technologies, Santa Clara, CA) operating 
in positive ion mode.  Nitrogen at 325 oC and 10 L/min flow rate was used as the drying gas, 
with a nebulizer pressure of 30 psig.  Fragmentor, skimmer, and capillary voltages were 150 V, 
50 V, and 4000 V, respectively.  Intact protein samples were checked using accurate mass 
measurements.  These mass checks ensured the absence of any post-translational 
modifications to the proteins and measured the extent of oxidation of stored protein, which was 
determined to be low enough so as not to cause interference in further experiments. 
3.2.7  Peptide Database 
Once chromatographically resolved peptide mass spectral data were collected, 
MassHunter Qualitative Analysis with Bioconfirm software (Agilent Technologies, Santa Clara, 
CA) was used to build a peptide database.  The MassHunter software provided a suite of 
methods to perform calculations and analyze mass-to-charge spectral features from mass 
spectrometer data.  The “Find by Molecular Feature” and “Define and Match Sequences” 
methods allowed for peptide features to be isolated and for clipped m/z spectra and extracted 
ion chromatograms specific to each peptide to be extracted and graphed.  Peak height minima, 
retention time windows, and peak spacing tolerances were defined by the user.  A pre-
calculated mass list or protein sequence with selected digest parameters can be used to include 
or exclude specific masses, with mass matching tolerances also defined by the user.  We built a 
peptide database from spectral features that matched a non-specific protease digestion of our 
undeuterated target protein sequence.  A mass matching tolerance of ±20 ppm was defined. 
Ambiguous peptide matches were identified using a rough CID technique, or nozzle-skimmer 
dissociation (NSD), as explained in section 1.6.3.  Protein sequences longer than those of CBP 
or ACTR require more complex MS/MS techniques, using instrumentation beyond TOF-MS, due 
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to the greater likelihood of an ambiguous assignment and the greater difficulty in resolving 
peptides. 
Peptic peptides of undeuterated ACTR and CBP were identified by matching accurate 
mass measurements with a non-specific protease digest in the MassHunter software (version 
B.03.01).  To resolve ambiguous near-isobaric peptide assignments, NSD product ion spectra 
were obtained by cycling the fragmentor voltage cycle every 0.5 seconds between 150 V, 200 
V, and 250 V.  Observed fragment ion peaks were matched against b/y ion fragmentation 
predictions (Protein Prospector, MS-Product, http://prospector.ucsf.edu).  The final list of 
identified peptides can be found in table 3.1.  Using the expected retention times and molecular 
feature extraction, mass spectra were extracted for each deuterated peptide sample. HX-
Express software43 was used to find the average mass of each peptide using the portion of the 
isotopic distribution that was at least 20% of the base peak.  Deuterium uptake for each peptide 
at each time point was calculated as the mass difference between the average peptide mass 
and the average mass of the undeuterated control.  Our deuterium uptake results are presented 
without back-exchange correction.27 
 Although the MassHunter software can extract specific mass-to-charge peak envelopes 
that match a given mass list, it was not able to identify deuterated peptide peak envelopes as 
peptide features, due to the presence of deuterons upsetting the distribution of m/z values within 
the envelope.  A deuterated peptide mass database was built by calculating the expected 
average mass of an undeuterated peptide, then adding new entries that replace amide 
hydrogen from the formula of the peptide with deuterium atoms one by one.  1.006277 Da was 
added to the average mass for each deuteron replacement.  In analyzing mass spectra, we 
measured the m/z values for the detected population of the peptide.  The distribution of 
deuterons will not be uniform, so deuterium uptake was measured as the average mass 
increase of the population relative to the average mass of undeuterated control for EX2 
exchange kinetics.  While current software packages such as HDExaminer (Sierra Analytics, 
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Modesto, CA) are able to extract deuterated peptide features and obtain average mass 
increase, other software packages were used to perform this calculation separately from 
MassHunter.  A manual survey of extracted spectra for deuterated peptides was also necessary 
to differentiate between actual peptides and small molecule interferences. 
 3.2.8  Intrinsic Exchange Calculations 
The progress of intrinsic amide H/D exchange for unstructured peptides was calculated 
according to equation 1: 
 ( )
( )( )int
3
1
im k t
i
D t e−
=
= −∑  (1) 
where m is the number of residues, ( )int
ik  is the rate constant for exchange for residue i of the 
peptide.44  Proline residues were assigned a rate constant of zero since proline has no amide 
hydrogen.  Upon proteolysis, the amide hydrogen i = 1 becomes a primary amine and hence 
back-exchanges rapidly.   Back-exchange at i = 2 is also generally quite rapid.44-45  Thus, index i 
begins at 3, since there will be no deuterium remaining at i = 1,2.  The calculations were 
implemented using an Excel spreadsheet (Microsoft, Redmond, WA) adapted from a 
spreadsheet available on Prof. Walter Englander’s website (http://hx2.med.upenn.edu).  Our 
adapted version is available upon request.  The intrinsic exchange calculations were normalized 
to the maximum observed deuterium uptake. 
 3.2.9  Kinetic Analysis 
 In this work, we have quantified the kinetics of H/D exchange using the method 
described by Englander and co-workers46 where the deuterium uptake has been fit to either a 
single or double stretched exponential function46-47: 
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D(t) is the extent of deuteration as a function of D2O exposure time, t; N is the number of 
exchangeable amides; k  represents the segment-averaged rate constant for exchange (either 
for intrinsic exchange intk or observed exchange HXk ); and β is an exponential stretching 
factor that accounts for the distribution in the intrinsic rates of H/D exchange of the individual 
amides.  β was determined using a fit to the intrinsic exchange calculation (see equation 1).  
The fit to intrinsic exchange also yields the segment-averaged rate constant for intrinsic 
exchange, intk .   The use of the stretched exponential function requires fewer adjustable 
parameters than multi-exponential48-49 fits commonly used to describe H/D exchange kinetics 
and thus the non-linear least-squares fit is more robust.  In either case, since the resulting rate 
constants are segment-averaged, they are best considered “phenomenological” 50 rate 
constants.  The ratio of the intrinsic exchange rate constant, intk , to the measured rate 
constant, HXk , can be used to estimate a segment-averaged protection factor, PF , a 
measure of the slow-down in exchange induced by the structure of the protein: 
 int
HX
k
PF
k
=  (3) 
An average protection factor of unity indicates a segment that is completely unstructured, i.e., 
the segment exchanges at its intrinsic rate, while a protection factor greater than 1 indicates the 
region is protected from H/D exchange.  Because the measured H/D exchange is segment-
averaged, these protections factors should not be interpreted thermodynamically as can be 
done for measurements obtained from single-residue resolution measurements.26 
3.3 Results 
 3.3.1  Ligand Binding Equilibrium for ACTR and CBP 
We initiated amide H/D exchange by rapidly diluting the individual proteins or the 
complex with a nineteen-fold excess of deuterated buffer.  After intervals ranging from 5 s to 12 
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hr, the exchange reaction was quenched by acidification.  Under quench conditions, labile D+ is 
rapidly back-exchanged to H+, but amide D back-exchanges much more slowly.  To localize the 
exchange measurements to short linear segments of the proteins, the quenched samples were 
digested with pepsin and then deuterium uptake as a function of D2O exposure time was 
quantified with mass spectrometry.  To compare the free and bound states of the proteins, H/D 
exchange was carried out for each protein separately and for each protein in the presence of a 
five-fold molar excess of its binding partner (i.e., 1:5 CPB:ACTR and 5:1 CBP:ACTR). 
 3.3.2  H/D-MS of ACTR and CBP 
 We quantified deuterium uptake by measuring the increase in the average mass of each 
segment.  The mass increases for the segments shown in figure 3.1, plotted as a function of 
time, are shown in figure 3.2.  Similar plots for all segments are provided in figure 3.3.  For ease 
of viewing, the results are plotted in figure 3.2 on both a logarithmic scale and on a linear scale 
for the early exchange times.  The maximum number of exchangeable amides is indicated by 
the limit of the vertical axis and the horizontal dashed lines on the plots represents the 
maximum observed exchange, measured after 12 hr of D2O exposure.  Also plotted in figure 3.2 
is the intrinsic exchange for each segment calculated using equation 1.  In the free state, both 
CBP 31-40 and CBP 43-59 are protected from exchange, as indicated by slower exchange than 
predicted using the intrinsic calculation.  In the free state, ACTR 33-47 exchanges at the 
intrinsic rate, but ACTR 48-59 is slightly protected from exchange.  In the complex, all four 
segments become substantially more protected from exchange.   
 To quantify the extent of protection, we derived segment-averaged protection factors, 
PF , by fitting the kinetic data to stretched exponential or bi-exponential functions, see 
equation 2.46  The results of the kinetic analysis are presented in table 3.2 and mapped onto the 
sequences of the proteins in figure 3.4.  For free ACTR, all segments exchange at or near the 
rate predicted for intrinsic exchange (figure 3.2) with protection factors ranging from 1.0 to 2.4 
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(table 3.2, figure 3.4).  In the deuterium uptake plots, however, there is a clear distinction 
between segments that exchange at the calculated intrinsic rate and those that exchange more 
slowly.  Deuterium uptake plots for segments 1-12, 33-42, 33-47, 36-47, and 60-71 capture only 
the plateau of H/D exchange (see figures 3.2 and 3.3).  In these segments, the observed H/D 
exchange is consistent with the intrinsic exchange calculation. In contrast, for the 13-22, 29-35, 
and 48-59 segments, our measurements at 5 and 10 sec of D2O exposure capture the knee of 
the H/D exchange curve and show clearly that these segments exchange more slowly than 
predicted by intrinsic exchange.  Unlike ACTR, all segments in free CBP exchange more slowly 
than predicted by the intrinsic exchange calculation.  Notably, all CBP segments follow similar 
H/D exchange kinetics leading to a narrow range in the protection factors of between 4.1 and 
5.7 (see table 3.2 and figure 3.4).  Hence, there is very little contrast between segments that 
span the helical core and segments that span the tails. 
 In the complex, there are substantial changes in protection in many, but not all ACTR 
segments.  Binding to CBP has no effect on exchange in the N- and C-terminal regions of ACTR 
(1-22 and 60-71).  These regions exchange at the intrinsic rate, indicating that they remain 
unprotected.  In the middle regions of ACTR (29-59), however, there is a substantial slow-down 
in H/D exchange.  Several segments, for example ACTR 48-59, show clear bi-exponential H/D 
exchange kinetics (see figure 3.2).  In the middle regions of ACTR, segment-averaged 
protection factors are as high as 180.  The bimodal exchange kinetics allowed us to subdivide 
several of the segments,48 wherein one part exchanges rapidly while other regions are more 
protected from exchange.  We have estimated the number of amides involved in the bi-
exponential fits as 
 1,2 max1,2
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where Nmax is the maximum number of detectable amide exchanges.  This essentially 
represents a back-exchange correction27 for the protection factors.  By this means we have 
been able to differentiate regions of high and low protection within a single peptide segment.  
For example, the 33-42 region of ACTR in the complex encompasses both a highly protected (
2PF  = 180, 4 residues) and a weakly protected ( 1PF = 4.4, 4 residues) sub-segments.  This 
segment spans four residues of helix 1 and four residues of the linker between helix 1 and helix 
2.   Although the resolution of H/D-MS data does not define the exact locations of the two amide 
populations, we have presented the data in figure 3.4 aligned with the known secondary 
structure of ACTR in the complex.  Several other segments of ACTR spanning the helix 1 to 
helix 2 region (33-42, 33-47, and 36-47) also exhibit bi-exponential kinetics.  The 62-71 segment 
spans both helix 3 and the unstructured C-terminal tail of ACTR, but there is no increase in 
protection in this region of ACTR in the complex.  
 The H/D exchange kinetics for CBP also change significantly upon complex formation.    
There are substantial increases in protection all along the length of CBP (table 3.2, figure 3.4).  
The largest increases in protection are in the Cα2 and Cα3 regions and in the linker connecting 
the two (30-38, 31-40, and 40-43).  Here, segment-averaged protection factors increase from ~6 
to 59-84.  Protection also increases in the segments covering the N-terminal half of Cα1 and the 
C-terminal half of Cα3, however the increases are not as large because these segments also 
cover the N- and C-terminal tails, respectively.  
3.4 Discussion 
 3.4.1  Application of H/D-MS to IDPs 
Amide H/D exchange is used widely to characterize ligand-induced changes in the 
conformation and dynamics of proteins.  Our objective in this work was to explore the 
capabilities and limitations of equilibrium H/D exchange to characterize intrinsically disordered 
proteins and reveal the details of their unstructured-to-structured transitions.  The intrinsically 
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disordered interaction domains of CBP and ACTR37 serve as a useful model system since both 
the free domains and their co-folded complex have been well-characterized.15, 36-39 
On the basis of NMR, CD, and urea unfolding, CBP has been described as a molten 
globule, but its ensemble is sufficiently well-defined that structures have been solved.38, 51  NMR 
secondary chemical shift measurements show well-formed helical structure in free CBP.37  The 
recent ensemble of structures38 shows that CBP has a fairly well-defined hydrophobic core 
comprising all three helices that aligns well with the structure of CBP in the complex,15 but the 
N- and C-terminal regions are less well-defined.  CBP is only marginally stable and undergoes 
two-state unfolding with ΔGu = 6.1 ± 0.4 kJ mol−1  38 from which it follows that approximately 8% 
of the CBP population occupies conformers belonging to the unfolded sub-population at 300 K.  
Absence of additional peaks in the NMR spectrum of free CBP led to the proposal that CBP 
inter-converts between different conformers slightly faster than intermediate exchange (104 s–
1).38 
CBP and ACTR form a tight 1:1 complex (Kd = 34 nM) with well-defined tertiary 
structure.  The structure consists of a helical bundle in which a series of leucine side chains in 
helix 1 of ACTR lie in a hydrophobic groove between helices 1 and 3 of CBP (see figure 3.5).15  
Secondary chemical shift measurements show dramatic increases in secondary structure 
across all of Aα1 and Aα2 but only a slight increase in secondary structure on the N-terminal 
side of helix Cα1 and the C-terminal end of helix Cα3.37  Relaxation measurements show that 
both proteins become less dynamic in the complex.37  
 3.4.2  Mechanism of Amide H/D Exchange 
 The simplest representation of the mechanism of amide H/D exchange is the 
Linderstrøm-Lang scheme: 
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Within the context of understanding proteins as a rapidly inter-converting ensemble of 
conformations,52 amide H/D exchange at residue i occurs when the protein enters an exchange-
competent, so-called open conformation(s), collectively represented here as ( )
op
H i
P .  In the open 
conformers, the hydrogen bond for amide i is transiently broken through some sort of dynamic 
process.  The opening reaction is followed by H/D exchange determined by the intrinsic rate 
constant, ( )int
ik .  The intrinsic rate of exchange depends on the amino acid sequence, 
temperature, and pH and is readily calculated from well-established kinetic parameters.44  The 
extent to which the conformation of the protein slows exchange ( ( )op
ik  and ( )cl
ik ) can be quantified 
using the protection factor, PF: 
 ( )
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where ( )HX
ik  is the observed rate constant.  An important distinction, that we shall return to later, 
between H/D measurements by NMR53  and MS is that MS measurements are averaged across 
a short segment of the protein whereas NMR measurements are made with single amide 
resolution.  To distinguish between single-amide and segment-averaging, we have adopted the 
convention of by applying a superscripted i to denote values at single-residue resolution and 
enclosing segment-averaged values within brackets. 
 3.4.3  The 31-40 Region of CBP as an Illustrative Example 
We begin by using the 31-40 segment of CBP to illustrate how we have analyzed our 
data.  Mass spectra of the 31-40 peptide of CBP show that the region undergoes rapid amide 
H/D exchange, reaching saturation within approximately 20 s of D2O exposure (figure 3.1).  In 
the CBP/ACTR complex, exchange in the 31-40 region of CBP is much slower, taking 
approximately 1 hr to reach saturation (figure 3.1).  We quantified H/D exchange by measuring 
the center of mass of the isotopic distributions shown in figure 3.1.  The results are plotted as a 
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function of D2O exposure time in figure 3.2 (black and grey symbols in the lower left-hand 
panel).  Following proteolysis under quench conditions (pH = 2.5, 0 °C), the first two residues 
undergo rapid D/H back-exchange so that measured deuteration at these two residues is zero.  
The 31-40 segment of CBP also includes one proline (see table 3.2).  Hence, there are a total of 
seven residues in the 31-40 segment of CBP in which deuterium uptake can be measured.  The 
maximum number of exchangeable amides is indicated in figure 3.2 by the upper limit of the 
vertical axis.  However, even under quenched conditions some D/H back-exchange still 
occurs,27, 45 so the horizontal dashed line on the plot represents the maximum observed 
exchange, +6.4 Da, measured after 24 hr of D2O exposure.  Hence, the deuterium recovery in 
this segment was 90%.  Also plotted in figure 3.2 is the intrinsic exchange for the 31-40 
segment of CBP (depicted as a dotted curve) calculated using equation 1.  That the 31-40 
segment of free CBP is protected from exchange is evident from its slower deuterium uptake 
relative to the intrinsic exchange.  Formation of the CBP/ACTR complex further increases 
protection. 
The kinetic analysis reveals that the 31-40 region of CBP is loosely structured and that 
the region undergoes coupled binding and folding in the presence of ACTR.  The segment-
averaged H/D exchange rate constants, HXk , for the 31-40 segment of CBP is 0.22 s
−1 for 
free CBP.  The rate constant decreases to 0.017 s−1 in the CBP/ACTR complex.  The intrinsic 
rate constant for exchange, intk , for this segment of CBP is 1.3 s
−1 (see table 3.2).  Thus, in 
the 31-40 segment of CPB, the average protection factor increased from 5.7 for free CBP to 73 
in the CBP/ACTR complex (table 3.2, figure 3.4).  While the deuterium uptake data for bound 
CBP (see figure 3.2) suggests a stretched bi-exponential, such fits were unsatisfactory.  It 
appears that the first exponential phase is nearly complete by the earliest time-point, 5 s, hence 
obtaining kinetic parameters for this first, rapid phase is difficult. 
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 3.4.4  Limitations of the Kinetic Analysis 
 There are two important limitations to interpreting the results obtained using the analysis 
described above.  The first limitation is that our measurements are segment-averaged.  The 
simplified scheme for H/D exchange depicted in equation 5 must be revised to incorporate the 
averaging of multiple rate constants.   Segment-averaged H/D exchange is not by itself difficult 
to describe mathematically and such simulations have been described.24, 54  Rather, the 
limitations lie with the inversion of segment-averaged H/D exchange kinetic data to obtain 
mechanistic insight into the dynamics of the protein, as would be represented by a set of ( )op
ik  
and ( )cl
ik  values.  Such an inversion appears to be intractable since the kinetic models would be 
over-parameterized.  Furthermore, it is not clear what the physical significance or 
reasonableness of using segment-averaged values would be.  Nevertheless, semi-quantitative 
interpretation of H/D-MS data is still possible as we shall address in subsequent sections of this 
paper. 
 The second limitation with our approach is that the physical significance of the protection 
factor is unclear because for intrinsically disordered proteins, such as the interacting domains of 
CBP and ACTR, the conventional EX1 and EX2 kinetics limits may not hold.  Under the 
conventional EX2 kinetic limit, PF(i) values are directly proportional to the ratio ( ) ( )op cl
i ik k , equal to 
the equilibrium constant for entry into the exchange competent state, ( )
op
H i
P .  Such a relationship 
follows directly from the EX2 kinetic limit that requires ( ) ( ) ( )cl op int
i i ik k k  .  Under the EX2 limit, 
protection factors can be related to the Gibbs free energy cost for entering the exchange-
competent state ( ( ) ( )op ln
i iG RT PF∆ = ).  The EX1 kinetic limit requires ( ) ( ) ( )int op cl
i i ik k k   and leads 
to ( ) ( )HX op
i ik k= .  The EX1 and EX2 kinetic limits, though reasonable for structured proteins, do not 
necessarily hold for intrinsically disordered proteins.  For example, a mostly unstructured protein 
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that inter-converts between protected and unprotected states with a kinetic limit of 
( ) ( ) ( )
op cl int
i i ik k k>   is easily envisioned.  Thus for disordered proteins it may be necessary to 
consider the full treatment of H/D exchange kinetics22 without assuming either EX1 or EX2 
kinetic limits (vide infra). 
 3.4.5  Residual Structure in ACTR 
 For free ACTR, all segments exchange at or near the rate predicted for intrinsic 
exchange (figure 3.2), yielding protection factors ranging from 1.0 to 2.4 (table 3.2, figure 3.4).  
Limited protection in ACTR is consistent with previous measurements by NMR and circular 
dichroism showing that free ACTR is unstructured.15, 37  In ACTR segments covering residues 1-
12 and 33-47 our H/D exchange measurements only captured the plateau of the H/D exchange 
(see figure 3.2), hence the protection factor of 1.6 in the 33-47 region is attributable to 
experimental error.  However, in the segments 13-22, 29-35, and 48-59, our measurements at 5 
and 10 sec of D2O exposure captured the knee of the H/D exchange curve (see figure 3.2).  In 
these regions, the differences between observed deuterium uptake and the deuterium uptake, 
predicted on the basis of intrinsic exchange, do appear to be significant (figure 3.2, dotted curve 
vs. black circles).  Hence, protection in these regions is significantly greater than unity.  Based 
on extensive NMR relaxation data and secondary chemical shifts, Ebert and co-workers37 
concluded that ACTR had the characteristics of an unstructured random coil.  More recently, 
however, the conformation of free ACTR was interrogated using CD, small-angle x-ray 
scattering (SAXS), and multidimensional NMR.39  In particular, secondary chemical shift 
measurements using reference shifts obtained from ACTR in urea indicated that a small 
percentage of alpha-helical propensity was present in the three regions of ACTR that form 
helices in complex with CBP, particularly in the Aα1.  Thus, our H/D-MS measurements support 
the existence of transient helical character in an otherwise unstructured protein. 
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 While our H/D exchange data shows evidence of residual structure, we are unable to 
determine the timescale for the formation/loss of this structure.  For a highly unstructured 
protein such as ACTR, it is reasonable to project that the life-time of the exchange competent 
state is long relative to the time-scale of H/D exchange (i.e., ( ) ( )int cl
i ik k> ).  Furthermore, we expect 
that such a relationship would extend to the segment level: int clk k> .  At the extreme, the 
rate constant for closing would be zero and the segment would exchange at the intrinsic rate.  
Under this limit, complete exchange will take place before the segment has time to adopt an 
exchange-protected conformation.  For segment-averaged kinetics, exchange under the limit 
int clk k>  would produce a bimodal isotope profile in which a population of a fully deuterated 
segment grows in at the expense of the undeuterated population.  Such an isotopic profile 
would resemble the isotopic profile that can be observed under the EX1 kinetic limit,24, 54-57 even 
though the EX1 kinetic limit would not necessarily apply here.  The lengthy dead-time of our 
experiments (5 sec) prevented us from detecting bimodal isotopic profiles since all of the ACTR 
peptides are nearly fully deuterated at 5 sec.  Equilibrium H/D exchange measured on the 
millisecond timescale using quench-flow58-59 may yield valuable insight into the nature of the 
transient helical structure in ACTR. 
 3.4.6  Limited, Uniform Protection Reveals Conformational Inter-conversion by Free 
CBP 
 Unlike ACTR, all segments in free CBP exchange more slowly than predicted for intrinsic 
exchange (see figure 3.2).  However, the protection factors span a narrow range between 4.1 
and 5.7 (see figure 3.4 and table 3.2).  One interpretation could be that the increased protection 
means that CBP is simply more structured than ACTR.  Indeed, free CBP has been described 
as a molten globule on the basis of NMR, CD, and urea unfolding, and is sufficiently well-
ordered that its structure has been solved.15, 38, 51  Secondary chemical shift NMR 
measurements clearly show well-formed helical structure in CBP.37  However, the nearly-
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uniform protection factors that we observe are not consistent with a molten globular state in 
which three alpha helical segments are connected by flexible linkers.  In addition, the magnitude 
of the protection factors is too small.  For example, when apolipoprotein A-I was analyzed by 
H/D-MS using the segment-averaged stretched exponential fitting, alpha helical segments of 
were found to have segment-averaged protection factors ranging from 101 to greater than 104.46  
In molten globular apomyoglobin at pH 4.2, protection factors ranged from 5-200 in helical 
regions while in the native state at pH 6.0, protection factors ranged between 103 to greater than 
105.60  Hence, the protection factors for CBP of 4-6 appear to be inconsistent with the available 
structural data for CBP. 
 The inconsistency between our measurements and the available structural data can be 
resolved if we interpret our data in terms of the more general two-process model of H/D 
exchange.61-62  According to the generalized two-process model, the protein conformational 
ensemble consists of two macroscopic states:  a folded population (F) and an unfolded 
population (U) that inter-convert with global folding and unfolding rate constants of kF and kU, 
respectively.  Within these macroscopic states are a collection of rapidly inter-converting 
conformers, some protected from exchange (denoted with the superscripted cl) and some 
locally exchange competent (denoted by the superscripted op).  The exchange process is 
depicted in the following scheme and also in figure 3.6. 
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 (7) 
In the two-process model, exchange at amide i can occur either through an exchange 
competent conformer of the folded ( )( )opH iF  or unfolded ( )( )opH iU  ensemble.  As well-illustrated 
though exchange flux calculations by Henkels and Oas,63 the observed H/D exchange kinetics 
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can be dominated by very poorly populated states when the rate of exchange by these states is 
much faster than exchange by majority states.  Since the usual kinetic limits for H/D exchange 
may not be relevant for intrinsically disordered proteins, the full kinetic treatment of H/D 
exchange for the two-process model62 is required.  In the limit of kF ≫ kint, the observed rate 
constant for exchange ( )HX
ik will be: 
 ( ) ( ) ( ) ( )op opHX int
i i i i
F F U Uk f f f f k ≈ +   (8) 
where fF and fU represent the fraction of molecules occupying the folded and unfolded 
ensembles, respectively (fF + fU = 1); and ( )
op i
Ff and 
( )op i
Uf represent the fractions of exchange-
competent molecules in the folded and unfolded conformational ensembles..  It follows that  
 ( ) ( ) ( )
1op opi i i
F F U UPF f f f f
−
 ≈ +   (9) 
It is obvious by inspection that the protection factors of the folded and unfolded states are the 
reciprocals of the fractions of molecules in exchange competent conformations (i.e., 
( )op
, ,1
i
F U F UPF f= ).  At the end of this section we will establish the relevance of the kinetic limit kF 
≫ kint that we have invoked here. 
 Equations 8 and 9 and figure 3.6 provide an intuitive description of H/D exchange 
kinetics for IDPs.  The first term represents the fraction of molecules in the folded ensemble that 
are in exchange-competent conformations and the second term represents the fraction of 
molecules in the unfolded ensemble that are in exchange-competent conformations.  Hence, the 
H/D exchange flux63 occurs through two separate channels:  exchange-competent conformers 
of the folded ensemble and exchange-competent conformers of the unfolded ensemble.  We 
can anticipate that for a marginally stable protein like CBP, the second term in equation 9 may 
be of the same order of magnitude or even larger than the first.  In other words, the CBP 
conformational ensemble could consist of inter-converting molten globular and unfolded 
ensembles with most unfolded conformers being exchange-competent (i.e., unprotected).  For 
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illustrative purposes, consider a protein that is 95% molten globular with ( )op 0.001iFf =  (PF= 
1000) and 5% unfolded ( )op 0.80iUf =  (PF = 1.25).  Under this scenario, the observed protection 
factor of 24 is primarily dictated by the unstructured state.  While there is a relatively low 
probability of being in the unfolded state (fU = 0.05), exchange flux63 through this pathway is 
much greater because most of the conformers are exchange competent ( ( )op 0.80iUf = ), as 
denoted by the heavy arrow for exchange flux in figure 3.6.  Although extension of the two-
process model to segment-averaged exchange is mathematically intractable, we assert that, 
qualitatively at least, the segment-averaged H/D exchange works in a similar manner. 
 Based on the two-process model, the small, near-uniform protection factors for CBP 
shown in figure 3.4 are consistent with a well-folded molten globular form of CBP that is in 
equilibrium with an unstructured state (see figure 3.6).  Both the apparent lack of secondary 
structure and the small magnitude of the protection factors arise because the majority of H/D 
exchange occurs during intervals when CBP molecules are in the unfolded conformational 
ensemble ( )( )opH iU .   Our observations are consistent with recent work by Kjaergaard and co-
workers who characterized free CBP using NMR, CD, and small angle X-ray scattering.38  The 
authors determined that free CBP is marginally stable and undergoes two-state unfolding (ΔGu 
= 6.1 ± 0.4 kJ mol−1, KU  = 0.085), hence under native conditions, ~8% of the molecules are in 
unfolded conformations at 300 K.  The accepted model of the molten globular state has well-
defined secondary structure, but fluctuating tertiary structure.   High protection factors have 
often been taken as evidence of the existence of well-defined secondary structure in molten 
globules.  The preceding treatment offers an explanation for why our observed protection 
factors are so much less than those expected for a molten globule and they support the 
conclusions of Kjaergaard et al. that CBP occupies both a molten globular state and an unfolded 
state.38 
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 The absence of bimodal isotopic profiles in spectra of the CBP segments indicates that 
the unstructured conformers are only transiently unprotected such that either the kinetic limits 
( )
int
i
fk k  and/or 
( ) ( )
cl, intU
i ik k  apply.  A bimodal isotopic profile would be evident in our spectra if 
the limits did not hold since unstructured peptide segments would become fully deuterated 
during its time in the unprotected state.  Since there is no evidence of such an EX1-like isotope 
profile in any of the CBP peptides (see figure 3.1), we conclude that CPB exchanges under one 
or both of the limits ( )int
i
fk k  and/or 
( ) ( )
cl, intU
i ik k .  Hence, the lifetime of the unstructured state 
must be msec or shorter (i.e., much less than kint−1 which is on the order of 1 s at pD 744).  The 
transient nature is consistent with the exchange constant (kF + kU) of 104 s–1 estimated by 
NMR38 and supports our use of the kinetic limit kF ≫ kint in equations 8 and 9. 
 3.4.7  Formation of the ACTR-CBP Complex 
 Our H/D exchange data can be used to map regions of ACTR and CBP that undergo 
coupled binding and folding in the complex.  For comparison, we have mapped the observed 
protection factors onto the primary sequences of the proteins and the secondary structural 
elements in the CBP/ACTR complex15 (see figure 3.4).  Binding to CBP has no effect on 
exchange kinetics in the N- and C-terminal regions of ACTR (1-22 and 60-71).  Even in the 
complex, these regions exchange at the intrinsic rate, indicating that these regions remain 
disordered (see figures 3.2 and 3.4, top).  In the middle regions of ACTR (29-59), however, 
there is a substantial slow-down in H/D exchange.  Several segments, for example ACTR 48-
59, show clear bimodal H/D exchange kinetics (see figure 3.2).  In the middle regions of ACTR, 
segment-averaged protection factors are as high as 180.  The bimodal exchange kinetics 
allowed us to subdivide several of the segments,48 wherein one part exchanges rapidly while 
other regions are more protected from exchange.  For example, the 33-42 region of ACTR in the 
CBP/ACTR complex encompasses both a highly protected sub-segment ( 2PF  = 180, 4 
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residues) and a weakly protected sub-segment ( 1PF = 4.4, 4 residues).  Hence, the observed 
protection factors are consistent with this segment spanning four residues of helix 1 and four 
residues of the linker between helix 1 and helix 2.   Although the resolution of our H/D-MS data 
does not allow us to define the exact locations of the two amide populations, we have presented 
the data in figure 3.4 aligned with the previously-assigned secondary structure of ACTR in the 
complex.  Several other segments of ACTR spanning the helix 1 to helix 2 region (33-42, 33-47, 
and 36-47) also exhibit bi-exponential kinetics.  The 62-71 segment spans both helix 3 and the 
unstructured C-terminal tail of ACTR, but there is no observed increase in protection in this 
region of ACTR in the complex.  We attribute this to both the difficulty of resolving bimodal 
kinetics involving only two residues and also to helix fraying at the end of helix three. 
 H/D exchange kinetics for CBP also change significantly when CBP binds to ACTR.    
There are substantial increases in protection all along the length of CBP (table 3.2, figure 3.5).  
The largest increases in protection are in the Cα2 and Cα3 regions and in the linker connecting 
the two (30-38, 31-40, and 40-43).  Here, segment-averaged protection factors increase from 
5.5-5.7 to 59-84.  Protection also increases in the segments covering the N-terminal half of Cα1 
and the C-terminal half of Cα3, however the increases are not as large because these 
segments also cover the N- and C-terminal tails, respectively.  The observed increases in 
protection are consistent with NMR measurements showing a decrease in backbone motions in 
CBP upon binding to ACTR.37   
 Figures 3.5 summarizes the effects of coupled binding and folding on the exchange 
kinetics of ACTR.  The figure shows the fold-changes in segment-averaged protection, 
complex freePF PF , that accompany complex formation. The observed fold-increases in 
protection in ACTR in the complex range from ~1 in the terminal regions to ~100 in helix 2 of 
ACTR (see table 3.2 and figure 3.4).  We have found that the C-terminal half of helix Aα1 and all 
of helix Aα2 become highly protected in the complex (see figure 3.4).  Helices Aα1 and Aα2 lie 
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in a hydrophobic groove formed by CBP helices Cα1 and Cα3.15  NMR measurements of 
secondary chemical shifts showed dramatic increases in secondary structure across all of Aα1 
and Aα2.37  We found that the linker between Aα1 and Aα2 remains unprotected from H/D 
exchange in the ACTR/CBP complex indicating that this region remains unstructured, consistent 
with NMR relaxation measurements showing that the linker is highly dynamic in the complex.37  
The largest increase in protection was in the N-terminal half of Aα3 (55-59) while the 60-71 
segment that covers the last two residues of Aα3 (62-63) has no increase in protection.  Only 
the N-terminal half of (residues 55-59 in our nomenclature) had significant increases in chemical 
shift upon complex formation.37 
 The effects of complex formation on protection in CBP are summarized in figure 3.5.  
Compared with ACTR, our H/D exchange data shows only modest increases in protection (9-
17-fold) in the complex.  This effect can be attributed to higher protection in free CBP that 
increases the denominator in the protection ratio.  Our H/D exchange measurements show that 
the C-terminal half of Cα2 and the N-terminal half of Cα3 (residues 30-43) become the most 
highly protected regions of bound CBP.  There are only small increases in protection in bound 
CBP in the segments that span the N-terminal of Cα1 and the C-terminal of Cα3 (1-14 and 43-
59, respectively).  Two factors limit the increase in protection in these regions in the complex.  
First, fraying of the ends of the helices is evident in the ensemble of structures of free CBP.38 
Second, the 1-14 and 43-59 segments encompass unstructured terminal tails.  Protection in the 
17-30 segment of bound CBP is greater than in the tail regions, but less than in the central core 
of CBP.  Since the 17-30 segment spans the long linker between Cα1 and Cα2 and the flexible 
polyQ region, limited increase in protection here is consistent with flexibility in this region of 
bound CBP.  Our results may at first appear to contradict the secondary chemical shift data37 
showing that CBP was well-structured and that binding to ACTR induced negligible changes in 
secondary chemical shifts across all of Cα1 and Cα2, with minor increases in secondary 
chemical shift only in Cα3.  This apparent contradiction arises because H/D exchange 
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measurements on free CBP reflect the inter-conversion between folded and unstructured 
conformers (see previous section).  Without this inter-conversion, the H/D exchange protection 
in free CBP would be much higher and the fold-increases upon binding would be much smaller. 
3.5 Conclusions 
 In this work, we have tested the capabilities of H/D-MS on the model IDPs CBP and 
ACTR and their synergistically folded complex.  Our results demonstrate that a great deal can 
be learned about IDPs using the technique.  We have demonstrated the ability to detect traces 
of residual structure in the unstructured protein ACTR.  In the case of molten globular CBP, 
limited, but uniform protection revealed rapid inter-conversion between ensembles of relatively 
well-protected conformers and unstructured conformers.  An important point that emerges from 
this work is that the seemingly rapid, uniform exchange, as we observed with CBP, could be 
easily misinterpreted as indicating an unstructured protein.  With the folded complex, we have 
identified short segments of CBP and ACTR that undergo coupled binding and folding and our 
results show that the inter-conversion between free and bound forms of the proteins is fast on 
the H/D exchange timescale.  Overall, the picture of ACTR and CBP that emerges from our H/D 
exchange measurements is consistent with previous biophysical measurements. 
 Our work also underscores the point that the effects of ligand binding need to be 
interpreted carefully.63-64 This is particularly important with IDPs since the free form of the IDP 
will often be weakly protected.  A small population of rapidly exchanging free IDP can dilute the 
protection observed in the complex.  Limited protection in the complex might be misinterpreted 
as a loosely folded complex. 
 H/D-MS holds the promise of making good progress in the difficult terrain of intrinsically 
disordered proteins.  While peptide-level H/D exchange lacks the single amide resolution 
afforded by NMR, mass spectrometry offers two distinct advantages.  First, mass spectrometry 
affords the ability to measure H/D exchange using only picomole quantities of protein under 
dilute solution conditions.  Given the difficulty that many laboratories have encountered in the 
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expression and purification of recombinant IDPs, there may simply never be enough protein for 
NMR or other biophysical methods.  The second advantage of mass spectrometry is that protein 
mass is nearly unlimited.  Recent work with ~150 kDa monoclonal antibodies65 and viral 
assemblies66 has clearly demonstrated the ability of H/D-MS to handle large proteins.  In large 
proteins, identification of short unstructured molecular recognition features (MoRFs) that 
undergo coupled binding and folding67 would be difficult by any other technique. 
 Our work also reveals a number of important unmet needs for continued development of 
H/D-MS as a tool to probe intrinsically disordered proteins.  While the stretched exponential 
equation46-47 does seem to empirically describe H/D exchange kinetics, the theoretical basis for 
its use and for the interpretation of the derived parameters is currently lacking.  In the absence 
of a good model to justify use of the stretched exponential, we believe derivation of 
thermodynamic values from segment-averaged protection should be approached with caution.  
There is clearly a need for an extension of the two-process model of H/D exchange to explicitly 
address both segment-averaging and the departure of IDPs from exchange under the 
conventional kinetic limits.  We speculate that such an extension might lend new insight into the 
analysis of H/D exchange kinetics in IDPs.  Finally, measurements at shorter dead times (msec-
sec) would also be beneficial for characterizing residual structure in unstructured proteins such 
as ACTR. 
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Figures and Tables 
Table 3.1. Peptide Assignments. 
 
  
ACTR(1-12) GTQNRPLLRNSL 9 5.0 456.93 3 1367.77 1367.76 2.21
ACTR(13-22) DDLVGPPSNL 6 6.5 1026.51 1 1025.50 1025.50 -0.12
ACTR(29-35) RALLDQL 5 6.2 414.75 2 827.49 827.49 1.17
ACTR(33-42) DQLHTLLSNT 8 6.6 571.30 2 1140.58 1140.58 0.67
ACTR(33-47) DQLHTLLSNTDATGL 13 7.2 799.91 2 1597.80 1597.79 1.43
ACTR(36-47) HTLLSNTDATGL 10 5.9 621.82 2 1241.63 1241.63 1.03
ACTR(48-59) EEIDRALGIPEL 9 7.2 677.87 2 1353.72 1353.71 1.68
ACTR(60-71) VNQGQALEPKQD 9 3.3 663.84 2 1325.66 1325.66 2.04
CBP(1-10) PNRSISPSAL 7 5.1 521.29 2 1040.56 1040.56 3.01
CBP(1-14) PNRSISPSALQDLL 11 7.1 755.92 2 1509.82 1509.82 3.52
CBP(17-30) LKSPSSPQQQQQVL 10 4.9 784.43 2 1566.84 1566.84 1.97
CBP(30-38) LNILKSNPQ 6 5.5 513.80 2 1025.59 1025.59 1.36
CBP(31-40) NILKSNPQLM 7 5.8 579.32 2 1156.63 1156.63 2.97
CBP(40-43) MAAF 2 5.9 439.20 1 438.19 438.19 1.17
CBP(43-59) FIKQRTAKYVANQPGMQ 14 4.1 660.69 3 1979.05 1979.04 3.48
Mass error 
(ppm)
# of exchangable 
amides RT (min)
Monoisotopic m/z 
(observed) zPeptide Sequence
Monoisotopic Mass 
(observed)
Monoisotopic Mass 
(calculated)
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Table 3.2. Peptide deuterium uptake kinetics. 
  
  
Protein Segment Residues β k int (s-1) N k HX,free (s-1) PF N 1 N 2 k HX,1 (s-1) k HX,2 (s-1) PF 1 PF 2 PF 1/PFfree PF 2/PFfree
ACTR 1-12 1018-1029 0.60 1.8 8.3 1.8 1.0 8.0 3.0 0.60 0.60
ACTR 13-22 1030-1039 0.61 1.1 5.0 0.44 2.4 5.1 0.54 1.9 0.80
ACTR 29-35 1046-1052 0.90 0.61 4.4 0.34 1.8 4.5 0.023 27 15
ACTR 33-42 1050-1059 0.66 1.9 7.0 1.2 1.6 3.2 3.7 0.43 0.010 4.4 181 2.7 113
ACTR 33-47 1050-1064 0.72 1.7 11 1.3 1.4 7.3 3.9 0.56 0.011 3.1 154 2.3 114
ACTR 36-47 1053-1064 0.73 1.5 7.9 0.93 1.7 5.4 2.6 0.66 0.012 2.3 131 1.4 79
ACTR 48-59 1065-1076 0.77 0.63 7.0 0.31 2.0 1.6 5.5 1.1 0.0046 0.59 136 0.29 67
ACTR 60-71 1077-1088 0.57 1.0 7.4 0.67 1.6 7.7 0.59 1.8 1.1
CBP 1-10 2059-2068 0.75 2.0 6.5 0.50 4.1 6.4 0.50 4.0 0.99
CBP 1-14 2059-2072 0.70 1.3 9.3 0.30 4.2 8.9 0.11 12 2.7
CBP 17-30 2075-2088 0.74 2.1 9.1 0.37 5.7 8.8 0.044 48 8.4
CBP 30-38 2088-2096 0.64 1.3 5.7 0.24 5.4 5.5 0.022 59 11
CBP 31-40 2089-2098 0.68 1.3 6.3 0.22 5.7 6.1 0.017 73 13
CBP 40-43 2098-2101 0.97 1.4 2.1 0.28 5.0 2.0 0.017 84 17
CBP 43-59 2101-2117 0.75 1.6 12 0.37 4.3 11 0.081 20 4.6
Intrinsic Free Complex
100 
 
 
Figure 3.1. Mass spectra showing deuterium uptake in several distinctive regions of CBP and 
ACTR in both the free and bound states for selected D2O exposure times.  The vertical dashed 
lines denote the undeuterated (0 s) and fully deuterated (12 hr) limits.  The mass spectra show 
a steady progression of deuterium uptake with no evidence of bimodal isotope profiles. 
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Figure 3.2.  Deuterium uptake curves for the distinctive regions of CBP and ACTR shown in 
figure 3.1.  The upper row of plots show the full time-course on a logarithmic scale while the 
lower row of plots are the early time points on a linear scale.  The dotted curves represent the 
calculated intrinsic rate of exchange calculated using equation 1.  Deuterium uptake data are 
shown with data points, with black points representing uptake by the free proteins and gray 
points representing uptake by the proteins in the complex.  Data points represent the average 
values obtained from two trials with error bars extended to the specific data points from each 
trial.  Stretched exponential (or bi-exponential for ACTR peptides 33-42, 33-47, 36-47, and 48-
59 in the complex state) curves overlay each set of data, with black broken curves and gray 
broken curves representing the free and protein complex states, respectively.  For reference, 
the maximum deuterium uptake, measured after 24 hr of exchange, is shown as a horizontal 
dashed line with the exception of ACTR 60-71, which did not produce a detectable spectral 
intensity.  The maximum number of exchangeable amides (nresidues – nproline – 2) is indicated by 
the limit of the vertical axis of the plot. 
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Figure 3.3.  Deuterium uptake curves for all measured peptides of CBP and ACTR, plotted as 
shown in figure 3.2, but only using a logarithmic time scale for D2O exposure. 
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Figure 3.4.  Protection factors mapped onto the sequences of ACTR and CBP for each peptide 
for both free and bound forms.  The assigned secondary structural elements from the 
CBP/ACTR complex15 are also indicated.   The first two residues of each peptide are shown in 
gray to indicate that rapid back exchange of deuterium label at these two positions leads to no 
measurable deuterium uptake. 
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Figure 3.5.  The structure of the ACTR/CBP complex (PDB: 1KBH)15 showing relative increases 
in protection of (a, b) ACTR and (c, d) CBP that accompany complex formation.  The cognate 
binding partner is shown in surface representation.  In a and b, a modeled unstructured N-
terminal region was appended to the NMR structure of ACTR.  This figure was rendered using 
Pymol (version 0.99, DeLano Scientific, South San Francisco, CA). 
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Figure 3.6.  This conceptual representation of the H/D exchange flux model illustrates how the 
low, uniform protection observed for free CBP can be explained by inter-conversion between an 
ensemble of folded conformers and an ensemble of unstructured conformers.  Since the 
unstructured conformers are much less protected from exchange, most of the total flux of 
exchange occurs through the unstructured ensemble, as depicted by the heavy arrow.  See text 
for additional details.  The protein structures presented in this figure are conceptual models only 
and do not imply any structural details about the conformations.  This figure was rendered with 
Pymol (version 0.99, DeLano Scientific, South San Francisco, CA) using the structure of CBP 
from the CBP/ACTR complex (PDB: 1KBH)15 as a starting point. 
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Chapter 4: Rapid H/D Exchange Analysis of IDPs Using a Quench-Flow Apparatus 
4.1 Introduction 
 4.1.1  Complete Exchange of IDPs with Short Labeling Time 
 Deuterium exchange mass spectrometry (H/D-MS) is a versatile method for studying 
conformational dynamics of intrinsically disordered proteins (IDPs).1-5  The previous chapter, 
chapter 3, discusses the H/D-MS analysis of the nuclear co-activator binding domain of the 
CREB binding protein (CBP) and the activation domain of the activator of thyroid and retinoid 
receptors (ACTR).  In that study, we were able to confirm that CBP is partially folded in its native 
state, proposing that it exists as a molten globule.  We observed that ACTR has little to no 
protection across its entire sequence in its native state.  We also observed marked increases in 
protection from exchange in both of these proteins as a result of their binding together.  
However, the deuterium exchange labeling technique was limited by our ability to consistently 
and reproducibly pipette deuterium label and quench, imposing a lower reaction time limit of 
about 5 seconds.  Because of the near-intrinsic exchange rate by native ACTR and fast 
exchange by native CBP, peptic peptide resolved analysis revealed that most amide hydrogens 
exchanged before 5 seconds of reaction. 
In describing the data in chapter 3, we used stretched exponentials to fit experimental 
H/D-MS data.  In fitting curves to mostly or completely exchanged peptides, much of the curve 
shape prior to the 5 second time point was estimated using only the theoretical intrinsic 
exchange curve shape.  This revealed the need for the ability to prepare deuterium exchange 
samples with on-exchange times on the millisecond time scale in order for us to form a more 
complete deuterium exchange curve.  In this chapter, we will discuss the construction and 
validation of a simple quench-flow apparatus, and its use in studying the rapid deuterium 
exchange kinetics of CBP and ACTR.  A simple design allows for easy construction of the 
apparatus.  Loop injections from a 6-port valve aid in sample conservation.  The quench-flow 
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apparatus is capable of preparing deuterium exchange samples with reaction times of 42 
milliseconds or longer. 
 4.1.2  Rapid H/D 
 Many instruments and devices have been designed for the study of sub-second 
timescale reactions.6-8  The rapid progression of such reactions, and the possibility for direct 
connection of these devices into detectors, such as a mass spectrometer, allows for the 
temporal resolution of reactions such as protein denaturation or folding.9-12  For a deuterium 
exchange experiment, one of the simplest designs used is the continuous-flow system, which 
uses multiple syringes to drive analyte buffer and labeling solution together in a mixer.13-14  
Continuous-flow systems are used to guide eluent directly into a detector for real time analysis.  
H/D exchange has been carried out using a continuous-flow apparatus with direct MS 
analysis.12  Conformational information about the intermediate states in the folding of 
apomyoglobin upon binding to free heme groups was captured with a short (7 ms) D2O pulse.12  
An adjustable reaction capillary allowed refolding progress to be monitored after varying times 
of the folding reaction.12  The design of the continuous-flow apparatus provided a basis by which 
the quench-flow system discussed in this chapter would be designed. 
Using a quench-flow system provides an alternative approach which allows eluted 
sample to be collected prior to analysis.  A quench-flow apparatus may be designed with a third 
syringe, which will drive a quench solution flow into a second mixer to quench the reaction 
online.15-18  Controlling the amount of time that a protein or peptide is exposed to D2O buffer in a 
quench-flow device will depend on capillary volume and flow rate.  Quench-flow devices may be 
designed to have an adjustable capillary length in order to preserve consistent flow rates.12, 19 
Using a variable flow rate and a fixed length of reaction capillary will also produce adjustable 
reaction times.16, 20  The quench-flow apparatus used in this chapter has been designed to use 
an adjustable flow rate, controlled by a syringe pump (see below, section 4.2.2, for construction 
details).   
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While the eluent from our quench-flow apparatus could possibly be directly connected to 
the HPLC for chromatography,15 we decided to collect quenched samples into test tubes set in 
liquid nitrogen.  The purpose for this collection prior to analysis is to reduce the variability in the 
amount of time quenched eluent spends in the solution phase.  Other quench-flow designs, 
such as one used to analyze horse heart cytochrome c,13 also integrated a proteolytic digestion 
stage in the quench-flow apparatus.  Quench-flow systems may also be designed on 
microfluidic devices or chips.17-18 One micro-reactor chip design produced H/D exchange times 
between 20 and 148 ms to study ribosomal proteins.17  Another microfluidic quench-flow chip 
integrated a proteolytic reactor for online digestion the study of cytochrome c, ubiquitin, and 
DAHP synthase properties.18 Utilizing an adjustable mixer position, H/D exchange times ranged 
from 42 ms to 10 s on this quench-flow chip.18  With reference to our previous work in chapter 3, 
we demonstrate that comparable datasets can be used to cover a wide range of D2O labeling 
times (42 ms to 3500 ms by quench-flow, 5 s to 12 hours by pipetting) and more complete 
deuterium uptake curves for IDPs can be measured. 
4.2 Materials and Methods 
 4.2.1  Materials 
 Deuterium oxide (99.9% D) and fluorescein isothiocyanate (FITC) conjugated albumin 
were obtained from Sigma (St. Louis, MO).  99+% formic acid, used as a mobile phase additive, 
was obtained from Thermo Scientific (West Palm Beach, FL).  Sodium phosphate monobasic, 
sodium phosphate dibasic, sodium hydroxide, hydrochloric acid, and sodium chloride were 
obtained from Fisher Scientific (Hanover Park, IL).  Optima LC/MS grade acetonitrile and water 
used in chromatography were also obtained from Fisher Scientific.  Individual components of 
the 9-peptide test mix were each obtained from AnaSpec, Inc. (Fremont, CA).  The sequences 
for each of 9 peptides are listed here and represented in figure 4.3: MQMKKVLDS (anti-
inflammatory peptide 1), SFLLRNP (thrombin receptor (42-48) agonist, human), 
PLARTLSVAGLPGKK (syntide – 2), ASHLGLAR (C3a (70-77)), DRVYIHPFHL (angiotensin 1, 
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human), YRQSMNNFQGLR (adrenomedullin (1-12), human), EQKLISEEDL (c-Myc peptide 
epitope), IKNLQSLDPSH (cholecystokinin (10-20)), and RRLIEDNEYTARG (pp60(v-SRC) 
autophosphorylation site).  CBP and ACTR stocks were obtained from previous in-house 
preparations, as described in chapter 3, with initial concentrations of 13.0 and 14.4 µM, 
respectively.  
 4.2.2  Quench-Flow Construction 
The quench-flow apparatus was constructed using entirely off-the-shelf parts, requiring 
no specialized machining or nano-flow components or chips.  P-662 luer-to-MicroTight adapters 
(IDEX, Oak Harbor, WA) allow users to quickly refill and replace luer-lock syringes.  Sample 
loop size, reaction line volume, and sample collection may also be customized.  The 
configuration of the quench-flow apparatus is shown in figure 4.1.  Solution flow and mixing was 
driven by a single Fusion 400 syringe pump (Chemyx, Stafford, TX).  Three syringes were 
selected by relative inner diameter and volume to deliver specific flow rates into the mixers.  In 
our studies, a 1 mL syringe delivered appropriate storage buffer into a 6-port valve (Valco 
Instruments Co. Inc.).  While the valve was in the “load” position, flow was directed through 40 
µm inner diameter (ID) fused silica capillary into the first mixer, a PEEK MicroTee (IDEX).  The 
valve was switched to the “inject” position, as shown in figure 4.1, where the syringe flow 
pushed a plug of sample into the first mixer.  The second syringe, a 5 mL syringe, delivered 
labeling buffer through 150 µm ID fused silica capillary into the first mixer.  The resulting 
reaction mixture eluted from the first mixer through a 4.0 cm length of 150 µm ID fused silica 
capillary into a second MicroTee.  A third syringe, also a 5 mL syringe, delivered the quench 
buffer through 150 µm ID fused silica capillary into the second mixer.  The labeling was 
quenched and the quenched solution eluted out of the quench-flow apparatus. 
To perform a qualitative assessment of mixing efficiency, magnified images of a 22 cm 
long, 150 µm ID fused silica capillary connected at the outlet of the first mixer were captured.  
An Axio Vert. A1 microscope (Carl Zeiss Microscopy, Thornwood, NY) was used to monitor the 
111 
capillary at about 6 cm downstream of the first mixer.  The fused silica capillary shown in the 
microscope images was stripped of its coating around the length being monitored using a brief 
exposure to open flame.  The microscope images were taken at 2500 ms exposure every 10 
seconds after sample injection.  A 20X magnification was used to capture the images.  A single 
10 µL injection of 1.2 mg mL-1 FITC conjugated albumin (prepared in 10 mM Tris-HCl) was 
pushed into the mixer by 10 mM Tris-HCl.  Also flowing into the mixer was a mock labeling 
buffer, which was also 10 mM Tris-HCl.  In the 1:20 flow ratio configuration (see section 4.3.1), 
the flow rates of sample and mock labeling buffer were 5 µL min-1 and 100 µL min-1, 
respectively.  In the 1:5 flow ratio, the flow rates of sample and mock labeling buffer were 20 µL 
min-1 and 100 µL min-1, respectively.  Fluorescence of the FITC conjugated albumin is observed 
upon excitation with ~470 nm light, produced by a DC4100 4-channel LED driver (Thorlabs, 
Newton, NJ). 
 4.2.3  Test Peptide Mixture Labeling by H/D Exchange 
 The rapid H/D exchange method was initially tested using a 9-peptide test mix. The test 
mix was prepared by diluting the peptides to a concentration of 1 ng µL−1 in 10 mM phosphate, 
50 mM sodium chloride, pH 6.9.  An undeuterated control was prepared by diluting 50 µL of the 
test mix with 250 µL 10 mM phosphate, 50 mM NaCl, pH 6.9 and 250 µL 200 mM phosphate, 
pH 2.6 to simulate the addition of labeling buffer and quench.  A totally deuterated control was 
prepared by diluting 50 µL of test mix with 250 µL phosphate buffer in D2O, pD 6.9, followed by 
the addition of 250 µL of pH 2.6 quench after 1 hour of reaction.  Rapid H/D exchange prepared 
samples were prepared using 10 µL injections of test mix, which was reacted with the same 
D2O labeling buffer as the totally deuterated control and quenched with 200 mM phosphate, pH 
2.6, as controlled by the quench-flow apparatus. 
 4.2.4  Protein Labeling by H/D Exchange 
 Each protein was prepared separately and in a 5-fold molar excess of its binding partner 
based on the reported dissociation constant of 34 nM for the CBP/ACTR complex.21  This molar 
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ratio will bind over 97.5% of the limited protein in their complex state samples during the D2O 
labeling stage.  Thus, in this study, four stock solutions were prepared: CBP only (2.3 µM CBP), 
CBP complex (2.3 µM CBP + 11.8 µM ACTR), ACTR only (2.2 µM ACTR), ACTR complex (2.2 
µM ACTR + 11.1 µM CBP).  The same labeling and quench buffers were used for CBP/ACTR 
samples as the 9-peptide test mix.  Undeuterated and totally deuterated controls were also 
prepared similarly to the test mix, with the exception that the totally deuterated samples were 
allowed to undergo H/D exchange for over 14 hours prior to quench. 
Adjustments to the configured syringe pump flow rates allow a wide range of H/D 
exchange labeling times to be covered.  In our protein studies, flow rates ranged from 10.0 to 
833.3 µL min−1 from the 5 mL syringes, and 2.0 to 166.7 µL min−1 from the 1 mL syringe.  Higher 
flow rates would have produced excessive back pressure in the syringes.  With a reaction 
capillary volume of 0.7 µL, the applied flow rates produced rapid H/D labeling times between 42 
and 3500 ms.  Reaction times ranged from 42 to 5250 ms for the 9-peptide mix samples. The 
5250 ms time point was included with the 9-peptide mix samples because there is no previous 
H/D-MS dataset with a 5 second time point to be used for comparison.  10 µL sample loop 
injections, enabled by the inclusion of the 6-port valve, ensured low sample consumption per 
sample collected.  Because of the dilution caused by mixing sample with label and quench, a 
volume of at least 150 µL was collected for the subsequent digestion, chromatography, and MS 
analysis steps (see below). 
Quenched samples were eluted directly into a micro-centrifuge tube set in liquid nitrogen 
(see figure 4.1).  The tube was held a few centimeters below the end of the outlet capillary to 
prevent blockage by rapidly frozen eluent.  The length of time required to collect sufficient 
volume of eluted sample varied from a few seconds to several minutes in our study.  The 
immediate freezing by liquid nitrogen ensured that each labeled droplet within a single sample 
run spent the same amount of time in the liquid state following quench (within a few seconds, 
due to slower flow rates taking longer to produce droplets).  An alternative method may include 
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collecting a full sample volume in a test tube first, capping the tube, and then placing the tube in 
liquid nitrogen or analyzing the sample immediately.  For the longest time points (slowest flow 
rates), this alternative method would result in the first eluted droplet spending several minutes at 
room temperature, while the final droplet will have only spent a few seconds at room 
temperature.  This would result in uneven back exchange within the same sample. 
 4.2.5  Chromatography and MS Analysis 
 The chromatographic method for the digestion and separation of protein was designed 
to replicate our previous CBP and ACTR study closely.  For the 9-peptide mix samples, the 
immobilized pepsin column was replaced by a narrow-bore union.  An Agilent Technologies 
1200 series binary pump was used to carry out a high performance liquid chromatography 
separation of peptides.  Solvents A and B were 0.1% formic acid in water and 90% acetonitrile / 
10% water / 0.1% formic acid, respectively. An A to B gradient (5-65% B over 5 minutes for 9-
peptide mix, 5-60% B over 5 minutes for digested protein) was applied to separate peptides on 
a C12 column (Jupiter 4 µm, 90 Å Phenomenex).  Intact protein samples were initially injected 
onto a self-packed C4 trap for desalting, and were separated using a 5-60% B over 2 minutes 
gradient with no HPLC column in place.  A thermoelectrically refrigerated system kept 
chromatography components at a stable temperature of about 0 oC (see chapter 2). 
 The MS analysis method was also designed to closely replicate previous work.  Due to 
improvements in protein preparation, sample dilutions, and instrument limits of detection and 
sensitivity, more peptic peptides were identified by mass spectrometry for both CBP and ACTR 
than were previously discovered.  The intact CBP and ACTR samples served as both a global 
rapid H/D exchange test and as an initial mass check for the CBP and ACTR protein stocks, 
which confirmed the absence of any extensive post-translational modifications.  Minor oxidation 
products were observed, but these did not produce an intense enough signal to interfere with 
deuterium uptake measurements. 
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Separate peptide databases were prepared for the 9-peptide mix, intact CBP, intact 
ACTR, digested CBP, and digested ACTR listing the appropriate retention time, charge state, 
and sequence information.  The HDExaminer software package (version 1.1.0, Sierra Analytics, 
Inc., Modesto, CA) was used to extract peptide mass spectra, measure average mass, and 
measure deuterium uptake using raw mass spectral data and the peptide databases. 
 4.2.6  Kinetic Analysis 
 An intrinsic exchange curve was calculated for each peptide analyzed in this study to 
predict the deuterium uptake kinetics for each peptide as if it was a random-coil, as previously 
described in chapter 3.  For CBP and ACTR samples, both intact and peptic digest, the intrinsic 
exchange curve was normalized by the ratio of average mass measured for totally deuterated 
control samples and the maximum number of exchangeable amide hydrogens.  This accounted 
for the 83.3% maximum deuteration (1:5 sample buffer to D2O buffer ratio) and peptide specific 
back-exchange.  For the 9-peptide test mix, the intrinsic exchange curve was normalized to 
match the measured uptake at the last measured time point (see figure 4.3), as totally 
deuterated control samples indicated deuterium uptake beyond theoretical limits (data not 
shown). 
The kinetic analysis was replicated from the previous work in chapter 3, which includes a 
stretched exponential curve-fitting to measure deuterium uptake protection factors, PF .  The 
curve fits were calculated using data only from 42 ms to 3500 ms of rapid H/D labeling and the 
totally deuterated controls.  Though shown for illustrative purposes in figure 4.6, the manually 
labeled H/D dataset encompassing labeling times from 5 seconds to 12 hours, originally 
presented in chapter 3, was not included in curve-fitting calculations.  Exceptions to the curve-fit 
method were made for peptides when the mass increase did not reach half of the number of 
exchangeable amides within 3500 ms of exchange.  The measured protection factors for ACTR 
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and CBP peptic peptides, both free and bound in complex, are mapped in figure 4.7 and listed 
in table 4.1. 
To correlate the dataset from this experiment with results presented in chapter 3, we 
normalized previously acquired deuterium uptake curves, Δmmanual(t), to fit newly acquired 
curves.  We adjusted the mass increase for each measurement by the ratio between the 
quench-flow experiment’s totally deuterated control, ΔmTDQF, and the previous experiment’s 
totally deuterated control, ΔmTDmanual, as shown in equation 1: 
 
(1) 
An exception was made for ACTR 1077-1088, which did not have a measurable totally 
deuterated MS feature in the previous dataset.  Instead, the uptake curve was normalized by 
the theoretical Dmax difference between the two datasets (i.e. 83.3%:95%).  The normalized, 
previous datasets, Δmmanual(t)adj., are shown by black points (free protein) points and white points 
(bound protein) in figure 4.6.  Intrinsic exchange curves (dotted lines on figure 4.6) were also 
normalized to totally deuterated samples from the rapid H/D dataset. 
4.3 Results and Discussion 
 4.3.1  Optimizing Mixer Design under Laminar Flow Conditions 
In designing a quench-flow mixing apparatus, several challenges needed to be 
overcome.  One challenge was accurately measuring the amount of time analyte spent 
undergoing a reaction in a short capillary.  Merging two streams of buffer together in a mixer to 
produce a uniform mixture at the outlet was another challenge.  The effects of laminar and plug 
flow were also considered, as these fluid behaviors affect the age distribution of reacting 
analyte.22  We adjusted the quench-flow apparatus design to address problems that arose with 
sample consumption, mixing efficiency, and sample collection and storage.   
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The homogenous velocity of a plug of solution traveling via turbulent flow makes the age 
of that plug easier to predict.22  Under ideal turbulent flow conditions, the reaction time, trxn, for 
analyte undergoing deuterium exchange in the reaction line following the mixing in of D2O is a 
function of the geometric reaction capillary volume, Vgeo (determined by reaction capillary length, 
L, and reaction capillary radius, rd), and total flow rate, F1+F2, as shown in equation 2:  
 
(2) 
Under laminar flow, the velocity of solution will be distributed across the capillary, 
depending on its radial position.19 The fastest stream will lie in the center of the capillary and the 
slowest will lie along the capillary walls.  Turbulent flow is desirable because it will maintain 
constant mixing between slow and fast streams of a fluid moving through a capillary.22  Whether 
a fluid is moving via turbulent flow or laminar flow through a capillary can be predicted using the 
Reynold’s number.  The Reynold’s number, Re, is calculated as in equation 3, where v 
represents linear velocity of the flow, d represents capillary diameter, ρ represents the fluid 
density, and µ represents the absolute viscosity of the fluid: 
 
(3) 
At the highest flow rate used in this rapid H/D study, v = 0.94 m s-1 through the reaction capillary 
of d = 1.5 × 10-4 m.  Assuming pure deuterium oxide and using ρ = 1105 kg m-3 and µ = 1.25 × 
10-3 N s m-2 at 20 °C,23 Re was about 125.  Since the Reynold’s number for all flow paths at the 
proposed flow rates was estimated to be below 2000, the approximate value necessary for 
turbulent flow,24 it would seem the possible effects of laminar flow on H/D exchange reaction 
time should be considered.   
The reaction age of molecules flowing through a capillary will be highly distributed due to 
laminar flow effects, but these effects will be partially corrected when molecular diffusion is 
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considered in a narrow capillary.19, 22  In simulations, molecules without molecular diffusion 
produced a wide, trailing distribution of reaction age in a capillary.  For larger molecules, such 
as protein, diffusion coefficients will be relatively small.  When higher diffusion coefficients and 
longer capillaries are applied, the highest frequency age (the peak of the distribution) moves 
closer to what it would be under turbulent plug flow.19, 22  In other words, radial diffusion counters 
the laminar flow effect of parabolic radial velocity distribution.  However, even in laminar flow 
reaction kinetics simulations,22 a laminar flow simulation without molecular diffusion still provides 
a fair first-approximation of fractional reaction progression for rate constants expected from 
intrinsic exchange calculations.  Even a small diffusion coefficient expected for proteins will 
improve the disparity between homogenous flow and laminar flow in reaction kinetics 
calculations.  In this chapter, we have calculated D2O exposure times as though flow in the 
reaction capillary was plug flow. 
Volumetric flow rates, F, are determined by the syringe pump with a single syringe pump 
piston producing flow rates based on syringe diameter. The respective radii of each capillary, r, 
will determine the linear velocity of the fluid, ν, which is proportional to the square of these radii 
as given by equation 4: 
 
(4) 
Therefore, if 150 µm ID (r = 75 µm) fused silica capillary was used to deliver both sample and 
labeling buffer into the first mixer, the linear velocities of each stream would be proportional to 
the flow rates. Using 150 µm ID for all capillary lines and a 1:20 sample to labeling buffer flow 
rate ratio would have produced a ratio of 1:20 in their linear velocities.  This 1:20 sample to 
labeling buffer flow rate ratio would have been desirable, as it would have allowed up to ~95% 
deuteration maxima before back exchange. 
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Simple tests using commercial food dye and water revealed problems with mixing two 
solution streams together at a flow rate ratio of 1:20.  When the outlet capillary of the first mixer 
was viewed under a microscope, both the food coloring stream and the water stream could be 
observed, still separate.  This observation revealed that the two streams were not mixing 
properly.  The dye stream appeared to be “pinned” to the edge of the capillary by the 
overwhelming water stream.  Initial trials may have been unsatisfactory due to a mismatch in the 
flow streams’ linear velocities. 
The sample buffer capillary was replaced with 40 µm ID (r = 20 µm) capillary, to better 
match the linear velocity of the sample stream and the label stream.  When using a 500 µL 
sample buffer syringe and a 10.0 mL labeling buffer syringe, this new capillary configuration 
produced a linear velocity ratio of about 14:20 between the sample and labeling streams, 
instead of the full 1:20 ratio as it would be with equal diameter capillaries.  Unfortunately, the 
two streams still failed to mix properly.  Figure 4.2A shows a sequence of magnified 
fluorescence images following injection of FITC conjugated albumin and mock labeling buffer 
into the first mixer at a flow rate ratio of 1:20 and a linear velocity ratio of 14:20.  These images 
show the coating-stripped, transparent portion of the capillary at a fixed 6 cm distance 
downstream of the first mixer.  Food dye molecules diffuse much faster than more bulky protein 
molecules, so food dye may not provide an accurate test model.  Therefore, the use of albumin, 
a 66 kDa protein, as an analyte better simulated mixing under the conditions of an H/D 
exchange labeling experiment.  As can be seen over the time course of figure 4.2A, the two flow 
streams remained separate following the first mixer.  The separate streams indicate incomplete 
mixing.  These images also reveal that the sample stream was delayed, taking the fluorescence 
over 300 seconds to fully disappear after its first appearance. The expected clearance time of 
analyte, tclear, may be calculated based on loop volume, Vloop, and sample stream flow rate, F1, 
as in equation 5:  
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(5) 
In the images captured in figure 4.2A, a 5 µL min-1 sample buffer flow rate pushed a 10 µL loop 
injection and mixed with a 100 µL min-1 labeling buffer flow rate out in the first mixer.  Under 
ideal plug flow, fluorescence disappearance should reflect the clearance time and only require 
120 seconds under these conditions.  The longer disappearance time could indicate that sample 
dwells within the reaction capillary for a long time.  This could mean that D2O exposure times 
are skewed to be much longer than what is expected.  This problem may be caused by the 
overwhelming 20-fold greater flow rate of labeling buffer, which pinned the smaller sample flow 
against the walls of the capillary under laminar flow. 
To eliminate these problems, a 1:5 mixing ratio was chosen, instead.  This syringe 
configuration actually made the linear velocity of the sample stream faster than that of the 
labeling buffer, with about a 2.8:1 ratio. When we repeated the food dye and fluorescent protein 
conjugate tests in this configuration, only a single stream of fluorescence or dye was observed 
in the outlet line from the first mixer.  Figure 4.2B shows time-resolved sequence of capillary 
images for the 1:5 configuration following the injection of FITC-albumin.  The fluorescence 
mostly disappeared about 30 seconds after its first appearance with some residual fluorescence 
persisting longer, which was close to the disappearance time of 30 seconds expected for ideal 
plug flow (i.e. 10 µL injection is pushed by 20 µL min-1 sample buffer flow).  The observations of 
a single stream and a narrow clearance time indicate a better mixing efficiency and plug-like 
flow in the 1:5 flow ratio configuration. 
 4.3.2  Validation of Quench-Flow Labeling 
We conducted a practical test to ensure deuterium exchange initiated by using the 
quench-flow apparatus produced measurable deuterium uptake at reaction times approximated 
by equation 2.  To perform this test, a mixture of 9 different peptides was deuterated then 
loop
clear
1
V
t
F
=
120 
analyzed by HPLC and mass spectrometry.  The deuterium uptake curves measured from these 
peptides, which have been labeled with D2O exposure times ranging from 42 ms to 5250 ms as 
calculated according to equation 2, are presented in figure 4.3.  The calculated intrinsic 
exchange curves (see chapter 3), Δmint(t), have been normalized to the ratio between the 
measured mass increase, ΔmQF, of the latest measured time point for each peptide, tmax and the 
predicted mass increase for intrinsic exchange, Δmint, at the same tmax. 
 
(6) 
Intrinsic exchange was normalized this way since some totally deuterated controls were either 
not detected or showed C-terminal amide deuteration that was slower than the measured 
timescale.  The 5250 ms time point for angiotensin 1 was also not detected.  We were able 
observe early exchange points with relatively small mass increase values and the progression 
of exchange as D2O exposure time lengthened. The closeness between calculated intrinsic 
exchange points and experimentally measured exchange points indicates that the calculated 
reaction times are accurate.  This agreement applies to both faster exchanging peptides, such 
as YRQSMNNFQGLR, and slower exchanging peptides, such as EQKLISEEDL. 
4.3.3.  Rapid H/D Exchange by Intact CBP/ACTR 
We also conducted an initial test using the quench-flow apparatus to rapidly label the 
ACTR and CBP proteins and analyze these samples without a peptic digest.  The deuterium 
uptake curves from this experiment are shown in figure 4.4.  The intrinsic exchange curves, 
Δmint(t), in this figure were normalized by the ratio between the measured mass increase of the 
totally deuterated control for the quench-flow experiment, ΔmQFTD, and the totally deuterated 
mass increase for calculated intrinsic exchange, ΔmintTD, as shown in equation 7: 
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The exchange for free ACTR and CBP is slower than intrinsic exchange, which is indicative of 
the residual structure discussed in chapter 3 and in previous work.21  We also observe that 
protection from exchange increases when either protein is in the presence of a 5-fold molar 
excess of its binding partner.  This effect validates the binding of ACTR to CBP and vice versa, 
the effects of which we will be able to analyze using rapid H/D-MS with peptic digestion. 
 4.3.4  Quench-Flow Precision 
 The quench-flow apparatus demonstrates remarkable precision in the amount of 
deuteration observed in H/D-MS measurements.  For the peptide-level analyses of CBP and 
ACTR outlined in the following sections, 653 standard deviation values for measured mass 
increase were calculated.  Most of these standard deviations were calculated for triplicate H/D-
MS runs.  666 averaged data points were expected (37 peptides × 9 time points × 2 protein 
states).  However, standard deviations were not calculated for 13 points, since a feature was 
either detected in only one or none of the triplicate trials.  Standard deviations from runs with 
peptide detection in 2 of the 3 trial runs were included.  Figure 4.5 is a histogram that shows the 
frequency of specific standard deviation values.  534 of these 653 standard deviations fell within 
±0.1 Da.  The mean of the 653 standard deviation values was ±0.07 Da.  The median of these 
653 values is ±0.04 Da.  The precision of the quench-flow system in H/D mass increase 
measurements should be considered excellent.  Replicate sampling with three or more trials 
was conducted in an H/D-MS biopharmaceutical comparability analysis of interferon-β-1a.25  A 
standard deviation of ±0.14 Da was reported for these measurements. 
 4.3.5  Rapid H/D Exchange by Free ACTR 
 Our previous H/D-MS analysis of free ACTR revealed rapid exchange by all of the 
analyzed segments. The goal of this rapid H/D-MS study was to extend the labeling timescale 
beyond the five second minimum to the millisecond range in order to reveal any residual 
structural elements in the protein.  The deuterium uptake curves shown in figure 4.6 reveal that 
exchange occurs at near intrinsic rates for unbound ACTR segments.  Calculated stretched 
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exponential fit parameters and protection factors are shown in table 4.1 and figure 4.7.  For the 
C- and N-terminal located regions, particularly ACTR(1018-1029) and ACTR(1077-1088), the 
stretched exponential function overlaps with the intrinsic exchange function very closely, giving 
measured protection factors of 1.5 or less.  Some segments located within the sequence, such 
as ACTR(1040-1049), (1052-1055), (1060-1064), (1065-1076), and (1067-1076), showed slight 
protection from exchange with measured protection factors greater than 2.0.  Deuterium uptake 
curves for these mid-sequence segments were shifted up the time axis, representing slightly 
slower exchange than terminally located segments.  In the NMR study by Ebert, et al., slightly 
positive Cα and CO secondary chemical shifts were observed around ACTR 1031.26  A similar 
study also observed positive 13C methyl group secondary chemical shifts around ACTR 1031.27  
A slight increase in protection was also observed in rapid H/D measurements for ACTR 
segments (1030-1039), (1031-1039), and (1032-1039).  While this region was determined to be 
unstructured in earlier NMR studies,21 both results presented by Ebert et al. and these rapid H/D 
results imply a slight reduction in dynamics in this region.  The region of the Aα1 helix also 
showed a reduction in dynamics in NMR studies of free ACTR.26-27  This result is supported by 
our rapid H/D-MS data, as segments located within this region, particularly ACTR(1040-1049) 
and (1052-1055), exhibited larger protection factors. 
 4.3.6  Rapid H/D Exchange by ACTR in Complex with CBP 
 When ACTR was bound to CBP, we observed a marked increase in protection from 
exchange in regions measured to be α-helical by NMR.  As shown in figure 4.7, several 
segments within each α-helix showed a deuterium uptake too slow to characterize by curve-
fitting.  Exchange that was too slow was defined as having a mass increase of less than half of 
the totally deuterated controls within the 3500 millisecond exposure limit.  Segments that best 
exhibited this slowing of exchange include ACTR(1046-1049), ACTR(1046-1052), and 
ACTR(1052-1055), which are all located within Aα1.  Likewise, the ACTR(1065-1076) and 
ACTR(1067-1076) segments are both located across the Aα2 region and into the Aα3 region 
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and also exhibited protection from exchange.  The combined information for the unbound and 
bound ACTR supports the analysis from previous studies.21, 26  Free ACTR is thought to exist as 
a near random-coil protein in its native state across most regions, but gains a more stable 
conformation upon binding with CBP, specifically in the regions of α-helices.  The regions near 
the N-terminus, up to about residue 1040, remain highly dynamic, even when ACTR is bound in 
complex.  This supports the findings of the NMR study, which showed similar chemical shift 
profiles for this region in both free and bound ACTR.26 
 4.3.7  Rapid H/D Exchange by Free CBP 
 Free CBP showed rapid exchange for most regions analyzed, with a few exceptions.  
Like ACTR, the C- and N-terminal regions from CBP showed near intrinsic deuterium exchange 
rates, with protection factors of 1.5 or less for CBP(2059-2068), CBP(2059-2071), CBP(2101-
2117), and CBP(2110-2117) (see figure 4.7).  Protection factors for CBP segments (2068-
2071), (2089-2098), (2091-2096), (2092-2100), (2098-2101), and (2099-2101) were measured 
to be larger than 3.0 for free CBP.  While the magnitudes of protection factors measured for 
these segments are small relative to studies of stable, structured proteins, they exhibit the 
usefulness of the application of rapid H/D to IDPs.  Previously, as shown in chapter 3, all 
analyzed segments from free CBP showed fairly uniform protection, with PF  ranging from 4.1 
to 5.7.  More of the deuterium uptake curve was covered with the rapid H/D exchange times 
(ranging from 42 ms to 3500 ms).  This improved the accuracy of this chapter’s stretched 
exponential fits over those from chapter 3.  While the PF  values were smaller in the quench-
flow data, there was a greater contrast between individual segments. Deuterium exchange in 
the millisecond time scale revealed subtle differences in conformations of mostly unstructured 
proteins.  Our data supports the model of CBP being a loosely structured protein that undergoes 
transient unfolding in its native, free state.21, 26, 28  Protection was observed to be greater in 
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regions predicted to have transient conformation, shown as the α-helical regions in figure 4.7.  
These results suggest that not all conformers in the ensemble are equally unfolded. 
 4.3.8  Rapid H/D Exchange by CBP in Complex with ACTR 
 All analyzed regions show that CBP gains protection as a result of binding to ACTR.  As 
shown in figure 4.6, many non-terminal located regions of bound CBP exhibited slowed 
deuterium uptake.  CBP segments (2071-2089), (2088-2096), (2089-2098), (2091-2096), (2092-
2100), and (2100-2109) did not show at least half the mass increase of totally deuterated 
controls within 3500 ms of labeling.  In the short segments, CBP (2068-2071), (2098-2101), and 
(2099-2101), no measurable increase in deuterium uptake was observed within 3500 
milliseconds of exchange, as listed on table 4.1.  A stretched exponential fit would be 
inappropriate to describe segments that exchanged too slowly or not at all.  C- and N-terminal 
regions of CBP also exhibited an increase in protection upon forming the CBP/ACTR complex.  
The overall gain in exchange protection supports the model for CBP gaining conformational 
stability as a result of binding, becoming a globular protein.26, 28  This gain in conformational 
stability represents a very different protein dynamic change in CBP than it does in ACTR.  
Because native CBP is predicted to be a loosely structured molten globule, the protein 
ensemble contains many conformers that are stable and share similar secondary structure 
characteristics.  NMR results support the prediction that the ensemble is undergoing rapid inter-
conversion between conformers, which suggests a conversion between tertiary structures.28  
This differs from the transitions observed in the NMR study of ACTR, which showed that ACTR 
gains both secondary structure and tertiary structure as a result of binding to CBP.26  When 
CBP interacts with other binding partners, a different secondary structure configuration might be 
observed.  An example of another CBP conformation was observed when the CBP domain 
interacts with IRF-3 (PDB: 1ZOQ).29  The secondary structure map of CBP in complex with IRF-
3 differs from CBP bound to ACTR primarily in that the first helix (2066-2072) and third helix 
(2094-2103) are shorter.  When bound to ACTR, CBP residues 2070-2071 and 2100-2101 were 
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found to have the greatest protection from exchange.  Interestingly, both of these sets of 
residues are located in α-helical regions of CBP in the CBP/ACTR complex and CBP/IRF-3 
complex models. 
Rapid H/D-MS results captured the dynamic inter-conversion of CBP conformers in the 
free state.  These conversions are likely to expose amide hydrogens to exchange, as hydrogen 
bonding is disrupted during the transitions.  The binding of CBP to ACTR reduces the probability 
of these inter-conversion events, favoring the structure bound conformers.  This reduction in 
inter-conversion events was reflected by the gain in exchange protection in rapid H/D-MS 
measurements. 
4.4 Conclusions 
 In this work, we have described the construction and validation of a quench-flow 
apparatus and its application in the rapid H/D-MS analysis of the IDPs, ACTR and CBP.  The 
extension of deuterium exchange labeling times to a lower limit of 42 milliseconds allows for 
more accurate deuterium uptake curves to be measured for rapidly exchanging segments.  
While the technology of constructing a quench-flow system was already established, our 
apparatus was constructed from low-cost, available materials and required no specialized 
machining.  An advantage of using our quench-flow apparatus is the adjustable sample loop 
size, which helps conserve sample.  A smaller loop could also be implemented in order to 
reduce the clearance time of sample, allowing more rapid analyses.  The reaction line volume is 
also variable, which can allow alteration in the range of labeling times available.  Modifications 
of the quench-flow design could allow the system to connect directly to an LC or ESI-MS for 
online sample labeling and analysis.  The elution line may be directed through a pepsin column, 
and peptic peptides can then be loaded directly onto a refrigerated trap.   
 Our rapid H/D-MS analysis of ACTR and CBP represents an initial application of the 
quench-flow apparatus to study conformational dynamics of intrinsically disordered proteins and 
binding induced folding.  Combining the rapid H/D technique with a traditional manually labeled 
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H/D technique allows an extended labeling time regime to be measured.  Lower limits in the 
tens of milliseconds range to upper limits of days or more can be measured by the 
experimenter.  Our study further supports the native form models of ACTR as a mostly random-
coil protein and CBP as a molten globule protein.  Even in the D2O exposure time range of 42 to 
3500 milliseconds, we can monitor the increase in conformational stability that results from 
ACTR binding to CBP and vice versa. 
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Figures 
Table 4.1. Peptide deuterium uptake kinetics. 
 
a Dmax is calculated as the number of exchangeable amide hydrogens adjusted for the 83.3% 
D2O composition of samples undergoing deuterium exchange. 
b N represents the average mass increase measured for totally deuterated controls.  N was 
used in stretched exponential curve calculations as discussed in chapter 3.  However, N was 
used as a constant and not an adjustable variable. 
c Stretched exponential rate constants were calculated using stretched exponential functions 
that had stretching factors, β, that differed from the exponential fit for intrinsic exchange. 
 
Peptide Sequence Dmax
a N (Da)b β int k int (ms
−1) β free k HX,free (ms
−1) β bound k HX,bound (ms
−1)
ACTR(1018-1025) GTQNRPLL 4.17 2.99 0.52 1.48E-03 0.52 2.43E-03 0.61 0.52 3.27E-03 0.45
ACTR(1018-1029) GTQNRPLLRNSL 7.50 5.73 0.56 2.15E-03 0.56 2.41E-03 0.89 0.56 2.83E-03 0.76
ACTR(1020-1029) QNRPLLRNSL 5.83 5.17 0.56 1.57E-03 0.56 2.09E-03 0.75 0.56 2.54E-03 0.62
ACTR(1030-1039) DDLVGPPSNL 5.00 3.90 0.60 1.22E-03 0.60 7.28E-04 1.68 0.60 1.09E-03 1.12
ACTR(1031-1039) DLVGPPSNL 4.17 3.21 0.61 1.70E-03 0.61 1.04E-03 1.64 0.61 1.55E-03 1.09
ACTR(1032-1039) LVGPPSNL 3.33 2.92 0.76 3.05E-03 0.76 1.68E-03 1.81 0.76 2.61E-03 1.17
ACTR(1033-1045) VGPPSNLEGQSDE 7.50 5.69 0.67 2.00E-03 0.67 1.73E-03 1.16 0.67 2.35E-03 0.85
ACTR(1040-1049) EGQSDERALL 6.67 4.35 0.76 1.91E-03 0.76 5.39E-04 3.55 0.76 3.24E-04 5.91
ACTR(1046-1049) RALL 1.67 1.53 0.98 4.48E-04 0.86 2.36E-04 1.90 c too slow
ACTR(1046-1052) RALLDQL 4.17 3.72 0.90 7.07E-04 0.80 3.82E-04 1.85 c too slow
ACTR(1046-1064) RALLDQLHTLLSNTDATGL 14.17 11.84 0.69 1.49E-03 0.69 8.88E-04 1.68 0.69 2.32E-04 6.42
ACTR(1050-1064) DQLHTLLSNTDATGL 10.83 9.19 0.72 2.17E-03 0.72 1.20E-03 1.82 0.72 3.62E-04 6.00
ACTR(1050-1059) DQLHTLLSNT 6.67 5.85 0.63 2.23E-03 0.63 1.43E-03 1.56 0.63 1.61E-04 13.79
ACTR(1052-1055) LHTL 1.67 1.22 0.64 2.32E-03 0.64 7.25E-04 3.19 too slow
ACTR(1053-1059) HTLLSNT 4.17 3.12 0.61 1.82E-03 0.61 1.32E-03 1.38 0.61 2.09E-04 8.68
ACTR(1053-1063) HTLLSNTDATG 7.50 5.37 0.72 2.01E-03 0.72 1.42E-03 1.41 0.72 6.66E-04 3.02
ACTR(1053-1065) HTLLSNTDATGLE 9.17 5.19 0.70 1.53E-03 0.70 1.49E-03 1.03 0.70 6.54E-04 2.34
ACTR(1060-1064) DATGL 2.50 2.01 0.77 1.95E-03 0.77 7.70E-04 2.53 0.77 1.14E-03 1.71
ACTR(1065-1076) EEIDRALGIPEL 7.50 5.61 0.79 7.52E-04 0.79 3.41E-04 2.20 too slow
ACTR(1067-1076) IDRALGIPEL 5.83 4.96 0.77 8.79E-04 0.77 3.61E-04 2.44 too slow
ACTR(1077-1088) VNQGQALEPKQD 7.50 6.38 0.57 1.18E-03 0.57 8.77E-04 1.35 0.57 8.97E-04 1.32
CBP(2059-2068) PNRSISPSAL 5.83 4.92 0.74 2.39E-03 0.74 3.68E-03 0.65 0.74 1.14E-03 2.10
CBP(2059-2071) PNRSISPSALQDL 8.33 6.89 0.73 1.76E-03 0.73 1.41E-03 1.25 0.73 3.62E-04 4.86
CBP(2059-2072) PNRSISPSALQDLL 9.17 7.66 0.70 1.46E-03 0.43 8.29E-04 1.76 c 0.39 1.52E-04 9.61 c
CBP(2068-2071) LQDL 1.67 1.46 0.80 7.59E-04 0.53 4.84E-05 15.68 c no exchange
CBP(2071-2089) LLRTLKSPSSPQQQQQVLN 12.50 10.93 0.77 2.20E-03 0.77 7.73E-04 2.85 too slow
CBP(2075-2088) LKSPSSPQQQQQVL 8.33 7.53 0.74 2.49E-03 0.74 9.36E-04 2.66
CBP(2077-2094) SPSSPQQQQQVLNILKSN 12.50 8.33 0.67 2.06E-03 0.67 2.66E-03 0.77 0.67 2.20E-04 9.35
CBP(2088-2096) LNILKSNPQ 5.00 4.24 0.62 1.50E-03 0.62 6.22E-04 2.42 too slow
CBP(2089-2098) NILKSNPQLM 5.83 5.23 0.67 1.48E-03 0.67 4.73E-04 3.13 too slow
CBP(2091-2096) LKSNPQ 2.50 2.00 0.69 4.61E-03 0.69 6.80E-04 6.78 too slow
CBP(2092-2100) KSNPQLMAA 5.00 4.24 0.78 1.99E-03 0.78 6.02E-04 3.31 too slow
CBP(2098-2101) MAAF 1.67 1.64 0.97 1.63E-03 0.76 4.76E-04 3.43 c no exchange
CBP(2099-2101) AAF 0.83 0.84 1.00 1.26E-03 0.75 3.67E-04 3.42 c no exchange
CBP(2100-2109) AFIKQRTAKY 6.67 5.16 0.85 1.91E-03 0.54 1.47E-03 1.30 c too slow
CBP(2101-2117) FIKQRTAKYVANQPGMQ 11.67 8.97 0.74 1.84E-03 0.74 2.32E-03 0.79 0.74 2.30E-04 7.98
CBP(2110-2117) VANQPGMQ 4.17 3.22 0.49 1.52E-03 0.49 2.41E-03 0.63 0.49 1.04E-03 1.47
<PF> bound<PF> free
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Figure 4.1. The quench-flow apparatus. The system is configured for a rapid H/D experiment, 
with quenched sample collected in a micro-centrifuge tube set in liquid nitrogen for rapid 
freezing and storage. 
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Figure 4.2. Time lapse photographs of a coating-stripped reaction capillary following injection of 
10 µL of FITC-conjugated albumin with ~470 nm excitation.  The capillary was photographed 
every 10 seconds, with 2500 ms exposures.  Capillary walls are shown in yellow dashed lines.  
A) The capillary when sample to label flow ratio is 1:20, with 105 µL min-1 overall flow rate 
through the capillary.  Due to the length of observed fluorescence, only photographs from every 
60 s are shown. B)  The capillary when sample to label flow ratio is 1:5, with 120 µL min-1 
overall flow rate through the capillary. C) An ambient light photograph of the reaction capillary, 
which was used to locate capillary walls in fluorescence images. 
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Figure 4.3. 9-peptide mix deuterium uptake curves. Red data points represent experimental 
average mass increase measurements. The intrinsic exchange curves, represented as the black 
dotted curve, were normalized to match the latest measured time point of each respective 
curve. 
  
MQMKKVLDS
0 1 2 3 4 5 6
M
as
s 
In
cr
ea
se
 (D
a)
0
1
2
3
4
5
SFLLRNP
0 1 2 3 4 5 6
0
1
2
3
4
PLARTLSVAGLPGKK
0 1 2 3 4 5 6
0
1
2
3
4
5
6
7
8
9
ASHLGLAR
0 1 2 3 4 5 6
0
1
2
3
DRVYIHPFHL
0 1 2 3 4 5 6
M
as
s 
In
cr
ea
se
 (D
a)
0
1
2
3
4
5
YRQSMNNFQGLR
D2O Exposure (s)
0 1 2 3 4 5 6
0
1
2
3
4
5
6
7
8
EQKLISEEDL
D2O Exposure (s)
0 1 2 3 4 5 6
0
1
2
3
4
5
IKNLQSLDPSH
D2O Exposure (s)
0 1 2 3 4 5 6
0
1
2
3
4
5
6
RRLIEDNEYTARG
D2O Exposure (s)
0 1 2 3 4 5 6
M
as
s 
In
cr
ea
se
 (D
a)
0
1
2
3
4
5
6
7
8
133 
 
Figure 4.4. Intact protein deuterium uptake curves of (a) ACTR and (b) CBP. Totally deuterated 
control average mass increase results plotted as a horizontal line marked “TD”. Intrinsic 
exchange curves (dotted black line) have been normalized to totally deuterated samples. 
Deuterium uptake data shown as data points, with red points representing free protein and blue 
points representing bound protein. 
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Figure 4.5. Histogram displaying the frequency of standard deviation values in CBP and ACTR 
peptide quench-flow H/D-MS measurements. 
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Figure 4.6. Deuterium uptake curves for peptides analyzed both in this study and in the 
previous work, where deuterium labeling was performed by hand (chapter 3).  Previously 
acquired data (black filled points for free state, white filled points for bound state) were 
normalized to account for experimental condition changes.  The average rapid H/D mass 
increase data are represented by red (free protein) and blue (bound in complex) colored points.  
The red and blue dashed lines represent the respective stretched exponential fits. 
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Figure 4.7. Peptide protection factors mapped onto ACTR and CBP sequences for both free 
and bound states.  Secondary structure assignments for the CBP/ACTR complex are 
transposed from previous NMR studies (PDB: 1KBH).21  Gray coloring indicates the rapid loss of 
deuterium label for the first two residues in each peptide due to back exchange.  Peptides were 
determined to be too slow for stretched exponential fits when the largest rapid H/D mass 
increase did not reach about half of the mass increase of the totally deuterated control samples 
within 3500 ms exchange.  Peptides with no discernible exchange within 3500 ms are also 
indicated. 
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Chapter 5: Improvements to H/D-MS Data Analysis for Multiple Protein States 
5.1  Analyzing H/D-MS Data 
 5.1.1  Amino Acid Residue Resolution 
 Protein conformational changes are observed using hydrogen/deuterium (H/D) 
exchange experiments.1-4  Structural perturbations, both local fluctuation events and global 
unfolding transitions, represent events necessary for H/D exchange in a structured protein.5-6  
The dynamic motions between such states, however, are difficult to predict and quantify 
accurately.  The conformational stability is described by the equilibrium, Ku, between protected 
and unprotected states within a conformational ensemble.  If single-residue resolution H/D 
exchange rate constants can be determined, then calculated protection factors, PF, can be used 
to calculate conformational stability, ΔGuo’:2 
 
(1) 
 (2) 
Determining single residue resolved exchange rate constants through H/D exchange 
mass spectrometry (H/D-MS) is more difficult than it is through NMR.  Depending on the protein 
being analyzed, NMR may be an obvious choice in determining localized H/D exchange 
protection.  The technique allows single residue resolution for solution phase, intact protein.5-6  
However, as discussed in chapter 1, NMR applications are limited by several factors.  These 
limitations include the requirement of isolating proteins in high enough concentrations for NMR, 
the difficulty of studying large proteins, and the unresolvable, overlapping signals that are 
characteristic for disordered protein regions.7   
Residue level localization of deuterium exchange information is a long sought after goal 
in H/D-MS experiments.  H/D-MS offers localized information through the use of tandem MS 
op ex,EX2
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fragmentation, which often produces overlapping fragments.  Using a residue specific analysis 
of overlapping fragment data, deuterium uptake localization would be improved.  Electron 
capture dissociation (ECD) and electron transfer dissociation (ETD) have demonstrated the 
greatest potential for near single residue resolution.8-11 The application of ETD-MS to study H/D 
exchange in a set of test peptides has been demonstrated.9  Single residue resolution of 
deuterium uptake is accomplished by comparing the average mass increase, Δm, of 
incremented c- or z-ions.9  For example, the Δm for the c6´ ion minus the Δm for a c5´ ion will 
yield the incremental increase in Δm for the sixth residue.) Another study demonstrated the 
analysis of horse myoglobin folding intermediates via a continuous-flow rapid mixing device and 
ECD-MS.8  The fragmentation of proteins with ECD allowed short sequence increments to be 
analyzed, giving an average resolution of about 2.2 residues.8 A possible advantage of top-
down MS techniques, such as these, is the reduction of back exchange effects when 
chromatography steps are bypassed.  However, bypassing chromatography requires the use of 
volatile buffer components.  The cost and expertise required for ECD and ETD instrumentation 
may place such techniques out of reach of laboratories that wish to perform routine H/D-MS 
analyses.  Large proteins, such as β-glucuronidase or monoclonal antibodies, will also prove 
impractically difficult to study in intact protein ECD and ETD experiments.12  New approaches, 
often referred to as middle-down, combine bottom-up digests and top-down analyses to H/D 
exchange experiments.13 
Computational techniques may provide an alternative for localized protection analyses.  
Overlapping peptide H/D-MS information was used to calculate exchange rate constants with 
near amino acid resolution in signal transduction kinase ERK2.14  Peptides were partitioned into 
short segments with estimated rate constants of exchange.  Overlapping peptide data was used 
to identify the residues that exhibited a specific rate constant.14 The use of qualitatively 
estimated rate constants and overlapping peptide average will limit quantitative analysis of 
deuterium uptake.   
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A second computational technique integrates controls to correct for back exchange and 
derive protection factors at an amino acid residue resolution.15 An automated platform to 
process experimental H/D-MS data was developed for analyzing proteins.  The use of a peptide 
mixture for back exchange correction and a tetrapeptide (PPPI) for intrinsic exchange correction 
helped inter- and intra-lab comparability in H/D exchange experiments.15  A modeling algorithm 
used experimentally measured uptake data and the above corrections to derive local protection 
factors.  The algorithms did not derive only a single set of protection factors for a specific 
sequence.  Instead, multiple probable protection factor solutions were calculated.  While 
protection factors for some specific regions were consistent across many of the solutions, most 
regions showed large variance in derived protection factors from these same solutions.  While 
overlapping peptide averaging may improve on the localization of estimated rate constants, 
amino-acid specific rate constant determination remains limited to top-down and middle-down 
studies.  Despite limitations listed above, H/D-MS could reveal information about relative 
protection from exchange and conformational stability.  The purpose of this chapter is to 
address the limitations in data analysis techniques when the above approaches cannot be 
applied for conventional peptide-level H/D-MS. 
5.1.2  Reference States and Differential Studies 
To quantify protein dynamics, measured deuterium uptake can be compared to 
theoretical uptake.  For example, protection factors can be calculated by comparing 
experimental exchange to calculated intrinsic exchange.16-18  However, protein conformation and 
intrinsic exchange rates are sensitive to individual experimental conditions.  The minor variability 
in intrinsic exchange rates is often overlooked as these rates serve as a comparable reference.  
Many labs continue to use the same set of published rate constants to calculate intrinsic 
exchange, adjusting the calculation for specific pH values and temperatures.16, 19 
Uneven sequence coverage can lead to multiple peptides covering the same region of 
the protein.  As mentioned in section 5.1.1, overlapping peptide information can better localize 
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H/D exchange information.  The issue of how to average overlapping peptide information must 
be addressed in H/D-MS studies.  While data should not be thrown out, the issue of how to 
describe a single residue covered by multiple peptides remains.  Data from each individual 
peptide only represents a segmented average.  This chapter explains how overlapping 
segments can be averaged to better resolve H/D exchange kinetics. 
Deuterium uptake kinetics are often analyzed as relative differences between two protein 
states.  Directly comparing two or more states of a single protein without using a theoretical 
baseline of exchange can provide useful information.  These comparisons can be used to 
identify protein-protein contact regions and the proximal and distal effects of ligand binding.20-21  
However, comparisons made in differential analyses are often qualitative and subjective.  It is 
difficult to classify major changes or minor fluctuations in a protein.  Even when quantified, 
differential H/D exchange experiments often overlook factors such as peptide length.  
Laboratories lack a widely accepted method of analyzing H/D exchange data.  Such a method 
would allow quantified deuterium uptake to be compared between laboratories, even though the 
reproducibility problems discussed above would remain.  A more universally applicable 
procedure for assigning and quantifying changes in conformation using H/D-MS should be 
established.22 The new approach outlined in this chapter delivers a possible normalization 
method for differential H/D-MS experiments.  This approach was developed using experimental 
H/D-MS measurements of a model protein, β-glucuronidase.  This differential analysis illustrates 
the localized effects of a single point mutation.  The conformational rescue caused by a small 
molecule additive is also illustrated. 
5.1.3  Restoring β-Glucuronidase Mutant Function with Allosteric Control 
The β-glucuronidase protein is responsible for β-D-glucuronic acid hydrolysis.  Its activity 
is lost when the tryptophan residue 492 is mutated to glycine.23  The loss of this structurally 
important residue causes a conformational disruption that extends to the active site.  When 
indole is added into solution with the mutant, enzyme activity is partially restored.23  This chapter 
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describes the application of H/D-MS to identify the conformational changes in β-glucuronidase 
that result from the W492G mutation, the introduction of indole to the W492G mutant, and any 
effects indole may have on the wild-type protein.24  The goal of this chapter is to present how a 
new data analysis method can resolve limitations in exchange localization in current H/D-MS 
data analysis strategies.  Mutated β-glucuronidase protein provides a model that will aid in 
demonstrating a new strategy to localize modification effects.24  By localizing where indole 
restores structural characteristics lost by mutation, it may be possible to form a link between 
region and function. 
5.2  Experimental 
5.2.1  β-Glucuronidase Experiment Overview 
Wild-type and W492G mutant β-glucuronidase stocks were provided by Professor John 
Karanicolas (University of Kansas, Lawrence, KS) at a concentration of 5 µg µL−1 in 50 mM 
sodium phosphate, 100 mM sodium chloride, pH 7.4. Protein stocks of both wild-type and 
W492G mutant were diluted to 0.5 µg µL−1 aliquots in 90% water / 10% ethanol, 50 mM sodium 
phosphate, 100 mM sodium chloride. Since indole addition was to be tested, one aliquot of wild-
type and one of W492G mutant contained 5 mM indole.  Ethanol was used to initially dissolve 
solid indole. 
All deuterium exchange experiments were carried out by a LEAP HDX-PAL robot (LEAP 
Technologies, Carrboro, NC). The robot was used to mix 2 µL of protein solution with 40 µL 
deuterium exchange buffer, followed by the addition of 40 µL quench buffer after the appropriate 
labeling time.  The deuterium exchange buffer was 50 mM sodium phosphate, 100 mM sodium 
chloride, with and without 5 mM indole in 90% D2O, 10% ethanol, pD 7.4.  Undeuterated control 
samples were prepared using similar buffers which contained 90% H2O instead of D2O, pH 7.4. 
All deuterium exchange buffers were kept at ambient room temperature. The exchange quench 
buffer was 0.75 M hydrochloric acid, kept at 1°C.  Deuterium exchange labeling times ranged 
from 10 seconds to 12 hours.  Following the labeling, quench buffer was added to sample at a 
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1:1 volume ratio.  Quenched samples were immediately injected onto a 100 µL loop prior to 
pepsin digestion and peptide separation (see chapter 2). 
An isocratic pump flowed 0.1% formic acid at 0.2 mL min-1 through the sample loop to 
inject samples through an immobilized pepsin column, prepared in-house, for online proteolysis 
of labeled samples3 (see chapter 2).  Peptides were captured on a C12 trap, packed in-house. A 
4.5-40.5% acetonitrile gradient over 10 minutes was used to separate peptides on a 50 mm × 1 
mm Ascentis Express ES-C18 column (2.7 μm particle size, 160 Å pore size, Supelco 
Analytical, Bellefonte, PA).  All HPLC components were kept at 0°C to reduce back-exchange. 
Eluted peptides were analyzed by TOF-MS (Agilent Technologies, Santa Clara, CA). 
HDExaminer (Sierra Analytics, Modesto, CA) was used to obtain average mass values for 
peptide spectra at each labeling time and for the undeuterated controls. 
5.3 Analysis of Differential H/D Exchange Data 
 5.3.1  Butterfly Plots 
A general method to interpret H/D-MS data should be developed.  When comparing two 
protein states using H/D-MS, one of the simplest qualitative assessments may come from 
comparing the two deuterium uptake curves.  Even a survey of deuteration at each time point 
can provide an idea of whether a specific peptide gains or loses protection, or stays about the 
same between two conditions.  Figure 5.1 shows four example plots with four deuterium uptake 
curves each.  These curves represent typical results from H/D-MS analyses, where the average 
deuterium uptake is plotted as a function of D2O exposure time.  The scaling of each y-axis to 
the maximum number of exchangeable amide hydrogens for a given peptide allows relative 
exchange to be observed when comparing plots.  There is little difference between wild-type 
and mutant deuterium uptake in peptide #61 as shown in figure 5.1.  The W492G point mutation 
in β-glucuronidase causes a loss of exchange protection in regions distant from the mutation 
site, such as in peptides #75 and #76.  The mutant protein’s peptide #140 is also less protected 
from exchange when compared to the wild-type protein.  The comparison of deuterium uptake 
143 
curves from one peptide to another may be more difficult due to differences in sequence.  The 
sequence influences intrinsic exchange behavior, as intrinsic exchange rate constants will 
depend on amino acid residue identity and the identity of neighboring residues.  Peptide length 
is also an important factor to consider when comparing different peptides, as the complete 
peptide sequence will determine the number of exchangeable amide hydrogens.  Simplifying the 
comparison of two curves with an overall difference measurement provides a comparable 
quantity that may be plotted along a list of peptides. 
Differential exchange data can be presented graphically in a “butterfly” plot.  Such a plot 
facilitates the comparison between two experimental conditions.  In butterfly plots, deuterium 
uptake is quantified using a relative fractional exchange; the average deuterium uptake is 
divided by the maximum number of exchangeable amide hydrogens.  This quantity represents 
what can be inferred from figure 5.1.  The relative fractional exchange for a reference 
experiment is plotted on the positive y-axis.  Exchange for an experimental condition change is 
mirrored and plotted along the negative y-axis.  Peptide position, ordered by its sequence 
location midpoint, is plotted along the x-axis.  The relative exchange at each time point is 
represented by a differently colored plot.  This representation can provide a comparison of 
where exchange occurs slower or faster along the protein, so a degree of protection can be 
inferred.  A quick survey of these mirrored plots can also reveal where deuterium uptake 
behavior differs between two states.  Multiple preparations of interferon-β-1a were compared 
using an H/D-MS method and butterfly plots.25   
A graph, such as figure 5.3, illustrates deuterium uptake differences between two 
conditions in measured peptides.  For each peptide, the difference in average mass increase 
values, ΔΔm, is calculated at a single time point, t, between the mass increase of a conditionally 
altered state, Δmi, and that of a reference state, Δmiref.  Figure 5.2 illustrates how ΔΔm is 
determined between two curves at a single time point.  On a graph such as figure 5.3, the sum 
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of the differences in deuterium uptake, ΣΔΔm, for all time points, nt, is plotted for each peptide 
to compare two protein states. 
 
(3) 
This summed difference can be positive or negative in value.  Protection factor may increase (a 
negative difference) or decrease (a positive difference) in transitioning from one form to the 
second.  The difference in deuterium uptake plots are summed for each peptide ordered along 
the x-axis.  Using β-glucuronidase data, figure 5.3 shows a graph where data is prepared in this 
manner.  Figure 5.3 illustrates the deuterium uptake differences between mutant β-
glucuronidase and wild-type protein (reference) as red bars.  Most of these uptake differences 
show an increase in deuterium uptake, and thus lower protection, across most of the mutant 
protein segments.  Figure 5.3 also illustrates deuterium uptake differences in mutant β-
glucuronidase with added indole as the conditional change and absence of indole as the 
reference state.  For most segments, the addition of indole causes a decrease in deuterium 
exchange. 
Presenting the data in this manner does not represent each peptide’s length.  A peptide 
may have a small summed deuterium uptake difference, such as ±1 Da.  If that difference is the 
result of one measurable amide gaining complete protection from previously having no 
protection, then it should still be considered a significant change.  On the other hand, a ±1 Da 
summed difference may also be the resulting sum of a minor structural fluctuation spread 
across many residues.  That is, a +1 Da difference on a 4 residue peptide shows a greater 
overall effect than a +1 Da difference on an 11 residue peptide.  For example, the summed 
deuterium uptake difference between mutant and wild-type protein in peptide #80, which is 4 
residues long, and peptide #129, which is 11 residues long, are very similar at around +4.6 Da.  
Thus, the relative difference between mutant and wild-type protein in peptide #80 is much larger 
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than that of peptide #129.  The important observation of a large relative difference in a small 
peptide may be missed as it may not produce a large value on the difference plot. 
Referring back to the difference plot in figure 5.3 and the individual uptake plots in figure 
5.1, the large difference between mutant and wild-type at peptide #76 (residues 331-357) is 
+18.4 Da.  This is a result of this particular peptide containing 24 exchangeable amide 
hydrogens. The magnitude of 18.4 Da almost reaches the difference magnitude of +22.2 Da for 
peptide #140 (residues 584-609), which contains 23 exchangeable amide hydrogens.  Peptide 
#76 and peptide #140, therefore, share similar summed difference magnitudes, but the uptake 
curves display differing uptake kinetics.  However, looking at peptide #75 (residues 331-339), 
which contains 7 exchangeable hydrogens located within peptide #76’s sequence, a summed 
difference of +3.8 Da is observed.  The uptake curves of peptides #75 and #76 share a similar 
profile, implying similar uptake kinetics.  The huge difference in the summed difference values 
between peptide #75 (+3.8 Da) and #76 (+18.4 Da) makes it difficult to infer this similarity 
between the peptides as plotted in figure 5.3 because peptide length is not represented.  A 
mathematical normalization to account for peptide length would allow direct comparison 
between these peptides. 
A similar plot in an earlier study of interferon-β-1a addressed this issue of comparing 
peptide lengths by plotting the relative length of peptides alongside fractional exchange data.26  
Peptides were ordered by their numerical sequence midpoint values to form a “quasi-
sequence.”25  Figure 5.4(A) shows a mock list of peptides mapped onto a brief sequence.  
Figure 5.4(B) shows how the mock list is translated to a quasi-sequence.  A normalized 
exchange difference plot would better aid in the visualization of differential exchange data as 
opposed to an absolute difference plot.  Absent from the plot in figure 5.4(B) is a depiction of 
which regions of the protein are represented and which regions are not covered.  The peptides 
used may have high overlap in one particular region, such as between residues 9 and 19.  
These peptides, which are colored in teal, dominate the quasi-sequence despite covering less 
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than half of the actual sequence.  Other regions may have no peptide coverage at all, such as 
between residues 20 and 24.  All peptides are presented as evenly spaced integers in figure 
5.4(B).  Regions with no peptide coverage are not represented in a plot such as figure 5.4(B).  
Mock deuterium uptake values are plotted along the quasi-sequence in figure 5.4(B).  While 
deuterium uptake for the teal colored peptides appears greater, it is difficult to infer relative 
exchange from figure 5.4(B) alone because peptide length is not established. 
5.3.2  Relative Deuterium Uptake Differences 
Relative deuterium uptake measurements allow two different peptides’ deuterium uptake 
behavior to be compared.  Differential deuterium exchange analyses can average the uptake 
difference between two curves at every measured time point to calculate and overall fractional 
difference between two conditions.  An average relative deuteration difference, ARDD, was 
used to quantify exchange protection in free and complex-bound recombinant cashew 11S 
globulin allergen, rAna o 2.21  ARDD values were calculated as the relative difference between 
the deuterium uptake of one conditional state and a reference state, averaged across all 
exchange time points:   
 
(4) 
Figure 5.2 illustrates two mock deuterium uptake curves being compared.  The strategy of 
averaging across all time points places equal statistical weight on each time point.  This may 
skew the average toward a range of closely spaced times points.  That is, if many points are 
taken for early time points, as shown in the left-side blue box on figure 5.2, and fewer at later 
times, the average skews toward early exchange behavior rather than exchange across the 
entire range.  Another possible problem with such an interpretation arises if two curves have 
many time points where the difference was near zero, such as in the two blue boxes on figure 
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5.2.  These points would be measured before any significant exchange occurs or after complete 
exchange occurs in both conditions.  The abundance of no-difference points may dilute the 
average difference in a way that overall difference information, shown by the large ΔΔm region, 
may be lost.  Curve differences are better described when time points are spaced evenly along 
a logarithmic scale and entire uptake curve profiles are covered by the D2O exposure time 
range. 
5.3.3  Stretched Exponential Fits 
To eliminate the problem of uneven time point spacing, deuterium uptake curves could 
be described as a function of a peptide’s deuterium exchange rate constant.  Rather than 
compare two curves point by point, a comparison of segment-averaged rate constants for a 
particular peptide would account for an overall difference in apparent deuterium uptake curves.  
This method of comparison was discussed in the study of CBP and ACTR free and bound 
states (see chapter 3).18 However, rate constants may be difficult to determine for a number of 
exchange behaviors.  Rapidly exchanging peptides may become fully deuterated before the 
smallest measurable D2O exposure time (a limitation addressed in chapter 4).  This results in an 
almost horizontal uptake curve near the value of the totally deuterated control.  Very slowly 
exchanging peptides may not show measurable deuterium uptake within an experiment’s 
longest time point (a limitation encountered in chapter 4).  This slow exchange results an almost 
horizontal uptake curve near 0 Da of mass increase.  A peptide may also exhibit multi-modal 
and/or slow deuterium uptake, which cannot described by any single, simple curve fit function.  
Previous work has demonstrated rate constant determination for bi-modal deuterium uptake 
curves,17 but such calculations introduce greater uncertainty as more parameters are 
incorporated into the interpretation.  Subjective alteration to fit parameters may also reduce 
quantitative validity.  The approach outlined in the next section introduces an averaging 
technique to better localize differential amide H/D exchange data between multiple conditions. 
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  The availability of overlapping peptides also raises another issue in data interpretation.  
To assign specific values to specific protein segments, extra peptide information can be 
discarded or merged mathematically or subjectively together.  An averaging of overlapping 
peptide information allows more useful experimental results to be included in the analysis and 
improves information localization, even if it is not truly single amino acid resolution.  The next 
section also explains how overlapping peptide data is averaged in order to improve H/D 
exchange localization. 
5.4 Normalized Deuterium Difference Approach 
5.4.1  Normalization of Deuteration Differences 
 An alternative method to compare deuterium uptake kinetics between a condition and a 
reference should include a normalized measurement of their differences in exchange. The first 
step in the data processing for this normalization is to calculate the summed mass difference 
between two deuterium uptake curves, ΣΔΔm using equation 3. This is done at each individual 
time point, t, for a specific peptide. Individual time point mass increase difference values, Δmi − 
Δmiref  in equation 3, are calculated and then summed from all measured time points.  The 
resulting sum value is assigned to that peptide’s location and sequence. 
Peptides will vary in length and time points may be lost due to limited detection or 
experimental conditions.  It is because of these reasons that these uptake curve difference 
sums alone will not be comparable from peptide to peptide.  Instead, normalized deuterium 
difference, NDD, values should be calculated to eliminate the factors of peptide length and 
number of measured time points from comparisons of uptake behavior. 
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By normalizing the sum of the differences between uptake curves by the maximum number of 
exchangeable amide hydrogens for a specific peptide, Dmax, the problem caused by varied 
peptide length is addressed (see chapters 3 and 4 for determination of Dmax values based on 
peptide sequence).  The sum is also normalized by the number of usable time points that are 
present in both uptake curves, nt.  Therefore, if one curve is missing one or more time points, 
those time points will not be used in subsequent analyses of either curve.  This also ensures 
that uptake difference results are not exaggerated by a particular peptide having more usable 
time points than another peptide. These NDD values can range from -1 to 1.  A value at either 
extreme represents the difference between no deuteration and complete deuteration at every 
time point, with no back-exchange. While the extremes represent an unrealistic possibility, they 
provide an easy to interpret boundary by which deuterium uptake curves for a single peptide or 
group of peptides can be compared. 
 5.4.2  Averaging Overlapping Peptides 
 Once a particular peptide’s deuterium uptake data has been normalized, it may be 
compared to the data from another peptide. Table 5.1 shows an abbreviated example 
spreadsheet calculator to average NDD values on a per-residue basis.  The amino acid 
sequence is listed in individual cells within a single row on the top of spreadsheet.  Residue start 
and end numbers are ordered along the two columns on the left.  The NDD value is assigned to 
all residues in the peptide, except for the first two residues and proline residues. The first two 
residues of each peptide are listed as cells with no data, “ND”, as these residues will rapidly 
back-exchange for H2O in the HPLC solvent.16, 19 Similarly, cells list “ND” for proline residues, as 
proline residues do not have amide hydrogens.  Once every peptide’s NDD values are listed, 
the NDD data for each residue is then averaged.  This NDD average will describe whether the 
deuterium uptake data showed an increase or decrease in protection relative to a reference 
state.  Negative values represent an increase in exchange protection in relation to the reference 
state.  Positive values represent a decrease in exchange protection in relation to the reference 
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state.  By including all measured peptides, sub-peptide resolved information is obtained for 
overlapped regions.  The region shown in Table 5.1 is covered by several overlapping peptides.  
NDD values for most peptides in this region were measured within a range of 0.011 to 0.030.  
The NDD value of 0.000 for peptide (23-40) is anomalously small compared to similar peptides 
covering the same region.  By using the experimental data averaging strategy described above, 
peptide (23-40)’s small NDD value is effectively overruled by the availability of other peptides 
covering the same region.  While this strategy can aid in difference localization, the measured 
average NDD values should not be considered truly residue-resolved. 
 5.4.3  Mapping the Regions of Maximum Differences 
 While a quantitative measurement of a condition’s effects is important, a graphical 
presentation may be more comprehensible.  In a spreadsheet bar chart, a protein’s sequence 
numbering is plotted along the x-axis and the per-residue NDD is plotted along the y-axis.  By 
using partial transparency and different coloring schemes, two sets of conditional changes can 
be easily compared on a single graph.  Examples of this type of chart are presented in figure 
5.5, which are representations of the data for the β-glucuronidase experiment. These numerical, 
per-residue averages can also be used as the basis for a color scale representation onto a 
model structure. 
 5.4.4  Estimated Significance Threshold 
H/D-MS is highly sensitive to changes in protein structure and results can be highly 
reproducible.  However, determining what constitutes a significant difference between two 
states of a single peptide requires uncertainty calculations provided by replicate sample 
analyses.  A single standard deviation of ±0.14 Da for a replicated time point (i.e. a Δm 
measurement) with a 98% confidence interval of about ±0.5 Da has been reported in previous 
work.25-26  The confidence interval appears to be unaffected by labeling time, peptide length, or 
mass difference caused by deuterium uptake.25  A difference between two peptide states, ΔΔm, 
that exceeds this confidence interval at any time point could then be considered statistically 
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significant.  The ±0.14 Da standard deviation may be used to calculate a statistical significance 
threshold between multiple datasets which contain all time points, ΣΔΔm, using the Student’s t-
distribution. (In the work noted above, 5 time points were sampled to give a 98% confidence 
interval of ±1.1 Da).25  Because of single trial sampling conducted for this chapter, uncertainty 
calculations are omitted.  Data herein is interpreted in terms of simple relative observations, 
instead.  If uncertainty and artificial triplicate sampling are applied to this work and assumed to 
be similar to that of the previous work, the significance threshold would be calculated to be 
about ±1.7 Da for the 9 sampled time points.  Peptides with only 1 exchangeable amide 
hydrogen could not meet this threshold, despite showing obvious effects on deuterium uptake 
relative to a reference state. 
5.5  Mutated β-Glucuronidase Rescue 
 5.5.1  Effects of Indole on Wild-Type β-Glucuronidase 
 β-glucuronidase protein activity can be inhibited by a single point mutation at residue 
492.  Residue 492 is tryptophan in the wild-type protein.  The mutation of residue 492 to glycine 
represents the loss of an indole for that residue’s side chain.23  Activity may be partially restored 
in the W492G mutant protein by the addition of indole to the solution.  This work outlines how 
H/D-MS is used to identify changes that result from the mutation as well as from the addition of 
indole.  As a control experiment, the effect of indole on the deuteration of wild-type β-
glucuronidase protein was measured.  The indole is expected to have no significant effects on 
the structure of wild-type protein.  Indeed, the addition of indole molecule to wild-type protein 
does not alter its enzymatic activity.23-24  The effect of indole on wild-type protein was measured 
using NDD values relative to wild-type protein without indole.  The results of this control 
experiment are graphed in figure 5.5(A).  NDD values calculated from equation 5 range from  
-0.033 to 0.032 for 220 analyzed peptides. Within these 220 analyzed peptides, only 50 have 
difference values beyond a -0.010 to 0.010 range.  As will be shown below, these 50 largest 
NDD magnitudes for this control experiment are relatively small compared to the magnitudes 
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given by the effects of mutation and the effects indole has on the mutant.  A significance 
threshold of |NDD|>0.050 would represent an average deuteration difference of 5% of Dmax at all 
measured time points between two deuterium uptake curves.  Because the subsequent 
experiments show much greater ranges of normalized deuteration difference values, this control 
experiment provides insight into the inherent variability of the deuterium exchange method and 
any slight effects the indole may have on exchange. 
 5.5.2  Effects of Mutation on Wild-Type β-Glucuronidase 
 The mutation of tryptophan to glycine at residue 492 of β-glucuronidase removes an 
indole side chain from the protein.  The effect of the W492G mutation was measured using NDD 
values relative to wild-type protein.  The averaged normalized deuteration differences for the 
mutation effects are mapped in figure 5.5(B) as red bars, with proline residues and regions with 
no peptide coverage occupying the gaps in the plot.  The W492G mutation causes pronounced 
changes across much of the protein, shown in figure 5.5(B).  Most peptides show an increase in 
deuterium uptake when compared to the wild-type protein.  One noticeable effect occurs 
between residues 65 and 89, where these difference values range from +0.021 to +0.120. 
These positive values indicate a loss of protection from exchange. The region between residues 
303 and 356 also show an increase in deuterium uptake, with difference values between +0.046 
and +0.089. Some shorter regions around residue 377 and between residues 401 and 406 have 
difference values greater than +0.120, as well.  Starting at about residue 433, the difference 
values become even greater in magnitude. Beyond residue 433 are the regions of the protein 
with closer structural proximity to the mutation site. Many portions of these regions, until about 
residue 603, have measured difference values greater than +0.100, with the maximum 
difference value of +0.295 at residues 547-549. 
Measured mutation effect NDD values are mapped onto a three dimensional crystal 
structure of β-glucuronidase in figure 5.6(A).  Figure 5.6(A) shows a scaled color scheme of the 
measured NDD values with green representing positive differences and magenta representing 
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negative differences.  Gaps in coverage and proline residues are colored yellow.  The largest 
effects of mutation reside in the α-helical lobe located around residue 492 in the crystal 
structure.  The loss of protection from exchange across much of the protein may indicate a 
partial destabilization process that results from the replacement of the tryptophan residue with 
glycine.  The measured difference values provide information on the destabilization of amide 
hydrogen bonding in the protein structures, but they do not provide information on secondary 
structural elements themselves.  Further analysis of the kinetics of deuterium uptake at the 
peptide level can also provide insight toward specific conformational elements. 
 5.5.3  Effects of Indole on Mutated β-Glucuronidase 
 Indole was added to the sample buffer and deuterium labeling buffer to understand how 
indole rescued the W492G mutated β-glucuronidase.23  W492G mutant β-glucuronidase acts as 
the reference state in this experiment.  The replacement of tryptophan with glycine at residue 
492 destabilized many regions of the protein and increased deuterium exchange in those 
regions, as discussed in section 5.5.2 and seen in figure 5.5(B) as red bars.  This destabilization 
correlates to the loss in enzymatic activity in the mutant protein.23  Figure 5.5(B) shows the 
averaged normalized deuteration difference values for the indole effects on W492G mutant β-
glucuronidase as blue bars. In contrast to the mutation effects, many regions possess negative 
difference values, indicating that indole increased protection in these regions. Indeed, in some 
regions, such as around residues 76, 276, and 403, the difference values indicate that indole 
has the opposite effect of mutation. This implies that indole returns some protection to regions 
destabilized by the mutation.  However, the smaller magnitudes of the NDD values indicate that 
wild-type levels of protection are not reached.   
Some regions gain protection from exchange even beyond that measured for the wild-
type protein. Residues 170-185 have a measured difference value of -0.053, a magnitude that 
exceeds the +0.012 difference value measured for the mutation effect alone.  Another region, 
between residues 380 and 406, shows increase in protection for the mutant β-glucuronidase, 
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though these changes do not have a directly opposite effect from the mutation effects. Some 
regions show a destabilization effect when indole is included, as indicated by positive average 
NDD values.  Between residues 410 and 432, the difference values range from +0.023 to 
+0.048.  Similarly, difference values range from +0.022 to +0.075 between residues 445 and 
466.  The largest negative difference values for the indole effects lie in the same regions of the 
largest positive values for the mutation effects.  Between residues 547 and 549, where the 
mutation effects have the largest difference values, the difference values measured for the 
effect of indole on mutated protein are -0.095. 
Measured indole effect on mutant protein NDD values are mapped onto the crystal 
structure of β-glucuronidase in figure 5.6(B).  Figure 5.6(B) shows a scaled color scheme of the 
measured NDD values for these indole effects, with green, again, representing positive 
differences and magenta representing negative differences.  The largest protection recovery 
effects reside in the α-helical lobe around residue 492.  Residue 492, shown as red spheres in 
figure 5.6(B), is where the largest effects of mutation were also located.  The pairing of the 
opposing maxima between the mutation effects on wild-type protein and indole on the mutant 
protein provides some important insights toward the dynamics of the protein structure. To 
reiterate, the W492G mutation destabilizes much of the β-glucuronidase protein, with the most 
pronounced increases in deuterium uptake located along the sequence close to the mutation 
site. These peptides which show the greatest deuterium uptake increase as a result of mutation 
also show a decrease in deuterium uptake once indole is added. While the indole fails to match 
the magnitude of difference that the mutation causes, it still has a stabilizing effect on the 
protein.  This implies that indole partially counteracts the mutation effects around the mutation 
site.  The shortfall may result from indole concentration limits and a difference between a 
structurally bound indole group, as with tryptophan, and indole simply being non-covalently 
bound in the indole pocket. 
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An assumption inherent in the calculations of NDD values is that every deuterium uptake 
time point carries the same statistical weight. The spacing of time points is often arbitrarily 
chosen by investigators to cover a broad range on a logarithmic scale.  Labeling will often range 
from several seconds to days.18, 27-28  The midpoint of exchange may change when altering the 
conditions under which exchange is taking place. If this midpoint lies out of the range of time 
points under one or both of conditions being compared, then the full magnitude of these 
difference values is not entirely realized. Again, figure 5.2 compares two uptake plots.  If time 
points are concentrated in either of the regions indicated by the blue boxes, then any 
comparison between the two curves will be skewed by the incompleteness and/or unevenness 
of sampled time points. 
5.5.4  Normalized Deuterium Uptake 
The information provided by ΔΔm values alone excludes a quantitation of conformational 
dynamics.  A limitation to interpreting deuterium uptake data solely as NDD values is that it 
provides no indication of native flexibility for each peptide studied.  A measurement of absolute 
deuterium uptake can aid in localizing protection or flexibility.  In the β-glucuronidase 
experiment, using a normalized deuterium uptake value, NDU, calculated as in equation 6, can 
measure absolute deuterium uptake in any one condition: 
 
(6) 
An NDU value differs from an NDD value in that mass increase is not related to any reference 
state in an NDU calculation.  An NDU value provides a normalized value of deuterium uptake 
that can be compared between peptides.  Figure 5.7 shows an example representation of NDU 
values calculated for the four β-glucuronidase conditions discussed in this chapter (wild-type, 
wild-type with indole, W496G mutant, W492G mutant with indole).  The NDU values for wild-
( )
1
max
tn
i
i
t
m
NDU
D n
=
∆
=
×
∑
156 
type protein without indole are mapped onto a three-dimensional model of β-glucuronidase as a 
white to red heat map in figure 5.8 (Gaps in peptide coverage and proline residues are, again, 
colored yellow).  This mapping of NDU values can provide a survey of backbone dynamics and 
flexibility.  A redder region in figure 5.8 corresponds to a larger NDU value and a faster 
deuterium uptake.  Regions more protected from exchange will have smaller NDU values and 
will be colored whiter in figure 5.8. 
Surveying deuterium uptake plots (figure 5.2) can indicate whether a peptide is 
exchanging rapidly (less protection) or more slowly (more protection) based on expected 
maximum exchange values.  Figure 5.7 shows NDU values measured for all four conditions of 
the β-glucuronidase protein.  Exchange is relatively slow for all conditions between residues 204 
and 365, with NDU values measured below 0.35 throughout.  Some regions, such as those near 
residues 161, 378, 489, and 576, exhibit relatively fast exchange with NDU values above 0.45.  
Measuring the difference between two plots alone, such as with NDD values, will not include 
this protection information.  As a result, folding or protection changing events cannot be readily 
quantified. A major structural conversion is indistinguishable from a less severe stabilization 
event with deuterium uptake difference information alone.  The inclusion of a theoretical dataset 
representing intrinsic exchange, Δmiint, could provide another degree by which the multiple 
experimental datasets could be compared.  Calculations of Δmiint can be conducted as 
discussed in chapter 3.  By calculating a normalized deuterium difference from intrinsic 
exchange, NDDI, this comparison may give some indication of initial protection present for each 
peptide: 
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NDDI values are calculated using equation 7 in the same manner as NDD values are calculated 
using equation 5, with the exception being that intrinsic exchange represents the reference state 
for the analyzed peptide.  A negative NDDI value, like a negative NDD value, will indicate an 
increase in protection.  NDDI values will always be expected to be negative, since intrinsic 
exchange is the expected deuterium exchange for a protein as if it were a random coil. 
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Figures and Tables 
Table 5.1. The abbreviated sub-peptide average deuterium difference spreadsheet.  Blue boxes 
are drawn to represent which NDD values contribute to each residue’s average calculation. 
Amino Acid ID: M L R P V E T P T R E I K
Start End sequence #: 21 22 23 24 25 26 27 28 29 30 31 32 33
21 31 ND ND 0.030 ND 0.030 0.030 0.030 ND 0.030 0.030 0.030
21 38 ND ND 0.017 ND 0.017 0.017 0.017 ND 0.017 0.017 0.017 0.017 0.017
21 39 ND ND 0.019 ND 0.019 0.019 0.019 ND 0.019 0.019 0.019 0.019 0.019
21 40 NDD ND ND 0.018 ND 0.018 0.018 0.018 ND 0.018 0.018 0.018 0.018 0.018
21 41 ND ND 0.016 ND 0.016 0.016 0.016 ND 0.016 0.016 0.016 0.016 0.016
23 40 ND ND 0.000 0.000 0.000 ND 0.000 0.000 0.000 0.000 0.000
21 43 ND ND 0.011 ND 0.011 0.011 0.011 ND 0.011 0.011 0.011 0.011 0.011
32 40 ND ND
Average NDD #N/A #N/A 0.019 #N/A 0.016 0.016 0.016 #N/A 0.016 0.016 0.016 0.014 0.014
Peptide
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Figure 5.1. Deuterium uptake curves for four selected peptides of β-glucuronidase.  Each y-axis 
is scaled to the maximum number of exchangeable amide hydrogens. 
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Figure 5.2. Mass increase over time is illustrated by two mock deuterium uptake curves.  If 
ΔΔm is measured at more late or early time points (as indicated by the blue boxes) and all time 
point ΔΔm values contribute equivalent weight to an average, then those time points where 
ΔΔm is small or near-zero will skew the average to a small value. 
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Figure 5.3. The deuterium uptake effects of mutation on wild-type β-glucuronidase (red) and of 
indole on mutated β-glucuronidase (blue) are presented simultaneously. The magnitude of 
deuteration difference is measured as the sum of the differences between deuterium curves at 
every time point, ΣΔΔm.  Peptides are ordered by their sequence midpoint location in reference 
to the sequence of the whole protein. 
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Figure 5.4. A set of mock peptides was used to illustrate a peptide data map. (A) Peptides are 
mapped along the sequence by their identities. (B) Peptide exchange information is translated 
to a plot that lists peptides in order of their “quasi-sequence”.25  Regions with no peptide 
coverage are not represented this plot. The red points overlaid onto (B) are mock exchange 
values. 
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Figure 5.5. A) The effects of indole on wild-type β-glucuronidase (green) deuterium uptake.    
B) The simultaneous representation of mutation effects on wild-type β-glucuronidase (red) and 
indole effects on mutated β-glucuronidase (blue) on deuterium uptake.  The magnitude of 
deuteration difference is measured as the normalized average difference between deuterium 
curves at each time point, NDD, in both plots. 
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Figure 5.6. An image of β-glucuronidase protein with mapped mutation effects ±indole.  The 
color scale transitions from negative NDD values in magenta, to zero NDD values in white, to 
positive NDD values in green.  Residue 492 is highlighted, using atomic spheres, as a red 
tryptophan in these models. Residues with no peptide coverage and prolines are colored in 
yellow. A) The W492G mutation decreases protection from H/D exchange across much of the 
protein, relative to wild-type protein. The effects appear more localized around the mutation site. 
The color intensity scale covers an NDD range between −0.30 and +0.30.  B) The addition of 
indole causes a recovery of protection, which is, again, more pronounced in helices in close 
proximity to the mutation site.  The color intensity scale covers an NDD range between −0.15 
and +0.15.  This is a PyMOL generated model of β-glucuronidase protein, PDB: 3K4D.29  The 
crystal structure used was the asymmetric unit structure. 
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Figure 5.7. A normalized deuterium uptake plot representing protection from exchange on a 
residue by residue basis.  Gaps in the data are not illustrated and the connecting line simply 
connects the points around them. 
  
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
1 41 81 12
1
16
1
20
1
24
1
28
1
32
1
36
1
40
1
44
1
48
1
52
1
56
1
60
1
N
or
m
al
iz
ed
 D
eu
te
riu
m
 U
pt
ak
e
Residue #
WT uptake WT+indole uptake Mutant uptake Mutant+indole uptake
170 
 
Figure 5.8. An image of β-glucuronidase protein with mapped NDU values for the wild-type 
protein control sample (no indole). The color scale transitions from 0.0 values in white to 0.8 
values in strong red.  Residue 492 is highlighted, using atomic spheres, as a blue tryptophan in 
this model.  Residues with no peptide coverage and prolines are colored in yellow. This is a 
PyMOL generated model of β-glucuronidase protein, PDB: 3K4D.29 The crystal structure used 
was the asymmetric unit structure. 
 
